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ABSTRACT 
 
Commercial air travel is amongst the safest forms of transportation yet the 
environment within the aircraft cabin to which the passenger is exposed may have 
adverse physiological and psychological effects on passengers, especially for those with 
pre-existing medical issues.  A comprehensive, systematic review and analysis of current 
literature was performed to develop evidenced-based guidelines for evaluation of 
passenger fitness to fly for integration into primary care practice.   Recommendations 
from the most current fitness to fly guidelines and disease-specific published research 
related to in-flight medical issues were evaluated and the Grades of Recommendation 
Assessment, Development and Evaluation (GRADE) method was utilized to assess the 
quality of available evidence and the strength of guideline recommendations.   
The clinical practice guideline provides an overview of the major health systems 
affected by air travel and conditions that warrant healthcare provider review for clearance 
to fly.  The need exists for randomized trials and large group research to further identify 
and evaluate health conditions that are impacted or affected by commercial air travel.  
True incidence of health related issues and further guidance for research would benefit 
from the establishment of a universal health related incidence reporting method or 
repository to collect data of in-flight health events.  The guidelines developed as a result 
of this capstone report will change practice and contribute to the development of 
evidence-based guidance to primary care providers and clinicians who are required to 
provide fitness to fly clearance exams for commercial airline passengers.   
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CHAPTER 1 
 
Introduction 
 
 Commercial passenger air travel has increased exponentially over recent years as 
a result of economic growth, increased affordability of air travel as a mode of 
transportation and appreciably larger long-range aircraft.  Every day over 1.7 million 
passengers travel by air within the U.S. and annually approximately 2 billion people 
travel in commercial aircraft (Kim & Lee, 2007; Silverman & Gendreau, 2009).  Current 
research of population and travel demographics estimate that the number of passengers 
traveling by commercial aircraft will double in the next 20 years (Patel & Simon, 2010).  
Increased globalization and improved medical care combined with an rapidly expanding 
number of aging and overweight population pose risks to air travelers who may not have 
previously considered air as a mode of travel (Budd et al., 2011; Valani, Cornacchia, & 
Kube, 2010).    
 By 2030, current estimates predict that at least half of all airline passengers will 
be over the age of 50 years (Sand, Bechara, Sand, & Mann, 2009).   The mean age of 
passengers who suffer from in-flight medical events is 44 years for men and 49 years for 
women.  Passengers older than 70 years have the highest rate of in-flight health related 
events (Silverman & Gendreau, 2009). The increasing number of elderly and more 
infirmed airline passengers in conjunction with the improved commercial airline ability 
to accommodate disabilities escalates the potential risk for more in-flight medical events 
(Valani et al., 2010). 
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Although air travel is amongst the safest forms of transportation, the environment 
within the aircraft cabin to which the passenger is exposed may have adverse 
physiological and psychological effects on passengers, especially for those passengers 
with pre-existing medical issues.  Air travel, especially over long distances, exposes 
passengers to multiplicity risk factors that can result in adverse effects on at-risk 
passenger’s general health and welfare (Budd, Warren, & Bell, 2011).  Passengers with 
pre-existing health conditions are at greater risk and should consult their primary care 
provider, specialist, or a travel medicine clinic before embarking on commercial airplanes 
(Silverman & Gendreau, 2009; Patel & Simon, 2010).   
Commercial aircraft passenger’s failure to disclose pertinent health information as 
well as failure of primary care providers to understand the risk of air travel and provide 
preventive health education to their patients can result increased incidence of preventable 
in-flight medical emergencies.  A study by Burnett (2006) found that greater than 95% of 
persons with preexisting health conditions who travel by air stated that they would like to 
receive more medical advice from their healthcare provider.  Routine medical histories 
and screening procedures rarely, if ever, involve questions related to travel or mode of 
travel (Price et al., 2011).  Primary care providers concerned for passengers with pre-
existing health problems need to be educated on the effect of air travel on these pre-
existing health conditions to incorporate pre-travel precautions in their preventive health 
education in order to minimize risks to their patients (Silverman & Gendreau, 2009). 
The ubiquity of commercial air travel as a dominant mode of transportation and 
ignorance of the potential health threats imposed upon passengers by the aircraft cabin 
environment can lead to emergency health issues and disrupted flight plans.   Aviation 
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medicine has long been the domain of the military and aircraft industry.  The majority of 
aviation research on the effects of flight physiology and fitness to fly focused on the pilot 
and crewmembers who are routinely subject to health screening for employment and by 
virtue of the health-related occupational requirements are in better health than the average 
traveling passenger.  Travel by air may not only exacerbate pre-existing medical 
conditions but may result in new onset of medical conditions that occur as a result of 
altitude and the cabin environment.  Medical emergencies can occur in-flight if traveling 
passengers do not disclose pertinent health information or their healthcare providers do 
not understand the potential health threats imposed on a passenger by the commercial 
passenger cabin environment and air travel (Valani et al., 2010; Archard & Nicholson, 
2007).  Aviation medicine is not typically addressed in primary care provider education 
and there is a general lack of awareness of the health effects of flying amongst primary 
care providers (Wise, 2008).   
Ultimately the commercial air carrier is responsible for making the determination 
whether or not a passenger is capable to fly on their airline (Patel & Simon, 2010).  Most 
airlines do not have medical personnel on staff to perform this function and there is no 
lone universally established clearance process or screening methodology utilized by the 
airlines for their passengers.  The air carrier possesses the right to request that a passenger 
obtain a fitness to fly certificate or other documentation related to the passenger’s health 
condition and their needs associated with air travel if the airline has reason to believe that 
a passenger’s health may be at risk during flight or may impact the flight plans.  In 
instances where pre-authorization fitness to fly is requested, the airline will rely on the 
documentation provided by the passenger’s health care provider to make their decision 
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related to risks associated with travel by air (Patel & Simon, 2010).   Regardless of 
whether or not a travelling passenger requests documentation from their primary care 
provider for fitness to fly, it is a responsibility of the primary care provider to include 
travel related preventive health counseling to patients, especially for those patients with 
pre-existing health conditions that can be adversely affected by air travel. 
At present there are neither universal reporting methods nor a central registry for 
health related air travel incidents (Rushkin, 2009). Each airline tracks its own diversions 
and medical events and has its own method of classifying the cause of the event.  As a 
result, accurate epidemiologic data related to the incidence and severity of air travel 
related medical emergencies does not exist (Sand et al., 2009).  Flight diversions due to 
medical emergencies cause significant financial and legal costs to airlines and can place a 
passenger at risk for suboptimal care due to the lack of appropriate emergency 
medications, equipment and skilled personnel onboard at the time of the incident as well 
as at the end destination (Valani et al., 2010).   
It has estimated that the frequency of in-flight medical incidents ranges from 1 per 
10,000 to 1 per 40,000 passengers with approximately 1 in 150,000 of these incidents 
resulting in the use of in-flight medical equipment or medications (Gallagher, Marienau, 
Illig, & Kozarsky, 2012).  Flight crew receive minimal training related to the use of 
medical equipment and medication and rely on available healthcare personnel flying as 
passengers or, when available, on air-to-ground medical advice services.  Vasovagal 
syncope, gastrointestinal events, respiratory events, cardiac events and neurologic events 
are the most commonly encountered in-flight medical events (Gallagher et al., 2012).  
Although fourth most common in incidence, cardiac events account for approximately 
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two-thirds of the estimated 0.3 per 1 million passenger deaths aboard commercial flights 
(Gallagher et al., 2012).   
There is no standard regulation and considerable variability exists amongst the 
contents of the onboard emergency medical kit (Rushkin, 2009).   Airline policies 
regarding the contents of medical equipment, crew training and treatment of passengers 
are at the discretion of each airline’s host country and vary by airline (ASMA, 2003).  
Typically cabin crew are trained in first aid,  resuscitation procedures and how to 
recognize medical conditions that may cause an emergency as well as how to 
appropriately act upon and manage such emergencies in flight (World Health 
Organization (WHO, 2005).    Regulations related to the presence of a medical kit 
onboard of a commercial aircraft outside of the U.S. vary and may be limited, especially 
on economy airlines (Rushkin, 2009).   
Appendix A provides the most recent recommendations for the contents of the 
emergency medical kit by the Aerospace Medical Association (IATA, 2011).    Most 
commercial airlines operating today also carry automated external defibrillator and many 
use on-ground telemedical assistance to provide medical advice and support for 
passengers suffering from in-flight medical issues (Silverman & Gendreau, 2009).  In the 
United States, the Federal Aviation Administration (FAA) requires U.S. airlines carrying 
30 or more passengers to have medical kits onboard but does not regulate the contents of 
the kits carried.  
Flight diversions and incidences of in-flight medical events could be reduced 
through pre-travel medical evaluation and screening.  The Aerospace Medical 
Association found that 62% of in-flight medical emergencies were associated with pre-
 6 
 
existing passenger medical conditions (Valani et al., 2010).  Unfortunately, while the 
number of passengers seeking medical clearance is increasing, so is the rate of diversions 
per million revenue-passenger miles flown.  Valani et al. (2010), posit that this may 
indicate that more passengers are flying with more severe medical conditions and support 
further research correlating pre-screening with passenger-related diversion.    
 Primary care health providers are confronted today with a limited amount of time 
to assess and manage patients and regulations related to reimbursement associated with 
the practice of evidenced based medicine.  Many of the chronic health conditions which 
place commercial airline passengers at risk are managed by primary care providers who 
can be called upon by an airline to make a determination of whether or not a passenger is 
safe to travel.  Health risks associated with air travel can be minimized if the passenger 
receives pre-travel preventive health education as well as advice for planning for travel-
related disruption or emergencies that may adversely affect the passenger’s health 
(Silverman & Gendreau, 2009).  An evidenced-based resource for primary care providers 
to utilize in assessing the physiologic and environmental stressors associated with 
commercial air travel and making the determination for a passenger’s fitness to fly is 
needed and could be used by primary care providers to guide both screening and 
healthcare decision-making. 
Fitness to Fly 
 Fitness to fly is the clearance by medical personnel which authorizes a passenger 
to travel and identifies any specific air travel-related needs in order to minimize the 
passenger’s health risks.  The IATA (2011) recommends that airlines request medical 
certificates for clearance to fly from a passenger’s personal healthcare provider.  Health 
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care professionals who are not familiar with the environmental and physiologic 
challenges of air travel may unknowingly place themselves and their patients at risk by 
completing requested fitness to fly medical clearances.   
 The IATA (2011) identifies the following instances when medical clearance is 
required prior to air travel if the passenger: 
a. suffers from any active contagious or communicable disease (Appendix B) 
b. may be at risk or cause discomfort to other passengers because of a physical 
or behavioral condition: 
c. may pose a potential safety hazard or affect the punctuality of a flight 
including the possibility of flight diversion or an unscheduled landing; 
d. requires special assistance and is incapable of caring for themselves: 
e. has an underlying medical condition that may be adversely affected by air 
travel or the aircraft environment. 
Passengers who do not meet any of the medical clearance criteria noted above do not 
routinely require medical clearance but those with pre-existing medical conditions may 
still be at risk and routine screening and preventive guidance should be included in 
primary care practice.  The recommendations provided by the IATA are developed by a 
working group of twelve aviation medical experts and the publication notes that there is 
“very limited amount of research data on this material and most of the guidelines are 
based on practical experience (IATA, 2011, p. 52).”   Airline personnel have the right to 
request a medical clearance for passengers who pose a concern to passenger or aircraft 
safety because of observed behaviors or symptoms of illness that occur prior to, during, 
or after air travel.  Each airline has the right to design its own procedure related to 
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documentation and wording requirements for medical clearance to fly and airlines may 
deny boarding to passengers who appear to have communicable diseases or health 
problems (IATA, 2011; WHO, n.d.).    
The British Medical Association (2004) suggested the following considerations 
that should be taken into account when assessing a patient's fitness to fly: 
 The effect of mild hypoxia and decreased cabin air pressure. 
 The effect of decreased range of motion and/or immobility 
 The ability in the event of an emergency landing to perform the bracing 
position. 
 The timing of prescribed medications for long distance travel. 
 The psychological and physiological effects and the patient's ability to 
cope with travel to and through the airport including embarkation and 
disembarkation. 
 The potential for a patient's medical condition to adversely affect aircraft 
operation and/or the comfort or safety of other passengers. 
 Travel health insurance, or financial resources, of the patient to deal with 
potential healthcare costs in case of problems that develop from travel. 
Effective travel health consultation relies not only on an understanding of the 
physiologic and psychological effects of flight on health conditions but also on 
appropriate risk assessment and risk management (Simons & Wong, 2011).  Risk 
assessment should include traveler specific risks as well as travel itinerary, medical 
facilities and resources at the planned destination and planned travel-related activities that 
may pose specific risks.  Identification of potential travel-related hazards and the relative 
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risk that they pose on an individual's health and able the healthcare provider and traveler 
to plan appropriately for preventive measures as well as to develop a plan for travel 
related emergencies and post travel evaluation.  
The patient's primary care provider is often called upon to provide a passenger 
clearance to fly and in order to do so needs to have a thorough understanding of the 
physiologic effects of air travel on a patient's health and well-being.  The most 
appropriate time to address fitness to fly for passengers is well in advance of travel.  As 
part of a preventive education plan, the healthcare provider can review with the patient 
concerns related to the effects of travel on their medical condition, timing of medication, 
immunizations and hygiene measures to reduce exposure to infectious disease and 
contagions and the need for any additional special assistance or devices in order to 
promote safe travel.  Cardiovascular disease, deep venous thrombosis, respiratory 
disease, surgical conditions, neurologic disorders, mental illness, pregnancy and chronic 
medical issues such as diabetes should trigger a discussion of pre-travel preventive 
medical education between a healthcare provider and their patient.  Healthcare providers 
who have questions or concerns related to their patient’s fitness to fly should contact the 
passenger’s airline medical department or consider referral of the patient to a travel 
medicine specialist for fitness to fly medical certification. 
Purpose of the Study 
This capstone project set out to develop clinical practice guidelines (CPG) for 
primary care providers to utilize in establishing commercial passenger fitness to fly.  The 
specific aims of the capstone project were 
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1) to identify the physiologic and environmental hazards associated with 
air travel that place a commercial airline passenger at risk,  
2) to review current guidelines on common health issues associated with 
commercial air travel, 
3)  to analyze and synthesize current research findings in the identified 
health areas 
4) to compile all data from the specific aims in an evidenced-based clinical 
practice guideline for dissemination via publication and use by primary 
care providers in determining passenger fitness to fly.     
Policy Implications 
 
The development of a CPG will change practice and provide evidence-based 
guidance to primary care providers and clinicians who are required to provide fitness to 
fly clearance exams for commercial airline passengers.  Publication by a peer-reviewed 
professional nurse practitioner journal will provide an avenue for dissemination of the 
CPG amongst the primary care provider community and support future CPG 
development by nurse practitioners.   
  
 11 
 
CHAPTER 2 
Review of Literature 
 The aircraft cabin environment places several different environmental and 
physiologic challenges upon passengers that do not routinely occur in other modes of 
public transportation.  During normal operation scientific evidence has not shown that the 
standard aircraft cabin environment poses any risks to healthy passengers (IATA, 2011).   
However, the unique aspects of the aircraft cabin environment may pose problems for 
passengers who may be traveling in less than optimum health or for those who may have 
underlying health conditions that can be affected by the physiologic challenges associated 
with commercial flight.  More passengers are traveling, including more elderly persons 
and patients with pre-existing medical issues that are at-risk for the adverse effects that 
the aircraft travel conditions may present.   An understanding of the aircraft cabin 
environment under normal operating circumstances is essential for healthcare providers 
who are making decisions related to a potential passenger’s fitness to fly. 
Hypobaric Hypoxia 
Modern commercial aircraft are pressurized to maintain a fairly constant air 
pressure. The primary difference between travel by air and by ground transportation is the 
difference in pressurization which is not equivalent to ground level barometric pressure 
(IATA, 2011).  Boyle’s law states that with altitude, the volume of a gas expands and so 
has a lower pressure.  As the aircraft ascends, cabin pressure decreases and resulting in 
gas volume expansions up to 30% (Patel & Simon, 2010).  While most commercial 
aircraft cruise at an altitude between 35,000 and 40,000 feet, cabin air pressure varies 
between the external environmental pressure at the altitude of the airport when the plane 
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is not in flight up to what is the airline industry accepted maximum air pressure equal to 
8,000 feet altitude. 
Aircraft are pressurized by bleeding air from the engines.  The pressurization 
system draws air from different stages of the engines (which act as compressors) before it 
enters the combustion chamber and redirects it to the internal aircraft environment 
(IATA, 2011).  The assistance of an outflow valve allows the pressure to be raised and 
maintained to a predetermined desirable level.  The maximum desired pressurization 
level of 8000 feet was selected based upon studies demonstrating that at that level the 
average healthy aircraft passenger hemoglobin oxygen saturation normally remains above 
ninety percent.  The 8,000 foot level is not an international aviation requirement but 
rather an industry-related practice that is meant to provide a concession between an 
acceptable level of mild hypoxia, a comfortable environment for traveling passengers, 
acceptable pressurization upon the aircraft, minimal structural weight penalty and 
economical fuel usage (Aerospace Medical Association, 2008).   The recommendation 
was put in place decades ago before the changing demographics of traveling passengers 
and questions exist as to whether or not the recommended maximum equivalent pressure 
is still valid in today’s environment where passengers may be older and suffering from 
acute or chronic health conditions (IATA, 2011).   
 In the United States, Federal Aviation Regulations require that an aircraft be 
capable of maintaining no greater than 8,000-ft cabin altitude at the maximum operating 
altitude but there is variability in aircraft cabin pressure with altitude and one in-flight 
study demonstrated cabin altitudes as high as 8915 feet (Aerospace Medical Association, 
2008).  Cabin air pressure is not maintained at a constant level during long-haul 
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commercial flight and decreases as aircraft cruise at higher altitudes in the latter part of 
longer flight sectors (Kelly, Seccombe, Rogers, & Peters, 2007).  Fitness to fly 
evaluations related to concerns for hypobaric hypoxia and related complications can be 
confounded by studies that have demonstrated cabin pressure simulation tests expose 
subjects to more hypoxic conditions than will be experienced during flight on a Boeing 
747 (Kelly et al., 2007).  Despite the possibility that cabin simulation studies may pose 
the potential for more hypoxia than a passenger may encounter in a true flight 
environment, it would be prudent to evaluate a potential passenger at risk during hypoxia 
at a lower standard to account for the variability in cabin environment, potential inability 
of an airline to support supplemental in-flight oxygen and the passenger’s inability to 
control for altitude during flight.  Passengers at risk for hypoxia at other high altitude 
environments will likely suffer from hypoxia in a cabin environment that is pressurized to 
8,000 feet. 
Aircraft flying at higher altitudes are more fuel-efficient and avoid turbulence for 
passengers comfort and for that reason it is estimated that many aircraft do exceed the 
8,000 feet pressurization limit at some time during a flight pattern.  Prediction of cabin 
altitude for any flight is difficult because the actual cabin altitude experienced is 
dependent upon variables such as aircraft model, weather patterns, and air traffic control 
(Kelly et al., 2009).  At cruising altitude there is a significant reduction of barometric 
pressure compared to the barometric metric pressure found at sea level which results in a 
concomitant decrease in the partial pressure of alveolar oxygen (PaO2) resulting in 
passenger hypoxemia (Patel & Simon, 2010; Aerospace Medical Association, 2008).  
PaO2 levels typically decrease from 103 mmHg at sea level to around 70 mm Hg while in 
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flight.  The end result is a drop in oxygen saturation levels by 3% when travelling at 
3,000 feet and at the highest cabin altitude of 8000 feet equates to an oxygen saturation of 
85 to 9% (Patel & Simon, 2010; Johnston, 2009).   
Dozing passengers have been found to have oxygen saturation levels around 80% 
(Hinninghofen & Enck, 2006).  The normal maximum cabin pressure is 750 hPa which is 
approximately equal to the pressure when breathing 15% oxygen at a typical sea level 
pressure of 1016 hPa (Kelly, Seccombe, Rogers, & Peters, 2007).  Most healthy 
passengers experience an average pulse oximetry of 92% in-flight and can compensate 
for the decreased oxygen saturation (Kelly et al., 2007).   The resultant decrease in 
oxygen saturation can exacerbate pre-existing conditions for some passengers bringing 
them to the steep part of the oxyhemoglobin dissociation curve resulting in very low 
oxygen saturation and may pose a health risk to coronary, pulmonary, cerebrovascular, 
ocular or hemodynamically challenged passengers as well as others suffering from acute 
medical issues (IATA, 2011; Bayer, Mutlu, Akay, & Bayraktar, 2008; ASMA, 2003).    
In the United States there is no requirement for all passengers to be provided with 
supplemental oxygen until the internal cabin pressure altitude exceeds 15,000 feet 
(Aerospace Medical Association, 2008).  Passengers over the age of 40 experience a 
steady decrease in oxygen saturation that is estimated at a decrease of 5 mmHg per 10 
years.  Elderly passengers as a result of decline in respiratory condition associated with 
aging, have even lower daily oxygen saturation levels.  When elderly passengers combine 
lower daily oxygen saturation levels with a decrease due to increased altitudes and cabin 
air pressure they may experience hypobaric hypoxia.  Hypoxia can have multiple effects 
on the circulatory system including: local vasodilatation of coronary and cerebral 
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vascular beds, increased heart rate, increased systemic blood pressure, increased 
myocardial contractility, increase in cardiac output and an increase in pulmonary artery 
pressure (Smith et al., 2010).  The issue of hypobaric hypoxia can be further compounded 
in passengers who consume alcohol due to the resultant increased hypoxic effect of 
alcohol on the brain (Girasek & Olsen, 2009). 
Hyperbaric Chamber (HC) exposure to flight simulated hypoxia and hypoxia-
altitude simulation test (HAST) are amongst the standard tests utilized to replicate the 
hypoxia of air travel at 8,000 feet, these tests may not be readily available and may be 
cost-prohibitive for pre-flight evaluation of commercial air passengers (Figure 6).   
A recent randomized cross-over study of oxygen titration during a HAST and in a HC 
was performed in which the data suggested that titration of supplemental oxygen via a 
nasal cannula during a HAST may provide falsely high PaO2 values as a result of oxygen 
accumulation in the facemask and therefore the HAST results may not be utilized with 
confidence due to individual variability (Akero et al., 2011).  Additional concerns 
resulting from the Akero et al. study (2011) include the results of their evaluation of 
various type of oxygen equipment in the HC and their findings that the use of a portable 
oxygen concentrator (POC) resulted in lower PaO2 values.  The POC at a pulse setting of  
two gave a PaO2 ≥ 5.7kPa (50mm Hg) and was needed to reach an SpO2 ≥ 90% in most 
of the patients evaluated.   Physical activity, including walking, in flight resulted in a 
drop of SpO2 requiring even higher doses of supplemental oxygen.  Akero et al. (2011) 
recommend that based upon the findings of their study patients traveling with POC 
should increase their oxygen flow compared with supplemental oxygen given with 
compressed gaseous oxygen systems.    
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Pulse oximetry can be utilized pre-flight and in-flight to monitor and titrate 
oxygen levels.  A small study (n=14) of oxygenation response to air travel in subjects 
without obstructive lung disease and not receiving supplemental oxygenation 
demonstrated that air travel resulted in desaturation including further declines associated 
with walking during the flight (Kelly et al., 2009).  Although in the Kelly et al. (2009) 
study there was significant desaturation in subjects, reported symptoms of respiratory 
distress were minimal leading to even further concerns of a flying patient with a 
compromised pre-travel oxygen status to be able to effectively evaluate their symptoms 
during flight.  The Kelly et al. (2009) study found that baseline SpO2 was a better 
predictor of in-flight desaturation than HCT.   Ultimately it is imperative that clinicians 
understand the individual characteristics of the patient’s oxygen control, need for 
supplemental oxygen in daily life, and the pre-flight health condition of the patient, flight 
duration, and altitude in order to make a determination of whether or not supplemental 
oxygen may be needed.   
Passengers with chronic obstructive pulmonary disease (COPD) have a limited 
capability of increasing minute ventilation in response to hypoxia and the presence of an 
alteration in the perfusion/ventilation ratio can make it hard to compensate during air 
travel (Tzani, Pisi, Aiello, Olivieri, & Chetta, 2010).  Passengers with hemoglobin levels 
less than 7.5 g/dl or in sickle cell crisis have an increased need for supplemental oxygen 
and may experience problems associated with decreased PaO2 levels (Aerospace Medical 
Association, Aviation Safety Committee, Civil Aviation Subcommittee, 2008).   
The decrease in cabin air pressure as the aircraft climbs in altitude causes gas to  
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expand increasing in volume by nearly 30% which can create problems when gasses 
become trapped in the body (WHO, 2011; Aerospace Medical Association, Aviation 
Safety Committee, Civil Aviation Subcommittee, 2008).  At 8,000 feet above sea level, 
the volume of a gas increases by a factor of 1.4.  The main areas affected by gas 
expansion in passengers are the middle ear, the sinuses, the stomach, pleural cavities, the 
skull and the bowels (IATA, 2011; Hinninghofen & Enck, 2006).  Aircraft descent causes 
a reduction in the trapped air which creates a vacuum in closed spaces such as the ear and 
sinuses.  Trapped gas leads to passenger discomfort and the potential for medical 
complications in passengers with pneumothorax, recent thoracic, abdominal or ocular 
surgery.  Gas expansion when trapped in the ears can cause minor to severe discomfort 
and possible perforation especially in infants and young children (Bagshaw, 2007).  
Divers and other passengers who have been exposed to hypobaric conditions prior to 
flight should wait at least 12 hours from their last dive or hypobaric incident, or 24 hours 
from multiple dives before flying to prevent decompression illness (WHO, 2011). 
Medical devices such as pneumatic splints, feeding tubes, urinary catheters and 
cuffed endotracheal or tracheostomy tubes are affected by gas expansion and the 
instillation of water rather than air can eliminate air-travel related adverse events 
(Silverman & Gendreau, 2009).  Gas expansion also may cause a multitude of problems 
for post-operative patients especially if gas has been introduced as a result of recent 
surgery such as abdominal or ophthalmologic procedures.  Passengers who are in the 
post-operative phase after a major or minor surgical procedure have a need for increased 
oxygen due to surgical trauma, rising adrenergic outflow, and possible sepsis (Aerospace 
Medical Association, Aviation Safety Committee, Civil Aviation Subcommittee, 2008).  
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It is not contraindicated for pregnant women less than 36 weeks gestation, to fly on 
commercial airlines however, the expansion of gas in the abdomen may cause some 
discomfort (Bagshaw, 2007).   Women over 28 weeks gestation may need additional 
documentation from their OB/GYN prior to travel (Archard & Nicholson, 2007). 
Aircraft Ventilation 
Ventilation of the pressurized cabin is required to provide for passenger comfort 
as well as to reduce air contaminants.  Aircraft cabins are supported by two types of 
ventilation systems, one which provides 100% fresh air continuously.  Air that is brought 
in from the engines is passed through air conditioning units to cool the air before it enters 
the aircraft cabin.  The cooled air is passed through the outflow valve and is replaced by 
fresh air coming from the outside as well as the air conditioning system (IATA, 2011).  A 
second ventilation system provides a combination of fresh air and recirculated cabin air.  
Recirculated cabin air is passed through a High Efficiency Particulate (HEPA) filter 
which traps particulates but have no effect on gases. HEPA filters vary in their level of 
efficiency and there are no federal or international regulations that require a minimum 
level of efficiency in aircraft cabins (IATA, 2011).  The ration of fresh air to recirculated 
air in commercial planes is typically 50:50 with the entire cabin air being exchanged 
approximately every 3-4 minutes (IATA, 2011).  While passenger concerns may exist 
related to the recirculation of air on planes, the aircraft ventilation systems are similar to 
those found in commercial buildings. 
One primary difference that exists between commercial building and aircraft 
space is the density of population per area.  Recently the transmission of disease by 
biologic contaminants has gained media attention due to concerns related to cases 
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involving tuberculosis and influenza transmission.  The HEPA filters when installed as 
part of the ventilation system are a means of trapping dust, bacteria, fungi and viruses 
which may circulate within the cabin environment (Figure 9).  No research to date has 
supported a significant risk of disease transmission when the aircraft ventilation systems 
are functioning adequately (IATA, 2011).  While the proximity of passengers to a 
potentially contagious person can increase transmission, the ventilation system within an 
aircraft has not been shown to be a factor in disease transmission. The risk of 
transmission of disease is greatest when the aircraft is on the ground and an auxiliary 
power unit provides ventilation.  Auxiliary ventilation is utilized before the main engines 
are started, but may not always be operated due to environmental noise or technical 
reasons (WHO, n.d.).   Transmission of infection may occur between passengers who are 
seated in the same area through direct contact with other passengers, aircraft cabin parts, 
furnishings or through respiratory droplet spread during coughing or sneezing. The risk 
associated with disease transmission in these circumstances is not different than the risk 
posed in any other public situation where individuals are in close contact. (WHO, n.d.).   
Most commercial aircraft have a laminar air flow system which moves the air 
from top to bottom and not from front to back or back to front.  In cases of suspect 
disease transmission the laminar airflow system limits risk of transmission to only those 
passengers within the immediate vicinity of a contagious passenger and not to all 
passengers travelling on the plane (WHO, n.d.). 
Relative Humidity 
Studies have shown that air travel does not result in a change in osmolality 
therefore cannot be linked to travel dehydration (Johnston, 2009).  However, inside an 
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aircraft cabin the humidity levels are fairly low, around 10-20%, compared to the 40 to 
50% found in a standard commercial building.   Flight distance exacerbates the problem 
of low relative humidity and at the end of a long distance flight the humidity can be as 
low as 2-3% (Hinninghofen & Enck, 2006).   Low cabin humidity results from air being 
drawn into the cabin from the outside air in which moisture is absent at high altitudes 
(Patel & Simon, 2010).  Aircraft traveling at an altitude of 35,000 feet draw in air that is 
atmospherically less dense, colder and drier than air conditions found at ground level 
(Budd, Bell, & Warren, 2011).   Superficial dehydration results from the decreased levels 
of humidity can cause dry, itchy or irritated eyes, nasal congestion and dried mucous 
membranes of the nose, throat and skin (IATA, 2011; Patel & Simon, 2010; Johnston, 
2008).  Flight related dehydration can be compounded by the diuretic effects of 
medications, alcohol and caffeine (Hinninghofen & Enck, 2006).  The effect of the low 
relative humidity and superficial dehydration, while temporarily uncomfortable to the 
passenger, does not pose any long term effects to passenger health or well-being (IATA, 
2011).   
Passenger Space and Comfort 
Long-haul aircraft today are capable of flying non-stop for 20 hours which makes 
passenger seat spacing and comfort important for both passenger health and well-being.  
Seat comfort includes seat pitch, seat width, leg room, upholstery quality and angle of 
recline (Silverman & Gendreau, 2009; Hinninghofen & Enck, 2006).  The minimum 
dimensions between aircraft cabin seats are regulated by the aircraft standards of the 
country of aircraft origin (Figure 10).   
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 The airline seat pitch is an indication of the available legroom and refers to the 
space between a point on one seat and the same point on the seat in front of it. Seat pitch 
is usually expressed in inches and ranges from 28 inches in low-cost carrier economy 
class to up to 100 inches in some long-haul carrier first class sections (Hinninghofen & 
Enck, 2006).  More seat pitch can mean more legroom, but it is also affected by the 
thickness of the seat back.  Airlines have claimed that a reduction of seat pitch can be 
compensated for by a thinner seat-back design.  Close seat pitch is associated restricted 
degree of seat tilt and the reduction in size correlates with poor passenger comfort 
(Brundrett, 2001).   
Seat width is measured by the distance from armrest to armrest and ranges 
averages between 16-18 inches in economy class to 21-36 inches in first class.  Narrow 
seat widths can impede normal circulation and combined with prolonged sitting can 
increase the risk of deep vein thrombosis and edema (Brundrett, 2001).  Cramped 
passenger seating affects not only passenger comfort but can also make it difficult for 
passengers to leave the seat for exercise and has been associated with disturbed 
respiration, restricted gastrointestinal mobility and blood circulation and may result in 
edema and ischemia of the lower extremities (Hinninghofen & Enck, 2006). 
Long-range air travel greater than 4 hours combined with decreased liquid 
consumption, increased inactivity and low humidity levels can place travelers at risk for 
traveler’s thrombosis.  Venous blood flow to the lower extremities is decreased by 2/3 
when people are in the sitting position.  Each hour people remain in the sitting position 
there is further reduced venous blood flow and increased hematocrit levels combined 
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with rises in plasma protein creating venous pooling “inducing hemoconcentration and 
depressed fibrinolytic activity contributing to hypercoagulability” put many passengers at 
risk for deep vein thrombosis (DVT) (Sandor, 2008; Brenner, 2006).   
Disrupted Circadian Rhythm 
The body’s natural cycle extends over a 24 hour period and is referred to as the 
circadian rhythm.  Jet lag is a result of the interruption or desynchronization of the 
circadian rhythm.  Jet lag is well tolerated by healthy individuals however with the loss or 
addition of time in the rhythm cycle there may be a need for an adjustment in some 
passenger medication dosages (Johnston, 2009; Aerospace Medical Association, Aviation 
Safety Committee, Civil Aviation Subcommittee, 2008).  East-west and west-east flights 
involving rapid transit through several time zones can upset the balance between extrinsic 
time and physiological time and result in indigestion, bowel disturbance, fatigue, malaise, 
daytime sedation, insomnia and reduced physical and mental performance and 
disorientation (WHO, 2011; Budd, Bell, & Warren, 2011).  Passengers travelling east 
bound lose time in their day and for those traveling west bound add time to their day.  
Typically westbound flights are more easily tolerated than eastbound flights. Other 
factors that may affect jetlagged include the number of time zones crossed, sleep 
deprivation, and environmental stimulation associated with the activities of the internal 
cabin (Patel & Simon, 2010).   
Insulin dependent diabetics may need to adjust regular or long-acting insulin 
dosages to account for the time change (Johnston, 2008; Bagshaw et al., 2002).  Jet lag 
combined with a time change can promote problems for passengers with cardiovascular 
disease as well.  Passengers often are confused as to when they should take their 
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medications at the new or previous time zone and alterations in daily routine often result 
in forgetting medications all together.  People travelling with stable heart failure, angina 
or arrhythmia it is very important that they maintain the regularity of their medication 
(Smith et al., 2010). 
Stress 
All passengers are subject to travel related stress regardless of the duration of 
their flight (ASMA, 2003).  In addition to the physiologic stress associated with pre-
existing health conditions, additional stressors that may occur as a result of traveling 
include walking long distances, carrying heavy baggage, and prolonged sitting in 
confined spaces.  Psychological stressors can impact a passengers health during travel 
and can manifest as new onset or exacerbations of existing psychiatric illnesses 
particularly in vulnerable individuals (Al-Zurba, Saab, & Musharrafieh, 2007; 
Hinninghofen & Enck, 2006).   For the average traveler potential psychological stressors 
include concern and anxiety related to preparation to travel, transportation to and from 
airport's, frustration associated with check-in and security procedures, and worry related 
to flight delay as well as fear of flying (Patel & Simon, 2010).  Business travelers have 
been shown to have high to very high levels of travel stress and cited social and 
emotional concerns such as isolation and the impact of travel on family as the greatest 
contributor to their stress level followed by health concerns (Burkholder, Joines, 
Cunningham-Hill, & Xu, 2010).   Cabin noise, vibration, turbulence, varying 
temperatures, and uncomfortable seating room can pose additional stressors in-flight 
(ASMA, 2003).   Alcohol, often consumed by anxious passengers pretravel and in-flight, 
can exacerbate psychological symptoms as well as pre-existing disorders. 
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Evidence Based Practice 
 
 In healthcare there are variations in practice making it both an art and a science.   
The Institute of Medicine (IOM) (2008) issued a report emphasizing the need for 
evidenced based practice (EBP) as a means of promoting quality care and improving 
practice outcomes.  Evidence-based practice requires clinicians to incorporate current 
scientific research with their clinical experience while balancing the individual 
characteristics and diverse needs of each patient (Turner, Misso, Harris, & Green, 2008).   
Inconsistent, absent, or inaccurate use of medical research can be a source of practice 
variation and ultimately lead to increased healthcare costs without improvement in 
outcomes (Shiffman et al., 2009).  Health care delivery and decision-making should be 
rooted in the use of evidenced-based current best practice with the ultimate goal of a 
standardized guideline development and implementation process which will result in 
improved clinical practice and outcomes (IOM, 2008; Harrison, Legare, Graham, & 
Fervers, 2010; Turner et al., 2008).    
Clinical Practice Guidelines 
 
Clinical practice guidelines are statements that contain recommendations designed 
to support clinical decision-making by healthcare professionals and patients in specific 
situations (IOM, 2008; Shiffman et al., 2009).  CPGs should be reflective of current 
scientific research and involve a systematic review and appraisal of the literature and 
available evidence (Poolman, Verheyen, Kerkhoffs, Bhandari, & Shunemann, 2009; 
Turner et al., 2008).   The goal of CPG development is to summarize the most current 
evidenced-based best practice (Shiffman et al., 2009). 
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CPGs are being developed by teams of experts at local, regional and national 
levels and may be subject to bias and development deficiencies depending upon the 
source of the guideline development, political or economic incentives for implementation 
and the priorities of the health care system in which they are being implemented 
(Bondmass, 2008; Clutter, 2009; Turner et al., 2008).  Shiffman et. al. (2009) identify 
problems in guideline quality, language, knowledge synthesis implementation, uptake 
and formulization that can impede the applicability of guidelines.  The IOM Report Brief 
(2008) notes that many current guidelines have been developed without the necessary 
scientific rigor and their reliability may be in question due to their lack of method 
transparency and failure to comprehensively and systematically assess all available 
clinical evidence.   
The Guideline Development Process 
 
The CPG development process includes a formal definition of a problem for 
study, review of the evidence, development of a consensus, formulation of the guideline, 
dissemination of the information with the goal of translation and implantation of the 
recommendations into clinical practice (Papadopoulos, 2003).  A comprehensive 
systematic review of the literature will provide information related to the problem being 
examined as well as current knowledge related to the effectiveness of healthcare 
interventions (IOM, 2008).  The development of a CPG involves not only the systematic 
review of the literature but the integration of the findings of the review into 
recommendations for care (IOM, 2008).  A panel of experts who have access to current 
evidence and an understanding of the clinical problem should be involved in the 
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development of the CPG as there may be inherent gaps in available research to support 
clinical recommendations (IOM, 2008).   
The process of CPG development should include the incorporation of two grading 
systems: one system to address the quality of available evidence and another to address 
the strength of study recommendation (IOM, 2008).  The quality of evidence grade 
represents the level of confidence that if the recommendations are followed appropriate 
outcomes will occur.  The grade given to the strength of the recommendation is a balance 
of the risk/benefit ratio associated with the recommended interventions and the expert 
panel’s interpretation of the importance associated with following guideline 
recommendations (IOM, 2008).   
An important determinant in the strength of the recommendation is the type of 
research evaluated in the CPG review.  Peer-reviewed, published controlled clinical trials 
are considered to provide the best information regarding the effectiveness of a therapeutic 
approach (Embree, 2000).  Peer-reviewed, published epidemiologic studies provide the 
next best level of evidence in support or against a therapy (Embree, 2000).  The lowest 
strength rating is assigned to published case report recommendations and opinions based 
upon personal clinical experience of the expert panel (Embree, 2000).    The IOM (2008) 
recommends that the CPG development process be scientifically rigorous, document 
standards utilized, and take efforts to protect from bias so that the final published 
guidelines are effective. 
GRADE Method 
 
 There are several systems available for evaluating and grading clinical evidence 
in the development of CPGs.  The Grades of Recommendation Assessment, Development 
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and Evaluation (GRADE) method was introduced in 2004 after the GRADE 
developmental working group compared six existing systems and found that they lacked 
consistency in agreement amongst the systems (Kavanagh, 2009).  GRADE has been 
accepted and adopted by national and international medical organizations, government 
and healthcare regulatory agencies (Kavanagh, 2009).   One advantage of the GRADE 
method in comparison to other grading modalities is that it allows for CPG reviewers to 
interpret, pass judgment and classify the quality of evidence classifying evidence as high, 
moderate, low and very low (Gugiu & Gugiu, 2010; Jaeschke et al., 2008).  The GRADE 
framework allows for definition of evidence quality based upon the guideline panel’s 
level of confidence related to the research validity and the benefit/risk ratio for 
implementation of a given recommendation (Ansari, Tsertsvadze, & Moher, 2009).   
 The factors that influence the strength of a recommendation in the GRADE 
framework include not only assessment of the quality of evidence but also the balance 
between risk/benefit effects, values, preferences and cost of recommendation 
implementation (Jaeschke et al., 2008).  Strengths of the GRADE system include 
transparency related to the judgments and opinions regarding the evidence and 
recommendations and the fact that while weight is provided to the study design it is not a 
singular factor in judging the evidence quality (Brozek et al., 2009).   Expert opinion, 
when applied in the GRADE system, is not a quality of evidence but serves as an 
interpretation of existing evidence.  The GRADE system of review recognizes the 
necessity of expert opinion for the translation and integration of clinical evidence into the 
final recommendation (Brozek et al., 2009).   The application of the GRADE system 
includes systematic literature review of all available diagnostic and management 
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approaches and the summary of evidence into tables that are succinct, transparent and 
informative related to the quality of the evidence, the effects of application on patient 
care outcomes, and the means for determining the evidence rating (Guyatt et al., 2011). 
Cardiovascular Disease 
 
 In-flight medical incidents related to cardiovascular disease are amongst the top 
five recorded incidents and account for two-thirds of all in-flight passenger mortalities.  
As previously discussed, the lack of an international aviation registry for passenger 
related medical incidents makes it difficult to statistically quantify the number of 
incidents that occur annually.  Classification of in-flight related events which may be 
cardiac related may also be recorded under different medical categories such as syncope 
or respiratory distress (Shurlock, 2011).  Recognizing the need for clear advice to guide 
general practitioners, a working group of the British Cardiovascular Society was 
established to develop guidelines for evaluation of fitness to fly in cardiovascular patients 
(Smith et al., 2010).    The guidelines presented by the group in 2010 were focused on 
conditions of the heart and great vessels alone and, in the absence of randomized 
controlled trials and clinical studies of passengers with existing cardiovascular disease 
the recommendations, were based on the physics and physiology of the aircraft cabin 
environment along with expert opinion of the Cardiologists serving on the working group 
(Shurlock, 2011).  
While most patients with cardiac conditions can travel safely by air, travel 
medicine experts suggest that the contraindications to commercial airline travel for 
patients with cardiovascular disease are included in along with GRADE evaluation of the 
quality and strength of supporting evidence presented.  Patients with cardiovascular 
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disease may be negatively affected by the decrease in oxygen saturation during flight 
which results in hypoxia that leads to increased heart rate and subsequent cardiac demand 
(ASMA, 2003).   As a result in-flight oxygen is indicated for patients with the following 
cardiovascular conditions:  
 require oxygen at their home baseline altitude  
 congestive heart failure class III-IV  
 baseline PaO2 less than 70 mm Hg 
 class III-IV  angina  
 cyanotic congenital heart disease  
 primary pulmonary hypertension  
 other cardiovascular disorders associated with baseline hypoxia. 
Passengers with pacemakers and implantable cardiac defibrillators are not 
restricted from flying once stable.  It is important to inform passengers with pacemakers 
and implantable defibrillators that they need to identify themselves in advance to the 
security screening personnel as they need to be screened by alternate devices other than 
the standard x-ray equipment. 
It is important for patients to understand that the airlines do not provide oxygen 
supply for their needs during flight and that it is the patient's responsibility to make 
arrangements in advance for portable oxygen that is approved for use in commercial 
airline travel as well as an adequate supply of oxygen tanks to meet their needs. 
Unanticipated delays related to weather, missed connections or aircraft equipment 
malfunction often results in extended travel time over that which is initially planned.  
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Therefore, patients should carry an excess supply of oxygen and rechargeable tanks for 
use in the event of delayed travel. 
 Available studies evaluating the effect of flight upon cardiopulmonary physiology 
principally evolve from studies of subjects living on land at high altitude or by studying 
the effects of normobaric hypoxia in a laboratory setting (Smith et al., 2010).  While 
some characteristics of these environments can simulate the effects of traveling by 
commercial aircraft the environments are not equivocal and therefore any application of 
such research would have to be considered to be speculative.   
  No direct studies of the effect of hypoxia during commercial air travel upon 
patients with cardiovascular ischemia were located and after applying the results of the 
evaluated studies to the physiology of ischemia the authors concluded that there would be 
little to no effect in precipitating ischemia on commercial airline passengers.   A 
retrospective analysis of 213 patients who were transported via commercial airlines after 
acute myocardial infarction controlled hypoxia with supplemental oxygen and therefore 
was unable to identify whether or not untreated hypoxic situations may have resulted in 
further cardiac ischemia or events (Thomas et al., 2006). 
The ability for patients with clinically stable pulmonary hypertension to tolerate 
air travel was evaluated in an anonymous survey (Thamm et al., 2011).  Patients with 
pulmonary hypertension were identified with inclusion criteria including a confirmed 
diagnosis of pulmonary arterial hypertension that were stable as identified as having no 
specific therapeutic changes three months prior to travel.  Patients with severe lung 
diseases, left ventricular diseases and other concurrent chronic diseases were excluded 
from the capstone project.  A total of 720 questionnaires were distributed with 430 
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returned (60% response rate).  Not all of the 430 respondents had flown since their 
diagnosis which resulted in only 179 diagnosed patients who had flown at least once 
since their diagnosis.  Of those flyers, 20 (11%) reported having had one or more adverse 
events during or directly after at least one of their flights.    Adverse events reported 
included dyspnea (3.4%), peripheral edema (3.4%), exhaustion (1.7%), heart palpitations 
(1.1%), chest pain (1.1%), headache (1.1%), worsening of general condition (1.1%) and 
fear of flying (0.6%).   
Thamm et al. (2011) acknowledge in their publication the potential for selection 
bias in their review.  An additional noted limitation was that the hemodynamic status of 
the respondents was not known prior to air travel and therefore the classification of 
disease severity into WHO classes was limited to patient self-report.  While the authors 
suggest that air travel can be safe and well-tolerated by patients with stable pulmonary 
hypertension, their final consensus was that physician evaluation is required prior to 
travel for every patient.  The Thamm et al. (2011) study size was small and the biases 
involved bring into question the generalizability of the statement of safety.   At present, 
there are no data from controlled trials examining the safety of air travel for patients with 
pulmonary hypertension (Thamm et al., 2011).     
Respiratory Disease 
 
Healthy passengers without underlying respiratory disease will experience a 
significant desaturation during commercial air travel as a result of hypobaric hypoxia but 
typically do not experience dyspnea (Kelly et al., 2008).  Due to the lack of a universal 
method for reporting air travel related illness and it’s cause there are no exact numbers of 
passengers with respiratory conditions that are affected by air travel.  What is known is 
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that respiratory symptoms are the third most frequent cause of flight diversion related to a 
medical issue (Ahmedzai et al., 2011).  In an effort to ease decision-making for fitness to 
fly in respiratory patients Tzani (2010) offered an algorithm to provide some direction for 
healthcare provides to evaluate respiratory patients and estimate the potential need for 
supplemental oxygen or further evaluation prior to air travel (Figure 11).   
The majority of in-flight oxygen requests and pre-flight oxygen clearances are for 
passengers with chronic respiratory diseases (Patel & Simon, 2010).  Overall 
recommendations for medical advice related to fitness to fly clearance should depend 
upon the type, reversibility and functional severity of the underlying respiratory condition 
and the healthcare provider’s assessment of the passenger’s ability to tolerate the 
commercial aircraft cabin environment and hypobaric hypoxia in flight (Patel & Simon, 
2010; UK Civil Aviation Authority, 2007).  Passengers who may be subject to worsening 
conditions associated with hypoxia in-flight can be cleared for travel with the assistance 
of an airline approved therapeutic oxygen device.   
 A cross-sectional study of 391 COPD passengers and 184 non-COPD passengers 
were evaluated for lung function, blood gas values, exercise capacity, air travel habits and 
in-flight symptoms to determine the prevalence of in-flight symptoms in patients with 
COPD (Edvardsen et al., 2011).  The Edvardsen et al. (2011) study was the first known 
flight outcome study comparing COPD patients with non-COPD subjects and the data 
from the study showed a 3-fold increase in hypoxia related symptoms and near 7-fold 
increase in dyspnea and air hunger amongst COPD patients compared to non-COPD 
patients.  No significant difference was noted in other air travel related symptoms such as 
ear pressure, sinus pressure or edema between the groups.  After adjustments were made 
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for smoking status, age and gender, the odds ratio for COPD passengers to experience 
dyspnea or air hunger was 6.6 (95% CI 2.5-17.3, p < 0.001) compared to non-COPD 
subjects.  Pre-flight scores on the Medical Research Council (MRC) Dyspnea scale were 
strongly associated with in-flight dyspnea (p < 0.001) and while the possibility of recall 
bias may have been a result of the design the strong association of the MRC Dyspnea 
score with the observed results offers an interesting avenue for further investigation of 
alternate means of evaluating respiratory patients pre-flight. 
 Several prior studies support Edvardsen et al. (2011) findings of increased 
incidence of dyspnea in patients with COPD.   The UK Flight Outcomes Study (Coker, 
Shiner, & Partridge, 2007) was a prospective multicenter observational study examining 
the outcomes of commercial air travel in patients with respiratory disease.  Of the patients 
evaluated, 243 (39%) had a diagnosis of COPD with disease severity ranging from mild 
(2%), moderate (29%), severe (43%) to very severe (26%).  During flight, 18% of the 
patients in the UK Flight Outcomes Study reported respiratory distress manifested as 
dyspnea.  Similarly, a retrospective study of 391 patients with COPD resulted in 25% 
reporting experienced hypoxia-related symptoms during air travel with increased 
symptom frequency in passengers with more severe baseline dyspnea (Dillard, Beninati, 
& Berg, 1991).   
The British Thoracic Society has recently issued new recommendations for 
managing air passengers with stable respiratory disease (Ahmedzai et al., 2011).    The 
decision by the British Thoracic Society (BTS) to revise the recommendations for 
passengers with respiratory disease traveling by air was based upon studies which 
confirmed that neither resting sea level oxygen saturations nor forced expiratory volume 
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in 1 second (FEV ) are reliable predictors of hypoxemia or complications associated with 
air travel in patients with respiratory disease.  Ahmedzai et al. (2011) determined that as a 
result of the failure to predict response that there is no reliable threshold that can 
accurately determine the safety of air travel or the need for in-flight oxygen in an 
individual traveler with respiratory disease.   
 The 2011 recommendations by the BTS included review of guidelines currently 
available from British, American, Canadian and European fitness to fly recommendations 
and acknowledged that there were not consistent, practical nor comprehensive coverage 
of recommendations for providers caring for patients with respiratory disease.  As was 
the case with their cardiology colleague’s recommendation for fitness to fly, Ahmedzai et 
al. (2011) developed consensus recommendations rather than clinical practice guidelines.  
The goals of the recommendations were to provide advice for respiratory specialists and 
other health care providers who are involved in determination of passenger fitness to fly. 
 Ahmedzai et al. (2011) provided a thorough guide for managing patients with 
stable respiratory disease planning air travel based upon the BTS recommendations.  Key 
points and recommendations from the guide for healthcare providers evaluating patients 
with respiratory disease for fitness to fly include:    
 Cabin altitude may worsen hypoxemia in pulmonary disease and the physiologic 
compensation for acute hypoxia is mild to moderate hyperventilation and 
moderate tachycardia 
 FEV1 and SpO2 are useful markers of clinical severity in patients with respiratory 
disease however, neither resting sea level SpO2 nor FEV1 appear to predict 
hypoxemia or complications of respiratory disease associated with air travel. 
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 Healthcare providers evaluating a patient with respiratory disease for fitness to fly 
should consider the patient’s prior flight experience, flight duration, destination 
and time since last exacerbation of their respiratory condition.   
 Hypoxic challenge test (HCT) is not a test to determine fitness to fly but is 
utilized to aid in the decision-making of whether a patient will require in-flight 
oxygen 
 Patients with complex respiratory disease can be referred for hypobaric chamber 
testing 
 The patient needs to take responsibility for the decision to fly and needs to 
understand that the airline can refuse travel if the passenger’s health or safety is in 
doubt at the time of presentation for travel. 
BTS recommendations also include the statement that Respiratory physicians or 
pediatricians should be the central referral point for consideration of safety to fly in all 
cases.  While this recommendation may be appropriate in the UK, the availability of 
specialists for decision-making may not be practical in the U.S. and guidelines could be 
evaluated by primary care providers with knowledge of flight physiology and patient 
disease history.    
Deep Vein Thrombosis 
 Venous stasis as a result of immobility in hospitalized patients has been 
documented as a risk factor for the development of Deep vein thrombosis (DVT).  
Passengers traveling for long distances who remained immobile have also been thought 
to be at increased risk for DVT development and amongst all health conditions associated 
with air travel is one with the most available studies (Scurr, Ahmad, Thavaraian, & 
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Fisher, 2010).  IATA (2011) fitness to fly guidelines for passengers with deep vein 
thrombosis recommend evaluation by a health care professional for patients with active 
DVT and clearance to fly for DVT patients who are asymptomatic.  
DVTs result when there is a partial or complete blockage of the deep venous 
system of the body by a blood clot, typically in the legs. Symptoms of DVT develop 
gradually and diagnosis can be difficult. The signs and symptoms attributed to DVT may 
include lower leg redness, a swollen or painful calf or thigh, increased skin temperature 
in a change in coloration of skin over the affected area. Untreated DVT’s place a patient 
at risk for developing pulmonary embolism which can result in death.  Two longitudinal 
cohort studies of ambulatory populations estimated 11% rate of 28-day mortality amongst 
first episode venous thromboembolism (VTE) subjects (Chandra, Parisini, & 
Mozaffarian, 2009). 
 In 1954, a 54-year-old doctor who had completed a 14 hour flight was the first 
documented report of a DVT which developed as a result of venous thrombosis related to 
air travel (Clarke, Hopewell, Juszczak, Eising, & Kjeldstrom, 2006).  In 1977, the term 
‘economy class syndrome’ was coined to describe DVTs which were thought to occur as 
a result of prolonged sitting in the confined conditions associated with air travel (Clarke 
et al., 2006).  Several systematic reviews have been undertaken over the past decade to 
attempt to definitively clarify the relationship between air travel and risk for venous 
thromboembolism (MacCallum et al., 2011).   
A 2002 systematic review of observational studies failed to conclude that there 
was definitive evidence that air travel increase the risk of deep vein thrombosis (Clarke et 
al., 2006).  In 2007, another systemic review of 25 studies (6 case-control studies, 10 
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cohort studies and 9 randomized controlled trials) was published with the end objective to 
measure the methodological strength of the literature, estimate the risk of thrombosis 
related to air travel, evaluate the efficacy of preventive treatments and develop evidence-
based recommendations for practice (Philbrick, Shumate, Siadaty, & Becker, 2007).    
The systematic review was once again unable to determine the risk of travel-related 
venous thromboembolism because of three main weaknesses noted.  The largest of the 
cohort studies did not include routine screening for DVT but instead identified cases 
through a retrospective medical record review.  The authors found that retrospective 
studies tended to report higher case counts attributable to the lack of limits on time or 
setting (Philbrick et al., 2007).  Routine screening in other case studies identified more 
cases, mostly of asymptomatic DVTs, which would have erroneously been reported in a 
retrospective study as related to travel.   
There has been evidence suggesting that flights of eight hours or more may 
increase the risk of deep vein thrombosis if a passenger has additional risk factors (Clarke 
et al., 2006).  Air travel-related risk factors for DVT include prolonged immobilization 
and narrow economy class seats with limited legroom, dehydration, insufficient fluid 
intake, and low humidity (Clarke et al., 2006).  Additional risk factors related to 
passenger’s personal health included hereditary or acquired clotting disorders, prior 
history of DVT, older age, recent surgery or trauma, cancer, smoking, pregnancy, chronic 
heart disease and obesity (Clarke et al., 2006).   
A systematic review and meta-analysis of studies of travel and the risk for VTE 
was published by Chandra, Parasini and Mozaffarian in 2009.  The authors followed the 
Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines 
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throughout the design, implementation and reporting of the meta-analysis.  The study 
selection identified 1560 abstracts via searches of MEDLINE, EMBASE, BIOSIS, 
CINAHL, the Cochrane library, grey literature sources and a hand-search of the studies 
identified in the reference lists of the selected abstracts.  Of the 1560 abstracts identified, 
1518 were excluded because they were commentaries, general reviews or case reports.  
The remaining 42 studies were further examined and an additional 28 studies were 
excluded because of study design issues such as lacking a non-traveling comparison 
group, preventive measures for travel-related VTE and failure to meet the criteria for 
VTE diagnosis. 
The 14 selected studies in the meta-analysis included one prospective cohort 
study (Schwarz et al., 2003), one retrospective cohort study (Kuipers et al., 2007), one 
case-crossover study (Kelman et al., 2003), and eleven case-control studies (Chandra et 
al., 2009).  Pooled risk estimates for risk for VTE with travel were obtained by using 
random-effects models with inverse-variance weighting.    The authors noted in their 
analysis that due to the uncommon outcome of travel-related VTE they pooled together 
the odds ratios from case-control studies approximate risk rations or relative risks from 
cohort studies to generate one common relative risk.   
 The pooled relative risk for VTE among air travelers across the studies was 2.0 
(95% CI, 1.5 to 2.7; p < 0.001) compared with non-travelers (Chandra et al., 2009).  
Significant heterogeneity (P for Q statistic < 0.001) was noted and determined to occur in 
the selection criteria for control participants in the case-control studies (P = 0.008).  
When the authors classified the 14 included studies by use of referred control 
participants, a case crossover design or a cohort they identified a statistically significant 
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association between travel and VTE with an overall pooled estimate of 2.8 (CI, 2.2 to 
3.7) as shown in Figure 14 (Chandra et al., 2009). 
The pooled risk estimate for travel by air (RR, 2.2 (CI, 1.4 to 3.2)) was noted to 
be higher but not statistically significant (P for heterogeneity = 0.140) than for travel by 
surface means (RR, 1.14 (CI, 1.0 to 2.1)) (Chandra et al., 2009).   
 The meta-analysis of more than 4000 cases of VTE identified a 2-fold higher risk 
for travelers compared to non-travelers.  In case-control studies using individuals referred 
for VTE evaluation as control participants there was no association found.  The results of 
the meta-analysis indicated that in non-referred control case studies, cohort or case-only 
studies there was nearly a 3-fold higher risk for VTE in travelers leading the authors to a 
conclusion that there was a higher risk for VTE associated with travel (Chandra et al., 
2009).   
 A dose-response relationship between duration of travel and risk of VTE was 
identified by evaluation of 4 of the studies included in the meta-analysis where the data 
was available for assessment (Figure 15).   The authors observed an 18% higher risk for 
VTE for each 2-hour increase in travel duration (Chandra et al., 2009). 
Of the 14 original studies included in the meta-analysis, only 4 studies contained 
the available data to assess risk associated with duration of travel and the resultant 
confidence limits of the effect estimate are wide (4% to 33% higher risk) (Chandra et al., 
2009).  Chandra et al. (2009) posit that the dose-response relationship appeared stronger 
(26% higher risk/2 travel hours) amongst passengers traveling by air but had insufficient 
data to compare direct pooled dose-response estimates for passengers travelling by air 
versus surface travel modes.  Regardless of the modality of travel, the dose-response 
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analysis highlights the importance of preventive measures for VTE as duration of travel 
increase.   
 The association between cumulative flight duration and risk of VTE was 
evaluated further in a British community-based case-control study (MacCallum et al., 
2011).  The authors sought to reduce bias by designing the selection of controls to include 
subjects registered within the same general practice, same gender and closest in age to the 
matched case in the practice register.   As illustrated in Figure 16, cases were excluded if  
the index events occurred outside of the pre-determined study entry, were not matched to 
controls or did not have objectively confirmed VTE (MacCallum et al., 2011).   Table 4 
illustrates the characteristics of case and controls along with the univariate analysis of 
risk factors.  The MacCallum et al. (2011) results indicate that a cumulative flying time 
of greater than 12 hours is associated with a similar risk of VTE within four weeks as 
long-haul air travel 
in which one or more flights is longer than 4 hours in duration. 
An increased risk of VTE was associated with previous VTE, increased weight 
and increased height (MacCallum et al., 2011).  These findings were consistent with other 
studies evaluating the risk factors associated with VTE (MacCallum et al., 2011).  Recent 
surgery was a significantly greater risk factor for VTE than air travel (MacCallum et al., 
2011).  The risks associated with minor surgery were a similar order of magnitude to 
those associated with long-haul air travel while the risk associated with major surgery 
was one or two orders of magnitude greater than the risk associated with long-haul travel 
(MacCallum et al., 2011).   
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A 2010 Cochrane review exists for evaluation of compression stockings for 
preventing deep vein thrombosis in airline passengers (Clarke, Hopewell, Juszczak, 
Eising, & Kjeldstrom, 2006).  The authors of the Cochrane review acknowledged the lack 
of correlative evidence between air travel and DVT but posited that due to the low 
incidence of deep vein thrombosis in the general population it is unlikely that studies with 
adequate sample sizes to detect slight increases in risk will ever be conducted (Clarke et 
al., 2006). The Cochrane review focused not on determining the correlation between air 
travel and DVT development but rather the effectiveness of wearing compression 
stockings in the prevention of DVT in passengers traveling for long distances.  
Randomized trials that compared passengers wearing compression stockings against 
passengers not wearing them during long-haul flights were included in the analysis. The 
primary outcome evaluated was the diagnosis of symptomatic or symptomless DVT 
(diagnosed by ultrasound, venogram or isotope).  Secondary outcome measures evaluated 
included diagnosis of pulmonary embolism, death, superficial venous thrombosis, edema, 
and adverse effects as a result of the use of compression stockings. 
A 2012 executive summary published by the American College of Chest 
Physicians (ACCP)  reviewed the current recommendations associated with prevention of 
thrombosis in traveling patients in an effort to establish an evidence-based clinical 
practice guideline for antithrombotic therapy and thrombosis prevention (Guyatt, Akl, 
Crowther, Gutterman, & Schunemann, 2012).  The ACCP reviewed available literature 
and graded the current recommendations for long-distance travelers at risk of VTE.  At 
risk travelers were identified in the guideline as those who had previous VTE, recent 
surgery or trauma, active malignancy, pregnancy, estrogen use, advanced age, limited 
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mobility, severe obesity or known thrombophilic disorders (Kahn et al., 2012).  The 
result of their evidence-based review included the following recommendations for 
prevention of VTE in non-surgical patients traveling long-distance: 
 frequent ambulation, calf muscle exercises or sitting in an aisle seat if feasible  
 during travel the use of properly fitted, below-knee graduated compression 
stockings (GCS) which provide 15-30 mm HG of pressure at the ankle 
In addition to the recommendations above, the guidelines advice against the use of GCS 
by long-distance travelers not meeting the conditions listed as at increased risk of VTE 
and avoidance of the use of aspirin or other anticoagulants to prevent VTE in long-
distance travelers (Kahn et al., 2012).   
 The recommendations by the ACCP in their 2012 supplement were analyzed 
using GRADE criteria.  Each of the recommendations received a Grade 2C rating 
identifying the recommendation as having a questionable benefit/risk and having been 
derived from a low quality of evidence (Guyatt et al., 2006).  The 2012 ACCP 
recommendations include a further downgrading from the 8
th
 edition of ACCP clinical 
practice guidelines which listed calf muscle contraction as an ACCP grade 1C 
recommendation and aspirin therapy as an ACCP grade 1B recommendation (Gerts et al., 
2008).  The ACCP published a disclaimer to their 2012 guidelines related to their 
recommendations requesting that caution be exercised in performance measure 
development and public reporting of guideline recommendations graded in the 1C, 2 A, 
2B and 2C category according to the ACCP Grading System (Guyatt et al., 2012).    The 
ACCP recommendations could be subject to future revision based upon the findings of 
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the  World Health Organization Research into Global Hazards of Travel (WRIGHT) 
Project’s phase 2 publication (WHO, 2007).   
Blood Disorders 
 The recommendations associated with assessment of fitness to fly for passengers 
with anemic disorders are based upon the principles of the effect of flight physiology on 
the hematologic system.  No recent research studies were found evaluating the 
parameters of fitness to fly and current guideline recommendations appear to be based 
upon experience and recommendations of the sponsoring organizations.   
The ASMA (2002) recommendations establishing hemoglobin levels for concern 
at less than 8.0 gm/dl are due to potential for passenger lightheadedness or potential for 
loss of consciousness during flight especially when associated with ambulation to the 
bathroom or physical activity during flight (ASMA, 2003).  Recommendation for oxygen 
in patients experiencing sickle cell crisis was made to avoid potential life-threatening 
sequela that may be induced as a result of the combination of sickle cell crisis and the 
hypobaric hypoxic environment induced with flight.  Per the ASMA (2002), sickle cell 
trait has not been associated with health problems at cruising altitude.  Recommendations 
for travel without use of supplemental oxygen in-flight ranged from 7.5 g/dl to the IATA 
recommendation of 9.5 g/dl (UK Civil Aviation Authority, 2007; Patel & Simon, 2010; 
DeHart, 2003; International Civil Aviation Organization and International Air Transport 
Association [ICAO & IATA], 2005) by publication regarding the absolute hemoglobin 
level.  While the recommendations appear to be prudent, no record of basis for 
determination of hemoglobin levels by evidence-based guidelines could be located in any 
of the available research.   
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Central Nervous System Disorders 
 The recommendations associated with assessment of fitness to fly for passengers 
with central nervous system disorders are based upon the principles of the effect of flight 
physiology on the central nervous system.  No recent research studies were found 
evaluating the parameters of fitness to fly and current guideline recommendations appear 
to be based upon experience and recommendations of the sponsoring organizations.  
General recommendations found by literature search, while lacking in reference source 
information, were consistent with the IATA (2011) recommendations are included in  
ASMA (2003) guidelines caution patients with epilepsy to refrain from consuming 
alcohol before or during air travel and note that epileptic patients should be informed of 
the potential seizure threshold-lowering effects of fatigue, delayed meals, hypoxia and 
circadian rhythm disruption associated with long-distance travel. 
 Seth, Mir, Dhir, Cheeseman & Singh (2009) addressed evaluation of fitness to fly 
post craniotomy.  The authors found sparse and contradictory data related to intercranial 
pressure changes (ICP) associated with cabin altitude and noted that there are no well-
conducted studies available that demonstrate the effect of long distance air travel on post 
craniotomy patients (Seth, Mir, Dhir, Cheeseman, & Singh, 2009).   
Sirven et al. (2002) evaluated a total of 2,042 medical incidents that were reported 
to the Mayo Clinic Department of Emergency Medicine and Medical Transportation 
Service that resulted in 312 flight diversions.  Neurologic symptoms were the largest 
category of medical incidents (31%) resulting in 626 air-to-ground medical calls to the 
clinics (Sirven et al., 2002).   Dizziness/vertigo was the most common report neurologic 
symptom (Table 8)  followed by seizures, headaches, pain, and cerebrovascular 
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symptoms yet the most common cause for flight diversion were seizures.   It was 
hypothesized that the increased incidence of diversion was likely due to the “dramatic 
presentations” which led to an immediate call for crew attention (Sirven et al., 2002, p. 
3).   
A prospective analysis of patients with neurologic symptoms referred from the 
Madrid-Barajas International Airport to the emergency department at the Hospital 
Universitario Ramon y Cajal for neurologic consultation resulted in the evaluation of 77 
patients over a 21 month period from May 2008 to January 2010 (Alonso-Canovas et al., 
2011).   Of the 77 cases identified, seizures were the cause for consultation for 39 
(50.6%), Stroke 18 (23.4%) and the remaining 20 (26%) were attributed to other causes.  
Twenty-five (61%) of the seizure patients identified had no prior history of seizure.  
Classification of causes of identified seizures included idiopathic (20/48/8%), acute 
symptomatic or provoked as a result of missed doses of antiepileptic medication or 
drugs/alcohol contributed to 39% of the remaining subjects.   Recreational drug use (p= 
0.0008) and past history of seizures (p = 0.0007) were significantly associated with 
referral for seizure activity in flight (Alonso-Canovas et al., 2011).  Eighteen patients 
referred for stroke (23.4%) of which 14 reported vascular risk factors including 
hypertension, tobacco use, cardiopathy, hypercholesterolemia and diabetes mellitus.  
Vascular risk factors were significantly associated with stroke (p = 0.0017).  Alonso-
Canovas et al. (2011) suggested that air travel may be a factor for induction of neurologic 
problems while noting that the study was limited by a lack of information related to the 
flight diversion or treatment applied in-flight.  Additionally, in patients diagnosed as 
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having a stroke, 1/3 were noted in post diagnostic evaluation to have carotid stenosis 
(over 50% occlusion) which likely was a significant contributor to stroke etiology. 
 Airplane headache has been reported as a new type of headache with specific 
symptoms temporarily related to air travel (Alonso-Canovas et al., 2011; Berilgen & 
Mungen, 2011).  The characteristics of airplane headache are a headache that starts 
suddenly during aircraft ascent and/or descent.  The headache associated with air travel is 
typically severe, stabbing, unilateral, most often localized to the periorbital region and 
has a mean duration of 20 minutes subsiding shortly after landing (Berilgen & Mungen, 
2011; Evans, Purdy, & Goodman, 2007; Berilgen & Mungen, 2006).   Thirty-three cases 
(28 male, 5 female) of suspected headache associated with air travel were identified 
Berilgen and Mungen (2011).  The case study headaches were not associated with other 
migraine history or symptoms and of those 33 cases, 22 were evaluated by a neurologist 
and found to be normal.  Berilgen and Mungen (2011) analyzed the cases and 
hypothesize that the headache associated with air trauma is likely due to temporary sinus 
barotraumas or local inflammation in the sinus area as a result of hypoxia or reduced 
cabin humidity.  Of note is that of the patients evaluated, 95% of the identified cases did 
not have recurrent headache symptoms in subsequent flights when premedicated one hour 
before take off with 550mg of naproxen sodium.  A separate self-reported case study of 
what was considered to be airplane headache also responded positively to premedication 
with naproxen (Marchioretto, Mainardi, & Zanchin, 2008).   
Eye, Ear, Nose and Throat 
 The recommendations associated with assessment of fitness to fly for passengers 
with ear, nose and throat (ENT) disorders are based upon the principles of the effect of 
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flight physiology on the ENT system.  The recommendations associated with assessment 
of fitness to fly for passengers with ophthalmologic disorders are based upon the 
principles of the effect of flight physiology on the ophthalmologic system.  In-flight 
evaluation of intraocular pressure (IOP) change in healthy subjects during air travel was 
examined by Bayer et al., 2008.  Twenty-five healthy volunteers underwent evaluation of 
IOP for change from ground level measurement, at cabin pressures of 8000 feet and post 
landing in an attempt to determine the effect of air travel on the IOP of healthy subjects 
(Bayer et al., 2008).  Total flight duration was 2 hours and 55 minutes and repeated 
ANOVA test was used for IOP value comparison between the consecutive measurements 
with p values of 0.05 considered to be significant.  A significant decrease in IOP was 
noted on the second hour of flight (13.4%, p = 0.005) and after landing (15.7%, p = 
0.001).   Bayer at al. (2008) were unable to determine the length of time post landing that 
the decrease in IOP persisted as no further measurements post landing were performed.  
Conclusions were drawn from hypobaric chamber studies which demonstrated a return to 
normal of IOP 2-5 hours after exposure to high altitude simulation (Bayer et al., 2008).  
The Bayer et al. (2008) study offers initial information related to the effects of air travel 
on IOP, the study is limited by the small sample size and does not offer information 
related to the effects of long-haul travel or the duration of IOP decrease post landing.  
The statistical significance of the study would support further investigation.  
 Exposure to allergens in flight is of particular concern for patients who have 
severe allergic reactions such as anaphlyaxis or exacerbation of asthma after exposure to 
irritants.  The consequences of a severe allergic reaction mid-flight without appropriate 
medical assistance can be life-threatening.  One in ten individuals is known to have 
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allergies to animals but few consider the potential for exposure that may occur in animals 
brought onboard the aircraft by other passengers.  Exposure to dander cannot be avoided 
by restricting seating away from animals within the cabin because of capacity filled 
flights as well as the persistence of dander even after a passenger with a pet has deplaned.  
Stanbrook, Kovesi and Hebert (2010) reported that one study found clinically significant 
cat dander concentrations have been noted on 100% of sampled domestic airline seats 
and 16% of seats on international flights.  As of 2010, the Canadian Transportation 
Agency began examining pet policies on commercial aircraft carriers to evaluate whether 
the admission of animals within aircraft cabins could pose a threat to the health and well-
being of some passengers (Kondro, 2010).   
Several airlines have ceased to serve peanuts following reported anaphylactic 
reactions in passengers who inhaled peanut dust (Stanbrook, Kovesi, & Hebert, 2010).  
While the removal of peanut, nut and seed products by airlines reduces the risk of 
exposure to passengers, the ability and commonplace occurrence of other passengers on 
an aircraft bringing food sources or items with peanut, nut or seed dust on them cannot be 
regulated by the airlines.  To assist at-risk passengers, the IATA (2011) recommends that 
passengers with severe allergies plan ahead by contacting their physician, discussing 
travel related risks and obtaining the prescription of an epinephrine auto-injector or other 
allergy medicine to be carried onboard for use as needed. 
Trauma 
 The recommendations associated with assessment of fitness to fly for passengers 
with trauma are based upon the principles disease management as well as the effect of 
flight physiology.  Key flight physiologic considerations for the healthcare provider to 
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consider when evaluating a post-surgical or post-trauma passenger for fitness to fly 
include: 
 Passengers in this category are at risk for increased oxygen consumption as a 
result of trauma or surgery.  Supplemental oxygen may be considered if the 
patient is anemic, volume depleted or known to have concomitant 
cardiopulmonary disease which may be further compromised by the hypoxic 
conditions of flight (ASMA, 2003). 
 Intestinal gas will expand 25% by volume at a cabin altitude of 8000 feet and 
patients who are post-abdominal surgery may be at risk for bleeding, perforation 
or tearing at suture sites as a result of increased pressure, stretching gastric or 
intestinal mucosa (ASMA, 2003). 
 Patients with bowel obstruction as well as post colonoscopy may not be able to 
accommodate the additional gastrointestinal gas expansion during flight (ASMA, 
2003). 
 Neurosurgical and passengers post ophthalmologic surgery may be subject to 
trapped gas which will cause increased pressure in flight (ASMA, 2003). 
No recent research studies were found evaluating the parameters of fitness to fly 
and current guideline recommendations appear to be based upon experience and 
recommendations of the sponsoring organizations.   
Pregnancy 
 There are various air travel restrictions placed upon pregnant passengers by both 
domestic and international airlines which vary by airline.  Yet, there is no clinical 
practice guideline nor formal clinical evidence exists that provides an absolute 
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contraindication to travel for pregnant women (Hezelgrave, Whitty, Shennan, & 
Chappell, 2011).  The decision upon whether to provide fitness to fly for a pregnant 
traveler is made on an individual basis by the passenger’s healthcare provider and is 
dependent upon gestational age, the degree of clinical compromise and the presence of 
pre-existing comorbid conditions (Hezelgrave et al., 2011).   The basis of concern for 
most airlines to restrict air travel for pregnant women is to avoid the undesirable 
consequence of flight diversion or delivery in flight where they may be a lack of 
appropriate facilities or care providers to manage labor and pregnancy complications 
(Royal College of Obstetricians and Gynaecologists [RCOG], 2008; UK Civil Aviation 
Authority, 2007).  The American College of Obstetricians and Gynecologists issued a 
committee opinion on obstetric practice in 2009 in which they posited that in the absence 
of medical or obstetrical complications that air travel is safe for pregnant women 
(American College of Obstetricians and Gynecologists [ACOG], 2009).   
 Not surprisingly, there is a paucity of research available on air travel during 
pregnancy and recommendations by obstetric sources are made based upon the scientific 
knowledge related to the physiology of flight and the physiologic changes of pregnancy.  
Hezelgrave, Whittey, Shennan and Chappell (2011) note that while most pregnant 
women are low risk pregnancy and can be expected to travel without any complications, 
there are additional risks that should be considered during each trimester which can be 
further complicated by comorbid medical conditions.   
 A search of the literature resulted in two research studies which directly addressed 
the issue of passenger air travel and pregnancy outcomes.  A retrospective analysis of 992 
healthy pregnant women with single pregnancies of gestational ages of 20 weeks or 
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greater admitted for delivery over a 12-month period between May 2003 and May 2004 
was performed to analyze whether there was an elevated risk of adverse pregnancy 
outcomes associated with air travel (Chibber, Al-Sibai, & Qahtani, 2006).  The study was 
performed in the antenatal clinics of a Saudi Arabian university teaching hospital 
designated as tertiary care centers.  The study group consisted of pregnant women who 
had travelled by air at least once during their pregnancy and the control group were those 
who did not travel.  Study group members were asked to provide gestational age, 
destination, length of flight and any complications during travel.  Chart review by an 
investigator blinded to the travel status of the participants was performed to obtain 
medical history, obstetric complications and pregnancy outcome information.  
 Women with any pre-pregnancy medical complications, vaginal bleeding, history 
of tocolysis administration for preterm labor, fetal anomalies, neonatal structural 
anomalies or chromosomal anomalies were excluded from the study.  The study group 
consisted of 546 women who travelled at least once during their pregnancy of which 312 
(57%) were primiparous, and 234 (43%) multiparous.  The study group flew for the first 
time during pregnancy at a gestation age of 11.2 +/- weeks with average flight times 
lasting 7.8 +/- 1.2 hours and a median of 7 flights (range 1-18).  There was a statistically 
significant incidence of expatriates among the travel group over Saudi nationals (see 
Table 15).  The control group consisted of 447 pregnant women of which 241(54%) were 
primiparous and 206 (46%) were multiparous.   
Amongst primiparous passengers, air travel during pregnancy was associated with 
an increased risk of preterm birth at <37 and > 34 week gestation (OR 1.5; 95% CI 1.2, 
1.8, see Table 16).  Regression analysis demonstrated a relationship between gestational 
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age at delivery and gestational age at first air travel (r = 0.002, P = 0.01) and total hours 
of flight (r = 0.012, P = 0.01) of which the risk factor associated for preterm delivery 
persisted when evaluated on the whole group analysis of data . When adjustments were 
made for age, socioeconomic status there was a decrease in magnitude of the association 
between travel and preterm primiparous delivery but the association remained statistically 
significant (Chibber et al., 2006).  While the birthweights of the preterm infants were 
lower than controls, no statistically significant increased risk of admission to the neonatal 
intensive care unit was noted suggesting that these infants were not at any greater risk 
than the controls for respiratory distress or intraventricular hemorrhage associated with 
preterm delivery.   
 Several confounding variables existed in the study which may have contributed to 
bias in the results.  There was a significant racial difference amongst the women who 
travelled and those who did not which Chibber at al. (2006) acknowledge correlates with 
cultural and lifestyle choices of foreigners in Saudi Arabia who  may be more likely to 
travel during months of greater heat or who may choose to travel because they are 
challenged by the local customs and find the lifestyle and dress codes restrictive.   The 
failure of the authors to assess tobacco use and alcohol consumption was another 
potentially significant confounding variable in the study as both substances are known to 
be associated with preterm delivery and lower birth weight.  In the absence of this data, 
the results, despite appropriate statistical analysis of the data, may be biased.   
 A strength of the Chibber et al. (2006) study was the ability to accurately assess 
gestational age of the women studied.  Additionally, the study had a larger sample size 
than prior research evaluating the effect of air travel and pregnancy outcomes.    
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A whole group analysis was performed and it was determined from the findings 
that air travel during pregnancy was associated with an increased risk of preterm births at 
< 37 and > 34 weeks gestation (Chibber et al., 2006).  Gestational age at delivery 
correlated with lower birthweight among the women.  No differences or risk elevations 
were found between pregnant air travelers and non-air travelers in the rates of other 
evaluated sequel.  
The second study located by literature search was a 6-month questionnaire of 
women admitted to Georgetown University Medical Center in Washington D.C. with 
impending delivery while at least one of the author’s of the study was on call (Freeman et 
al., 2004).  The study population accounted for 13% of the deliveries in the facility during 
the study period.    
Exclusion criteria included fetal anomalies, neonatal structural or chromosomal 
anomalies (n= 3).  Medical history obstetric complications and pregnancy outcomes were 
obtained by a chart review blinded to air travel status.  Variables collected on the study 
population included maternal age and race, parity, history of adverse pregnancy outcome, 
presence of pre-pregnancy complications, medications during pregnancy, initial 
hematocrit at first prenatal visit and hematocrit at the time of delivery (Freeman et al., 
2004).   Adverse pregnancy outcomes were evaluated using a composite analysis of 
stillbirth, Apgar score at 5-minutes, preterm delivery <37 weeks, preeclampsia and birth 
weight and the between group prevalence (Table 19).  Logistic regression analysis was 
performed to account for the significant differences in racial distribution between the 
groups.   
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Limitations of the Freeman et al. (2004) study included the sample size as well as 
the convenience sampling criteria associated with investigator availability.  Power 
analysis performed by the Freeman et al. (2004) found that a sample size of 2,803 women 
per group would be needed in order to demonstrate that air travel has a protective effect 
against adverse pregnancy outcome (alpha = 0.05, beta = 0.80).  The sample studied was 
substantially smaller and to date there are no studies performed with sample sizes of 
pregnant travelers that large.    
Another potential for bias and study limitation was that the questionnaire was 
administered by the authors and it is therefore subject to recall reliability and failure to 
disclose information may have impacted the results as well as selection bias.  The authors 
note that women admitted in preterm labor or experiencing pregnancy complications 
generally manifest a over-recall rather than an under-recall of potential causative factors 
(Freeman et al., 2004).  The bias related to recall may still exist in this study as it was a 
convenience sample that included both women presenting to deliver without 
complications as well as those who may be delivering preterm or with complications. 
Racial differences, as noted previously, was another potential confounding 
variable in the study and the authors noted in the study that the higher rate of Caucasian 
women who traveled may reflect a sociodemographic difference between the two groups 
and may also be reflective of the higher hematocrit in air travelers since they were 
predominantly Caucasian which is a race known to normally have higher hematocrit 
levels than other races (Freeman et al., 2004).    No significant association between air 
travel and composite adverse pregnancy outcomes were found when a logistic regression 
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analysis was performed taking into account race as well as other demographic variables 
(Freeman et al., 2004).   
  A literature search was published in 2010 which aimed at evaluating the 
relationship of air travel and spontaneous abortion, intrauterine fetal demise (IUFD), low 
birth weight (<10
th
 percentile), preterm delivery and neonatal intensive care unit 
admissions (Magann et al., 2010).  The literature search identified 128 publications of 
which 9 abstracts evaluated air travel and pregnancy outcomes.  The Chibber et al. (2009) 
and Freeman et al. (2004) studies addressed previously was the only two studies of the 
nine which specifically evaluated the outcomes in traveling passengers and not flight 
attendants and/or aviators.  Flight attendants and aviators were excluded from our review 
based upon the concept that their health, risk factors, flight times and number of flights 
differ significantly from the average travelling passenger.  Regardless, with the inclusion 
of the flight attendants and aviators in their review, Magann et al. (2010) were unable to 
identify an increased risk of neonatal intensive care unit admissions (OR: 1.19, 95% CI: 
0.74, 1.82), low birth weight (OR: 1.25, 95% CI: 0.62, 2.48) or pre-eclampsia (OR: 0.86, 
95% CI: 0.58, 1.27) when subjects were compared to controls.  The risk of pregnancy 
loss (spontaneous abortion or IUFD) was greater in flight attendants than controls (OR: 
1.62, 95% confidence interval: 1.29, 2.04) but none of these studies evaluated pregnant 
passengers versus controls so a generalization may not be valid given the increased risk 
factors of flight time exposure amongst flight attendants (Magann et al., 2010).  No 
similar increased risk of pregnancy loss was found in either the Chibber et al. (2009) or 
the Freeman et al. (2004). Results of the Chibber et al. (2009) study indicating an 
associated increased risk of preterm birth (<37 weeks) was reported by the authors.  
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Magann et al. (2010) noted that the correlation between air travel on pregnancy outcomes 
has been poorly studied and the inadequacy and lack of data on air travel an pregnancy 
outcomes makes an evidence-based recommendation impossible to provide. 
Psychological Disorders 
  It is estimated that fear of flying affects 10-40% of the commercial air 
traveling population (Van Gerwen, Spinhoven, & Van Dyck, 2006).  Symptoms 
associated with flight related anxiety range from mild anxiety to pathological fear.  Air 
rage is described as disruptive behavior associated with air travel and is thought to be 
associated with travel related stress and exacerbated by alcohol ([WHO], 2011).  
Matsumoto and Goebert (2001) retrospectively reviewed 1375 physician consultation 
calls in 1997 to a 24 hours medical consultation service that provided coverage to 9 
commercial domestic and international airlines and found that 3.5% of all medical in-
flight emergencies fell under the category of mental disorders.   Of the consultations 
provided in the Matsumoto and Goebert study, 90% were had anxiety as their primary 
symptom and 4% psychosis.  Avoidance behavior, behavior and cognitive therapy and 
anxiolytic medications may be means by which transient anxiety and stress associated 
with air travel can be controlled and therefore fear of flying is not considered to be a 
condition that would warrant a fitness to fly examination (Bogaerde & De Raedt, 2008; 
Van Gerwen, Spinhoven, & Van Dyck, 2006; Waterhouse, Reilly, & Edwards, 2004). 
Concern exists that the stress associated with traveling to and within a busy 
airport terminal as well as the physiologic changes of flight and environmental conditions 
within the aircraft cabin may lead to exacerbation on underlying psychiatric conditions or 
decompensation of previously stable conditions (DeHart, 2003).  Jet lag and disruption of 
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the circadian rhythm is also thought to be a contributory factor for the potential 
exacerbation of psychotic conditions (Katz, 2011).  While conditions leading to 
exacerbations of psychiatric disorders are temporary and not likely to lead to long-term 
problems with the passenger’s health, concern for the ability of the crew to safely 
conduct a flight may require prior medical clearance for passengers exhibiting psychiatric 
symptoms of concern to air or ground crew.  Passengers who are aggressive, 
unpredictable, disruptive, disorganized or unsafe may trigger airline personnel to request 
further evaluation which prohibits the passenger from flying (ASMA, 2003).   Most 
guideline recommendations for fitness to fly related to psychotic patients recommend that 
travel be accompanied by a trained medical escort or other individual who can ensure 
psychiatric medication management and assist with control of the affected passenger 
when needed (Patel & Simon, 2010; UK Civil Aviation Authority, 2007).   
Diabetes 
Evaluation of the effects of air travel on patients with diabetes is an emerging area 
of comorbidity that has only recently begun to be evaluated in terms of flight related 
physiology.  A study of the effects of atmospheric pressure on insulin pump delivery 
during flight identified unintended insulin delivery in pumps by bubble formation and 
expansion of bubbles (King, Goss, Paterson, Crock, & Anderson, 2011).   King, et al. 
(2011) evaluated the effect of ambient pressure during simulated flight in hypobaric 
chambers mimicking ascent, descent and catastrophic depressurization on insulin pump 
delivery, bubble formation, bubble size and cartridge plunger movement in ten insulin 
pumps connected to capillary tubes.  A Student t test of the results found that excess 
insulin delivery of 0.623% of the cartridge volume occurred (p < 0.001) in both types of 
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pumps evaluated (Animas and Medtronic).   No statistical difference was noted between 
pump types when abnormal insulin delivery was evaluated as a percentage of insulin 
volume (King et al., 2011).  While this study was not performed on diabetic patients with 
insulin pumps in place, it does raise the question of whether or not there may be 
unintentional hypoglycemia that results during air travel for passengers with insulin 
pumps.  Unintentional hypoglycemia in combination with travel fatigue, jet lag, limited 
food availability in flight can result in serious consequences if not monitored 
(Waterhouse, Kao, Edwards, Atkinson, & Reilly, 2006). 
Miscellaneous Conditions 
 The recommendations associated with assessment of fitness to fly for passengers 
with communicable disease, terminal illness and decompression syndrome are based 
upon the principles disease management as well as the effect of flight physiology.  
Despite concerns associated with spread of infection in aircraft cabins, there is very little 
risk of infectious disease transmission on board of commercial aircraft (WHO, 2011). 
Transmission of infection may occur between passengers in close contact related to 
seating areas but the aircraft ventilation system utilized in commercial aircraft is similar 
to that found in hospital surgical suites and intensive care units.  HEPA filter systems 
help reduce transmission of particles, bacteria, fungi and viruses during recirculation 
exchange and the rate of disease transmission onboard an aircraft is no more likely than 
that which would occur for the same passenger in a commercial building (WHO, 2011).  
Recommendations to avoid travel until passengers with infectious disease are beyond the 
period of contagion are the same as would be offered for the patient avoidance of public 
areas to reduce the spread of disease.   
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CHAPTER 3 
Conceptual Framework 
 
 The ACE Star Model of Knowledge Transformation (ACE) is the conceptual 
framework chosen for this capstone project as it is a model which allows for the 
transformation of knowledge and integration it into evidence based practice (EBP) 
(Kirchhoff, 2008).  The ACE model is based upon a five point star (Appendix C) that 
depicts the stages of knowledge transformation (Stevens, 2004).  The model stages 
include discovery, summary, translation, integration and evaluation.   In the ACE model 
evidence translation is developed as each stage of transformation is a building block for 
the previous stage resulting in newly discovered knowledge being implemented into 
practice (Kirchhoff, 2008).  
Discovery is the first star point of the ACE model (Stevens, 2004).  The discovery 
stage involves knowledge generated through the conduction of quantitative and 
qualitative primary research studies. The evidence generated from these primary studies 
is utilized to develop clinical decisions (Stevens, 2004). 
 Evidence summary, the second star point, generates knowledge through the 
development of a summary of available research into statements to guide practice.   A 
systemic approach is utilized to reduce bias and provide for reliability of the evidence 
(Stevens, 2004).  Systematic reviews, evidence summaries, review of the literature and 
meta-analyses are examples of evidence summaries (Stevens, 2004).   
 The third star point, translation, involves the summary of evidence into standards 
of practice or clinical practice guidelines (CPG).  CPGs provide a means for healthcare 
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providers, patients and organizations to make informed clinical decisions and provide for 
standardization of clinical practice (Stevens, 2004).  
Integration, the fourth star point, is the stage at which CPGs are implemented into 
practice.  Practice integration of evidence occurs at individual and/or organizational 
levels with the goal of the stage being the adoption of recommendations into routine 
practice (Stevens, 2004; Kirchhoff, 2008). 
Evaluation is the fifth star point of the ACE process.  The assessment of the effect 
of the utilization of the CPG on patient outcomes, patient satisfaction ratings, system 
efficiency, and cost analysis are methods by which the evaluation stage leads to 
continued improvement in clinical practice (Stevens, 2004). 
The proposed capstone project will focus on the development of a CPG for 
primary care providers to be able to utilize in their daily practice.  The capstone project 
will focus predominantly on the evaluation and integration stages of the ACE Star Model.  
The CPG developed will provide an evidenced-based guideline for integration into 
primary care practice. 
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CHAPTER 4 
Methodology 
Evidence-based Project Plan 
The intent of the capstone project was to perform an evidence-based systematic 
review and synthesis for the purpose of the development of a clinical practice guideline 
(CPG).   Literature from was obtained by internet and electronic database searches of 
published evidence via Medline, PubMed, the Cochrane Library CINAHL (EBSCOHost), 
and other electronic sources for admissible evidence or studies published between 
February 2001 and February 2012.  Search terms included  air, plane, aircraft, travel, 
airline, fitness to fly, commercial air, hypoxia, hypoxemia, pre-flight, post-flight, 
cardiovascular, circulatory, blood, hematology, anemia, pulmonary, COPD, respiratory, 
asthma, restrictive lung, non-restrictive lung, neurologic, neurology, central nervous 
system, gastrointestinal, abdomen, ear, nose, throat, psychiatric, anxiety, psychosis, eye, 
ophthalmologic, pregnancy, children, pediatric, orthopedic, surgical, surgery, trauma, 
disease, infection, pain, and prevention.  Identified studies were limited to those written 
in English or with available English translations.  Expert opinion and guidelines 
developed by other sources were included in the guideline development and all efforts 
were be made to correlate opinion and published guidelines to primary sources of 
research.   
Patient outcomes of interest were identified and the GRADE approach (Appendix D) 
was utilized to assess the magnitude of effect of recommendations and quality of 
evidence.  Categories of evaluation for the capstone project followed the areas of the 
IATA medical group recommendations related to passenger fitness for air travel: 
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cardiovascular disease, blood disorders, pulmonary disorders, central nervous system 
disorders, gastrointestinal disorders, ear/nose/throat disorders, psychiatric illness, 
ophthalmologic disorders, pregnancy, trauma and miscellaneous conditions.   
Resources Required 
 No funding was required for completion of the capstone project.  The primary 
resource requirement was the investigator’s time to perform the search for studies, grade 
the reviews and synthesize the data into an evidenced-based practice guideline.   There 
was no cost associated with the review of the guideline by the clinical content 
professionals.    Minimal costs were associated with printing necessary for project 
completion and were covered by the project author. 
IRB Approval 
 
 The project was submitted to the University of Nevada Las Vegas Office of 
Research Integrity for IRB approval for exempted research consideration based upon the 
criteria as being a collection or study of publicly available data that does not involve 
human subjects or individual subject identifiers.  On October 18, 2011 the protocol was 
reviewed by the University of Nevada Las Vegas Office of Research Integrity – Human 
Subjects and was deemed excluded from IRB review (Appendix E).    
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CHAPTER 5 
Results 
A comprehensive systematic review of the literature was performed and current 
knowledge in the form of expert opinion and published guidelines was incorporated into 
the final clinical practice guideline.  The CPG developed graded the applicable data 
according to both the quality of available evidence and the strength of the 
recommendations.  The CPG was developed in the format accepted by the Agency for 
Healthcare Research and Quality and is included in this paper as Appendix G. 
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CHAPTER 6 
Summary, Conclusions and Recommendations 
After an exhaustive review of the literature it became evident that although 
published research existed on fitness to fly guidelines for a variety of health related 
issues, there were few direct clinical evidence studies of the pathophysiologic effects of 
commercial airline travel on passengers with pre-existing diseases.  The majority of 
published research and fitness to fly guidelines were developed by applying the principles 
of the effects of flight on physiologic systems, based upon research conducted in hypoxic 
simulated laboratory environments, developed from studies performed on subjects 
adapting to altitude on land, or formulated as opinion by expert individuals or working 
groups.  Attempts to apply the grade approach to the research resulted in downgrading of 
evidence recommendations in the developed guidelines due to the small sample sizes, 
lack of study randomization and blinding, failure to control for bias and other design-
related issues that affected the research reliability.  The majority of the available research 
anecdotal clinical case studies and expert opinion and therefore fell under the category of 
very low quality of strength of recommendation.   
Shurlock (2010) acknowledged the lack of clinical data available to make 
appropriate guidelines for fitness to fly.  Instead of focusing on diseases, per se, the 
Working Group of the British Cardiovascular Society (Smith et al., 2010) focused on the 
cabin environment and stratifications of levels of risk.  The final published report of the 
Working Group acknowledges that here are few direct clinical studies of the 
pathophysiological effects of air travel on patients with existing diseases and therefore 
their guideline advice was based on the physics and physiology of the aircraft cabin 
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environment and its potential impact on patients with pre-existing conditions.  
Ultimately, the British Cardiovascular Society working group gave their 
recommendations based upon their expert knowledge because of the lack of randomized 
controlled trials available to meet the criteria of a clinical practice guideline.  The aim of 
the guidelines, according to Smith et al. (2010), was not to be restrictive but to allow 
passengers to fly.  Smith et al. (2010) also acknowledged that the lack of randomized 
controlled trials, meta-analysis and registries regarding the effect or risks of air travel 
upon patients with cardiovascular disease prevented them from developing clinical 
practice guidelines.  As a result, the working group chose to review available evidence 
and then apply clinical professional judgment in conjunction with present knowledge of 
the physiological effects of the aircraft environment on the pathophysiology of 
cardiovascular disease as had other expert panels addressing the issues associated with 
fitness to fly.   
The currently available clinical guidelines for establishing fitness to fly produced 
by disease-specific specialty group sources such as ASMA (2003),  IATA (2011), the UK 
Civil Aviation Authority (2009), the British Thoracic Society (Ahmedzai et al., 2011), the 
British Cardiovascular Society (Smith et al., 2010) and ACOG (2009) provide similar 
recommendations related to passenger disease or pre-existing condition and the need for 
evaluation prior to travel.  Their recommendations are also based predominantly on case 
study reports, expert opinion, simulated environment research studies and small studies 
with limitations in quality outcome measures.  A review of the  updated BTS  fitness to 
fly guidelines suggested that based on the “lack of clarity” in the available advice, 
inadequate data for classification of in-flight events and “anachronistic advice that did not 
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consider levels of risk” it would be best to not develop fitness to fly guidelines but rather 
to determine which patient should be cleared to fly on the basis of the risk of a 
spontaneous event in an aircraft cabin environment with limited available emergency 
treatment (Shurlock, 2011, p. 1045).   
There is validity associated with concerns related to guidelines that are not 
supported by evidence-based research and it can be argued that no evidence-based 
clinical practice guideline could be developed for commercial airline passenger fitness to 
fly due to the lack of quality clinical research findings.  Few of the available published 
studies evaluated for this capstone project exceeded the GRADE guideline for low 
quality research because of the lack of the reliance on case reports, consensus opinion 
and contradictory small studies with limitations lowering the strength of the results.  
Regardless, evidence-based analysis can be applied and the guideline presented as a 
result of this capstone project can be implemented as a resource to guide primary care 
professional screening, decision-making and preventive care based upon currently 
available information. 
The field of travel medicine is a new and emergency specialty area and 
recommendations for further evaluation include improving undergraduate and 
postgraduate travel medicine education, adding travel history to initial health history 
forms, development of instruction sheets for dissemination to primary care providers, 
airlines and the traveling public as well as performing larger, higher quality research 
studies to clinically evaluate travel related health issues (Talbot, Chen, Sanford, 
McCarthy, & Leder, 2010; Ruis, Van Rijckevorsel, Van den Hoek, Koeman, & Sonder, 
2009; Van De Winkel, Van den Daele, Van Gompel, & Van den Ende, 2007).  The 
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research, expert opinion and published guidelines identified in this study focused on 
individual issues or health problems and the paucity of studies in each of the IATA 
identified areas warrants further investigation to validate recommendations.   Several 
areas of future research and opportunity were identified during the review of the 
evidence.    
One means of improving the reliability of information and data gathering would 
be for the implementation of an international registry to document in-flight medical 
emergencies.  Accuracy of data collected related to in-flight medical events would be 
improved significantly if standardized reporting requirements and terminology were 
implemented as part of the registry process.   Data collected from an international 
database with standardized categories could be used to identify actual incidences of 
health related occurrences and provide direction for further epidemiologic research.  
International flight related medical occurrence data could be utilized to adapt and 
standardize the contents of the onboard medical kits to meet the actual identified needs of 
in-flight health issues.  Extrapolated epidemiologic data could also be utilized to develop 
preventive health information and improved pre-flight screening strategies for healthcare 
providers.  Future recommendations and research should include patients with comorbid 
conditions to evaluate the potential for cumulative negative effects.   
 Hypobaric hypoxia is one of the physiologic changes that occur during flight as a 
result of the cabin pressurization.  Hypoxia can have effect the circulation by causing 
local coronary and cerebral vasodilatation, increase in heart rate, hyperventilation, 
increase in blood pressure, increased myocardial contractility, increase in cardiac 
pressure, increase in cardiac output and increase in pulmonary artery pressure (Bartsch & 
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Gibbs, 2007).  In addition to the effect of altitude and cabin pressurization on oxygen 
partial pressure in healthy adults, there is an age related decrease in oxygen partial 
pressure that occurs above the age of 40 years which is approximated to be a loss of 5 
mm Hg per decade of age (Smith et al., 2010).    
 Patients who present to their primary care provider requesting a medical 
certificate of fitness to fly, approval for use of portable oxygen concentrators for air 
travel, a pregnancy information form, or a medical information form (MEDIF) for air 
travel should trigger preventive screening for the status of current health conditions that 
may be affected by the stressors of travel and the aircraft environment.  Primary care 
providers completing these supporting documents need to have an understanding of the 
impact of air travel on medical issues and use available information and prudent 
judgment before establishing a patient’s approval to fly in order to prevent patient 
adverse health events  as well as the potential liability issues that can occur with negative 
outcomes.  Recommendations from the British Medical Association (BMA) advise health 
care providers to carefully word statements on an individual’s fitness to fly indicating the 
information on which the healthcare provider’s advice is based rather than providing a 
positive certification of a person’s fitness to fly (UK Civil Aviation Authority, 2007).  
BMA recommendations include the use of statements on MEDIF forms such as: 
 I know of no obvious reason why this person should not fly or  
 There is nothing available in the medical record to indicate that flying may place 
this patient at a health risk 
These types of statements do not provide a guarantee of a patient being able to travel 
without incident but rather indicate that evidence available to the healthcare provider 
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does not indicate that air travel will place their patient at a greater risk than other 
traveling passengers. 
 The proposed next step of translation of the capstone project findings will be to 
submit the capstone guidelines recommendations, once approved by the capstone 
committee and successfully defended, for a review and recommendation of approval by 
subject matter experts at the International Society of Travel Medicine.   Capstone 
recommendations will be summarized for an invited podium presentation at the American 
Academy of Nurse Practitioner 2012 National Conference.  The summarized clinical 
practice guidelines will be submitted to the Journal of the American Academy of Nurse 
Practitioners for publication consideration.  Publication in a peer-reviewed primary care 
journal is preferential so that the information can reach the intended audience of primary 
care professionals who may benefit from integrating the capstone project findings into 
practice. 
 The Aerospace Medical Association (2009) estimates that 62% of in-flight 
emergencies occur in passengers with pre-existing medical conditions.  Preparation and 
thorough screening of passengers with known medical conditions would prevent most in-
flight medical emergencies (Valani et al., 2010).  Further examination and research 
related to air travel health issues for passengers with comorbid conditions is needed 
especially in light of the fact that the air travel population is aging and therefore more 
likely to have one or more comorbid conditions that could be adversely affected by air 
travel.  Traveling passengers may be reluctant to disclose pre-existing medical 
information to airline personnel that could prohibit them from a planned flight, especially 
when such a delay may cause the passenger to incur additional fees and financial 
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consequences associated with disrupted travel plans.  Preventive evaluation, 
identification and proactive management of conditions by healthcare providers who are 
knowledgeable regarding the risks associated with air travel can reduce air travel related 
adverse health events.  Health care providers who have an understanding of the 
physiologic changes that occur in flight can provide individual plans of prevention 
tailored to meet the specific conditions of at-risk patients.   
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APPENDIX A: AERSOPACE MEDICAL ASSOCIATION  RECOMMENDATIONS 
FOR ONBOARD EMERGENCY MEDICAL KIT 
 
Medication  Equipment 
Epinephrine 1:1000  Stethoscope 
Antihistaminic Injectable  Sphygmomanometer (electronic preferred) 
Dextrose 50% inj. 50 ml (or 
equivalent) 
 Airways, oropharyngeal (appropriate range of 
sizes) 
Nitroglycerin tab. or spray  Syringes (appropriate range of sizes) 
Major analgesic, inj. Or oral  Needles (appropriate range of sizes) 
Sedative anticonvulsant inj.  Intravenous catheters (appropriate range of sizes) 
Antiemetic inj.  Antiseptic wipes 
Bronchial dilator inhaler  Gloves (disposable) 
Atropine inj.  Sharps disposal box 
Adrenocortical steroid inj.  Urinary catheter 
Diuretic inj.  System for delivering intravenous fluids 
Medication for postpartum bleeding  Venous tourniquet 
Sodium chloride 0.9% (minimum 250 
ml) 
 Sponge gauze 
Acetyl Salicylic Acid (aspirin) for oral 
use 
 Tape Adhesive 
Oral beta blocker  Surgical mask 
A list of medications (Generic names 
with trade names if and as it appears 
on the item 
 Emergency tracheal catheter (or large gauge 
intravenous cannula 
 
  Umbilical cord clamp 
If a cardiac monitor is available (with 
or without an AED) add to the above 
list: 
Epinephrine 1:10000 (can be a dilution 
of epinephrine 1:1000) 
 Thermometer 
  Basic Life Support and Advanced Life Support 
cards 
  Bag-valve mask 
  Flashlight and batteries (Operator may decide to 
have one per aircraft in an easily accessible 
location) 
  A list of equipments 
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APPENDIX B:  INCUBATION AND INFECTIVITY COMMUNICABLE DISEASE 
 
INCUBATION PERIODS OF IMPORTANT INFECTIONS 
           INFECTION                                              INCUBATION PERIOD 
 Maximum Range Usual Range 
Anthrax 2-5 days  
Amoebiasis 14-28 days 21 days 
Bacillary Dysentery 1-7 days  
Brucellosis 7-21 days  
Chicken Pox 14-21 days * Infectious 5 days before rash – 
6 days after last lesion 
Cholera Hours – days 2-3 hours 
Diptheria 2-5 days * Infectious 2-3 weeks, shorter 
with antibiotic therapy 
Filariasis 3+ months  
Gonorrhea   2-5 days  
Hepatitis A 2-6 weeks 4 weeks 
Hepatitis B 6wks – 16 mos 12 weeks 
Leishmaniasis (cutaneous) 1 wk –months  
Leishmaniasis (visceral) 2 weeks – 12 years 2-4 months 
Leprosy Months – years  
Malaria 10-14 days  
Measles 7-14 days * Infectious from onset of 
prodromal symptoms until 4 days 
after onset of rash 
Meningococcacemia 2-10 days 3-4 days 
Mumps 12-21 days * Infectious days before salivary 
swelling – 7 days after 
Pertussis 7-10 days * Infectious 7days after exposure  
to 3 weeks after onset of rash, 
shortened to 7 days by antibiotics 
Poliomyelitis 3-21 days 7-10 days 
Psittacosis 4-14 days 10 days 
Rabies Variable 2-8 weeks 
Rubella 14-21 days * Infectious 7 days before onset 
of rash – 4 days after 
Scarlet Fever 1-3 days * Infectious 10-21 days after 
onset of rash, shortened to 1 day 
by antibiotics 
Smallpox 7-17 days 11 days 
Trypanosoma (rhodesiense) 14-21 days  
Trypanosoma (gamiense) weeks - years  
Typhoid fever 7-21 days  
Typhus fever 7-14 days 12 days 
 
‘ 
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APPENDIX C: ACE STAR MODEL OF KNOWLEDGE TRANSFORMATION 
 
 
 
 
 
 
Retrieved from: http://www.acestar.uthscsa.edu/acestar-model.asp  
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APPENDIX D: GRADE SYSTEM TABLE 
 
Retrieved from http://www.ichrc.org/evaluate.html 
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APPENDIX E: UNLV BIOMEDICAL IRB NOTICE OF EXCLUDED ACTIVITY 
 
Biomedical IRB  
Notice of Excluded Activity 
 
 
DATE:  October 18, 2011 
 
TO:  Dr. Mary Bondmass, Physiological Nursing 
 
FROM: Office of Research Integrity – Human Subjects 
     
RE:  Notification of review by /Cindy Lee-Tataseo/Cindy Lee-Tataseo, BS, CIP, CIM 
 Protocol Title: Clinical Practice Guidelines for Primary Care Providers' Evaluation 
of Patient Fitness to Fly 
 Protocol# 1110-3942M 
__________________________________________________________________________________ 
 
This memorandum is notification that the project referenced above has been reviewed as indicated in 
Federal regulatory statutes 45CFR46.   
 
The protocol has been reviewed and deemed excluded from IRB review.  It is not in need of further 
review or approval by the IRB. 
 
Any changes to the excluded activity may cause this project to require a different level of IRB review.  
Should any changes need to be made, please submit a Modification Form. 
 
If you have questions or require any assistance, please contact the Office of Research Integrity – 
Human Subjects at IRB@unlv.edu or call 895-2794. 
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APPENDIX F: SUMMARY OF EVIDENCE TABLES 
Evidence Table: Cardiovascular Disorders 
 
Author/Year Study Design 
 
Study Purpose/Study 
Sample 
Study Intervention 
Study Outcome 
Results GRADE 
Quality of 
Evidence 
Ingle, 2011 Cross-sectional 
Survey 
 
Purpose: Evaluate air travel 
experiences of stable chronic 
heart failure (CHF) patients   
Sample Size: 464/1293 (39% 
response rate) cohort of 
patients from UK community 
heart failure clinic 
Intervention:  
travel by commercial aircraft 
Outcome: 
Location of health problems: 
to airport, to flight-gate, 
through security, during 
flight, disembarkation, to 
destination, at destination 
 
Type of health problems: 
breathlessness, dizziness, 
ankle edema, headache, chest 
pain, fatigue, labored 
walking, palpitations, angina 
or defibrillator firing. 
 65 % (165/252) no 
health-related problems  
 35% (46/262) problem 
at one 
location,6%(16/252) at 
two locations, 5% 
(12/252) at three 
locations and 5% at 
more than three 
locations 
 9% (8/89) problem with 
security at airport due 
to pacemaker/ICD 
 9% (8/89) in-flight 
dyspnea, dizziness, 
edema, headache and 
chest pain 
 3/8 experiencing 
dyspnea required O2 
supplementation 
 25% (22/89) had 
health-related 
cardiovascular 
problems at final 
destination 
 2/22  had defibrillator 
firing 
 27% (125/464) would 
not fly in future due to 
difficulty (32%), health 
concerns (23%) 
●●○○ 
Low 
IATA, 2011 Executive 
summary of the 
International Air 
Transport 
Association of 
travel  
restrictions 
based on expert 
opinion 
Purpose: Establish a guide to 
the timeframe that should 
elapse between a medical 
event and commercial air 
travel 
Studies utilized to establish 
recommendation were not 
identified in the report. 
Patients are cleared to fly 
without restriction who have 
the following cardiovascular 
conditions: 
Angina – no restriction if 
controlled at rest 
 
MI (uncomplicated): after ≥ 
10 days 
 
Cardiac Failure: 
controlled(able to walk 50 
meters or climb one flight of 
stairs on room air at a normal 
pace without breathlessness) 
and condition is stable. 
In-flight oxygen needs to be 
considered 
 
Pulmonary Edema: resolved 
and any precipitating 
condition  
May need to comply with MI 
rules 
 
Cardiac Surgery:  
after  ≥ 10 days 
  
●○○○ 
Very low 
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Angiography: 
 after ≥ 24 hours if original 
condition stable 
 
Angioplasty:  
after ≥ 3 days if 
asymptomatic 
 
Pulmonary embolism: 
≥ 5 days if anticoagulation 
stable and PaO2 normal on 
room air 
 
All other conditions require 
“assessment by a doctor with 
aviation medicine 
experience” (IATA, 2011 p. 
53). 
Smith, 2010 
 
Review of 
clinical studies 
and development 
of expert 
consensus 
statement by 
British 
Cardiovascular 
Society 
Purpose: establish guidance 
for general practitioners and 
passengers to determine the 
risks of travel by commercial 
air for patients with 
cardiovascular disorders. 
Studies utilized to establish 
recommendation were not 
identified in the report. 
 
Travel post acute MI: 
 Low risk passengers 
(age <65 years, fist 
event, successful 
reperfusion, EF> 45%, 
no complications and 
no planned 
interventions)  
post acute coronary 
syndrome may safely 
fly as early as 3 days 
after event. 
 Medium risk (EF>40%, 
no symptoms of heart 
failure, no evidence of 
inducible ischemia or 
arrhythmia and no 
further interventions 
planned) may fly 10 
days after 
 High risk (EF<40% 
with signs and 
symptoms of heart 
failure, those pending 
further investigation 
and possible 
revascularization or 
device therapy)  defer 
until stable 
Chronic Heart failure: 
 Stable without recent 
changes in symptoms or 
medication clear to fly. 
 NYHA class IV 
symptoms may require 
in-flight O2 
Arrhythmia: 
 symptomatically stable 
with low frequency of 
events, no restriction 
 permanent or persistent 
atrial fibrillation, 
should be be stable with 
rate control and 
●○○○ 
Very low 
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anticoagulation before 
flying 
 uncontrolled 
hemodynamically 
significant ventricular 
arrhythmia should not 
travel on commercial 
aircraft 
Cyanotic congenital heart 
disease: (Eisenmenger 
syndrome) – no restriction 
but O2 in-flight may be 
needed 
Cardiac catheterization: delay 
flight for one day post 
uneventful procedure 
Elective PCI: 
uncomplicated delay flying 
for 2 days 
 
Pacemaker insertion:  
in absence of post-insertion 
pneumothorax or other 
complications, delay flight 1-
2 days after implantation 
Ablation: 
delay until stable 
anticoagulation 
Open heart surgery: including 
coronary artery bypass 
grafting and valve 
replacement 
- without complications delay 
10 days for travel.  10days – 
6 wks postop may require 
ground assistance 
Pacemakers and ICDS: 
stable, may travel without 
restriction  
Ross, 2004 Executive 
summary of 
Canadian 
Cardiovascular 
Society based on 
expert opinion 
Purpose: establish 
recommendations for fitness 
of passengers with 
cardiovascular disease to fly 
on commercial airlines. 
Fitness to fly 
recommendations based on 
New York Heart Association 
(NYHA) functional class 
 
Angina Pectoris: 
 I & II - no restriction 
III - supplemental O2 
IV only if medically 
necessary and accompanied 
by physician with attached 
ECG/defibrillator, O2 and 
appropriate medications 
 
Post MI: 
I delay travel one to two 
weeks if uncomplicated 
II to IV – only if medically 
necessary and accompanied 
by physician with attached 
ECG/defibrillator, O2 and 
appropriate medications 
 
Heart failure: 
 I & II – unrestricted 
●●○○ 
Low 
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III - supplemental O2 
required 
 
Valvular disease: 
I & II – unrestricted, 
supplemental O2 if 
pulmonary hypertension 
III - supplemental O2 
required 
IV – only if medically 
necessary and accompanied 
by physician with attached 
ECG/defibrillator, O2 and 
appropriate medications 
 
Congenital disease: 
I & II – unrestricted, 
supplemental O2 if PaO2 < 
70mmHg 
III - supplemental O2 
required 
IV – only if medically 
necessary and accompanied 
by physician with attached 
ECG/defibrillator, O2 and 
appropriate medications 
 
Post-CABG/valve surgery: 
I-II- 4 days postop if 
hemoglobin ≥ 90g/L if flight 
< 2 hours or 7 days postop if 
hemoglobin ≥ 90g/L if flight 
≥ 2 hours 
 
Therapeutic intervention- 
PCI/ASD closure: 
I-II – 1 day postprocedure.  If 
PCI following MI, follow 
post-MI guidelines 
 
Arrhythmia/post arrhythmia 
procedure: 
I-II – unrestricted if well-
controlled supraventricular 
arrhythmia, 2 days post 
procedure for ventricular 
arrhythmias 
II-IV – restrict flying by 
commercial aircraft if 
uncontrolled 
hemodynamically significant 
ventricular arrhythmia 
 
Post-pacemaker/ICD/loop 
recorder implant: 
I-II – delay flight 1 day 
postimplant if no 
pneumothorax and device 
functions normally and is 
programmed appropriately 
ICD patients: 
I-II – delay travel 1 month 
following last intervention 
from device associated with 
severe presyncope /syncope 
Roby, 2002 Randomized, 
single-blind, 
controlled trial 
Purpose: 
1) Examine the safety of 
2% (1/38) Myocardial 
ischemia diagnosed by Holter 
monitor 
●●●○ 
Moderate 
 80 
 
patients traveling by 
commercial air 2 weeks 
after myocardial 
infarction (MI) 
2) Determine if 
supplemental oxygen 
was associated with 
reduced risk of in-flight 
adverse events 
3) Determine the need for 
a medical escort 
Sample : 38 patient with 
mean of 15-16 days post 
acute Myocardial Infarction  
Intervention:  
travel by commercial aircraft 
Oxygen 
Outcomes: 
Major endpoint: 
 Myocardial ischemia 
detected by Holter 
monitoring 
Minor endpoints: 
 Chest pain 
 Dyspnea 
 O2 saturation <90% 
13% (5/38) decreased O2 
saturation 
2 % (1/38) evidence of S-T 
depression 
5% (2/38) chest pain 
13% (5/38) ventricular 
ectopy or tachycardia 
No difference in minor 
endpoints between O2 (5/13) 
and non-O2  (6/15) groups 
(p=0.93)  
ASMA, 2003 Recommendatio
ns based on 
expert opinion 
for primary care 
and specialist 
physicians to 
advise patients 
with medical 
conditions 
Purpose: establish 
recommendations for fitness 
of passengers with 
cardiovascular and other 
medical diseases to fly on 
commercial airlines 
Studies utilized to establish 
recommendation were not 
identified in the report. 
 
Uncomplicated acute MI: 
Delay travel 2-3 weeks after 
resumption of usual daily 
activities 
 
Old MI: no contraindication 
unless significant angina or 
left ventricular dysfunction 
Severe decompensated CHF: 
flying contraindicated 
 
CABG and other chest 
surgeries: no risk after fully 
recovered without 
complications.  Recommend 
10-14 day delay post surgery 
to prevent risk associated 
with barotraumas 
 
PCI: uncomplicated: no risk 
after fully recovered without 
complications.   
PCI: complicated: delay 
travel 1-2 weeks  
Symptomatic valvular heart 
disease – flying 
contraindicated 
 
Hypertension: no 
contraindication if controlled 
 
Pacemakers/ICD: no 
contraindication if controlled 
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Cardiovascular 
contraindications to 
commercial airline flight: 
1. Uncomplicated MI within 
2-3 weeks 
2. Complicated MI within 6 
weeks 
3. Unstable angina 
4. Congestive heart failure, 
severe, decompensated 
5. Uncontrolled hypertension 
6. CABG within 10-14 days 
7. CVA within 2 weeks 
8. Uncontrolled ventricular or 
supraventricular tachycardia 
9. Eisenmenger syndrome 
10. Severe symptomatic 
valvular heart disease 
Zahger, 2000 Longitudinal 
Study 
Purpose: evaluate patients 
returning by commercial air 
after acute coronary 
syndrome, effect of timing 
and short-term complications 
Sample: 21 tourists admitted 
to an Israeli coronary care 
unit with acute coronary 
syndrome between May 1996 
– May 1999. 
 
Intervention: 
travel by commercial aircraft 
Outcomes: 
- flight duration 
- symptoms during flight 
- recurrent angina requiring 
hospitalization 
Days from acute event to 
flight home 18.2 ± 11 days 
Flight duration 12.5 ± 3 hours 
0 - Cardiac symptoms in 
flight  
90% - 19/21 remained 
symptom free at follow up 21 
days ± 13  
●○○○ 
Very Low 
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Evidence Table: Respiratory Disorders 
 
Author/Year Study Design 
Level of Evidence 
Study Purpose/Study Sample 
Study Intervention 
Study Outcome 
Results GRADE 
Quality 
of 
Evidence 
Akero, 2011 Randomized crossover  
trial 
Purpose: evaluate efficacy of pre-
flight testing of COPD patient’s to 
predict oxygen needs at 8,000 ft 
altitude  
 
Sample: 16 patients with COPD 
from two Norwegian outpatient 
pulmonary clinics 
 
Interventions: 
Hypoxia induced by a hypoxia-
altitude simulation test (HAST) 
and in a hypobaric chamber (HC) 
Oxygen 
 
Outcome: 
Pao2 with and without 
supplemental oxygen  
 
Secondary outcome – comparison 
of effect of  Pao2 on various types 
of oxygen equipment in the HC 
Without supplemental 
O2, PaO2 was lower 
during the HAST than 
in the HC (p=0.005) 
 
56% (9/16) patients 
reported dyspnea 
during exposure to 
hypoxia.  
 
Continuous oxygen at 
2L/min or an oxygen 
conserving device at 
pulse setting 2 is 
needed to reach an 
Spo2 of 90% (p<.001) 
 
 
In-flight physical 
activity resulted in a 
drop in Spo2 and 
increased supplemental 
oxygen. 
 
In a HC simulating 
altitude of 8,000ft, 
compressed gaseous O2 
with continuous flow 
or with an oxygen-
conserving device 
resulted in the same 
Pao2.  Portable Oxygen 
Concentrator (POC) 
showed significantly 
lower Pao2 values than 
continuous flow or 
oxygen conserving 
devices (p=.003) 
●●●○ 
Moderate 
Tam, 2011 Cross-sectional survey Purpose: evaluate the safety of air 
travel after percutaneous 
transthoracic needle biopsy 
(PTNB)  
 
Study population: 179 patients 
who underwent PTNB followed 
by air travel within 14 days of the 
procedure.  36% (65/179) patients 
experienced a post-biopsy 
pneumothorax prior to travel. 
 
Intervention:  
travel by commercial aircraft 
 
Outcomes: 
In-flight medial event requiring 
attention or diversion 
 
Worsening of existing respiratory 
symptoms or new onset of 
respiratory symptoms 
81% of all patients and 
77% of patients with 
post-biopsy 
pneumothorax traveled 
within 4 days of the 
final post-biopsy chest 
radiograph. 
No patient reported in-
flight medical events 
 
8% (14/179) 
experienced worsening 
of existing respiratory 
symptoms or new onset 
of symptoms during or 
after the flight. 
●●○○ 
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Bossley, 2011 Case Control Study Perform fitness to fly tests using a 
body  plethysmograph in ex-
preterm babies without 
bronchopulmonary dysplasia 
(BPD) and compare them with 
normal term babies to determine 
whether routine prefight testing 
should be recommended in ex-
preterm babies without BPD. 
41 term infants and 30 ex-preterm 
infants recruited from neonatal 
units and postnatal wards in 
Australia 
 
Intervention: 
Hypoxia induced environment in 
sealed body  plethysmograph 
Outcomes: 
Changes in SpO2, pulse and FiO2  
All subjects 
experienced a 
significant desaturation 
(median drop of 6%) 
when breathing FiO2 
0.15.   
 
No difference was 
noted between the 
healthy term and ex-
preterm babies at 3 or 6 
months corrected 
gestational age during 
testing.   
Feeding at FiOs 0.15 
resulted in a significant 
drop in SpO2 for both 
groups (P<0.0001) 
without any significant 
difference among 
groups.  The fall in 
SpO2 occurred at the 
initiation of feeding 
and was transient. 
●●○○ 
Low 
Edvardsen, 2011 Case Control Study Purpose: determine the prevalence 
of in-flight symptoms in COPD 
patients and non-COPD subjects 
and to evaluate associations 
between symptoms and pre-flight 
variables 
Subjects: 391 COPD patients and 
184 non-COPD subjects were 
recruited from hospital and 
specialist practices in Norway.  Of 
the recruited patients, 54% 
(211/391) with COPD and 86.4% 
(159/184) flew during the 
previous 2 years 
Intervention:  
travel by commercial aircraft 
Outcomes: 
lung function, blood gas values, 
Medical Research Council (MRC) 
dyspnea scale , 6-minute walk 
test, air travel habits (frequency & 
duration of travel, pre-flight 
medical consultation)  and in-
flight symptoms (dyspnea, 
dizziness, headache, chest pain, 
air hunger, cough, fainting, 
palpitations) 
One or more hypoxia 
related symptoms were 
reported by 24.6% 
(52/211) of the COPD 
group and by 8.8% 
(14/159) of the non-
COPD group (OR = 
3.4, 95% CI, 1.8-5.4, p 
< 0.001). 
 
COPD patients 
experienced 
significantly more 
frequent hypoxia-
related symptoms of 
dyspnea and air hunger 
during air travel than 
non-COPD subjects 
(P<0.001). 
 
Odds ratio for COPD 
patients to experience 
dyspnea or air hunger 
was 6.6 (95% CI, 2.5-
17.3, p<0.001) after 
adjusting for smoking 
status, age and gender 
compared to non-
COPD subjects.  
 
In-flight dyspnea 
correlated with pre-
flight sea-level MRC 
dyspnea scores.  
●●●○ 
Moderate 
IATA, 2011 Executive summary of 
the International Air 
Transport Association 
of travel  restrictions 
based on expert 
opinion 
Purpose: establish a guide to the 
timeframe that should elapse 
between a medical event and 
commercial air travel 
Studies utilized to establish 
recommendation were not 
identified in the report. 
 
Patients are cleared to 
fly without restriction 
who have the following 
respiratory conditions: 
 
Pneumothorax – 7 days 
after full inflation 
 
Chest surgery ≥ 11 
days with 
uncomplicated 
recovery 
●○○○ 
Very low 
 84 
 
 
Pneumonia – fully 
resolved or symptom 
free with X-ray signs 
persistent 
 
COPD – exercise 
tolerance >50 meters 
without dyspnea and 
stable condition.  Full 
recovery if recent 
exacerbation. 
  
All conditions not 
meeting above 
requirements for 
clearance should have 
“assessment by a 
doctor with aviation 
medicine experience” 
(IATA, 2011 p. 54). 
Thamm, 2011 Cross-sectional survey Purpose: determine the proportion 
of patients with pulmonary 
hypertension (PH) who had 
travelled by air contrary to 
medical advice 
Subjects: 430 patients completed 
the survey sent to 720 patients 
(60% response rate).  42% 
(179/430) had flown since PH 
diagnoses.   
Intervention:  
travel by commercial aircraft 
Outcomes: 
Worsening of respiratory and new 
onset of other health symptoms 
89% (159/179) had no 
adverse events during 
or directly after their 
air travel 
11% (20/179) reported 
one or more events 
associated with travel – 
3.4 %( 6) dyspnea 
3.4% (6), peripheral 
edema, 3 (1.7%) 
exhaustion, 2 (1.1%) 
heart palpitations, chest 
pain, headache or 
worsening of general 
condition.  
●●○○ 
Low 
Ahmedzai, 2011 Review of clinical 
studies and 
development of expert 
consensus statement 
by British Thoracic 
Society 
Purpose: establish guidance for 
general practitioners and 
passengers to determine the risks 
of travel by commercial air for 
patients with respiratory disorders. 
 
Studies utilized to establish 
recommendation were not 
identified in the report. 
 
Summary of potential 
risks posed by air 
travel by condition: 
 
Asthma & COPD: 
acute bronchospasm, 
hypoxemia or infective 
exacerbation 
 
Bronchiectasis: 
hypoxemia, infective 
exacerbation 
 
Lung cancer: 
hypoxemia, overall 
deterioration or sepsis 
 
Cardiac comorbidity: 
myocardial ischemia, 
hypoxemia, 
arrhythmia, peripheral 
edema, venous 
thromboembolism, 
worsening of heart 
failure 
 
Hyperventilation or 
dysfunctional 
breathing: acute 
●○○○ 
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exacerbation 
 
Airborne infections: 
hypoxia, transmission 
to other passengers 
 
HIV infection: 
exacerbation of pre-
existing opportunistic 
infection 
 
Interstitial lung 
disease: hypoxemia, 
infective exacerbation 
 
Neuromuscular disease 
and kyphoscoliosis: 
hypoxemia 
 
Obstructive sleep 
apnea syndrome 
(OSAS): worsening 
hypoxemia when 
asleep, exacerbation of 
jet lag with potential 
adverse effect on 
driving 
 
Obesity: hypoxemia, 
VTE 
 
Pneumothorax: 38% 
expansion of residual 
air at 8000ft; possible 
recurrence within at 
least 1 year unless 
pleurodesis has been 
performed via 
thoracotomy 
 
Pulmonary 
arteriovenous 
malformations 
(PAVM): hypoxemia, 
stroke, VTE and 
PAVM hemorrhage 
 
Sinus and middle ear 
disease: barotraumas 
 
Thoracic surgery: 38% 
expansion of residual 
air at 8000 ft 
 
At risk of VTE: 
increased risk of VTE 
on all flights especially 
those >8 hour or 
following multiple 
shorter journeys over a 
short period. 
Tiemensma, 2010 Case study report Patient being treated for 
pulmonary tuberculosis with a 
medical history which included 
drainage of pneumothoraces and 
pleural effusions  
Patient experienced 
shortness of breath and 
chest pain shortly after 
take-off and 
subsequently died from 
pneumothorax. 
Patients with 
●○○○ 
Very 
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pulmonary diseases 
need pre-flight 
evaluation and possible 
supplemental oxygen 
in –flight to prevent 
complications. 
Lapostolle, 2009 Case study report Two, 26 year old, female patients 
traveling long-distance (17,000km 
and 20:45h) suffered sudden 
asystolic cardiac arrest upon 
arrival 
Embolectomy and clot 
examination revealed 
that both pulmonary 
emboli were newly 
formed. 
The most likely risk 
factor for pulmonary 
embolism was long 
distance air travel 
●○○○ 
Very 
Low 
Kelly, 2009 Longitudinal cohort Purpose: quantify the hypoxemic 
response to air travel and to 
identify baseline correlates to 
predict the response in passengers 
with non-obstructive lung disease. 
Subjects: 14 volunteers (7 
female/7 male)  
Intervention: 
Hypoxemic challenge test 
Travel by commercial aircraft 
Outcomes: 
respiratory function testing, 
in-flight SpO2, cabin pressure and 
dyspnea and post flight hematocrit 
level  
13/14 subjects 
experienced in-flight 
significant hypoxia 
(SpO2 <89%) 
Respiratory function 
did not predict in-flight 
desaturation. 
Pre-flight SpO2 
measures had strongest 
correlation (r=0.91, 
p<0.001) with in-flight 
SpO2.   
Respiratory function 
testing showed no 
correlation with in-
flight measurements or 
the Hct response.   
In-flight desaturation 
did not correlate with 
increased symptoms of 
respiratory distress. 
●○○○ 
Very 
Low 
Lehmann, 2009 Cross-sectional survey Purpose: evaluate the incidence of 
travel-associated pulmonary 
embolism (PE) 
Subjects: 257 patients with PE as 
primary diagnosis at discharge 
Outcome: 
Prognosis post event  
 
18% (45/257) patients 
were identified to have 
PE associated with air 
travel, only patients 
with idiopathic PE 
(32%, n= 83) and 
thrombophilia (30%, 
n=78) occurred with 
more frequency. 
 
Intrahospital mortality 
was not statistically 
significant between 
both groups (4.3% 
overall) 
3-month mortality rate 
in both groups was 
similar (p>0.999).   
 
Low incidence of 
flight-associated PD 
(0.2 cases per 1 million 
passengers arriving at 
Frankfort airport) 
●●○○ 
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compared with other 
trial estimates 
Taveira-DaSilva, 
2009 
Cross-sectional study 
 
Purpose: determine the prevalence 
of pneumothorax associated with 
air travel in patients with 
lymphangioleiomyomatosis 
(LAM), idiopathic pulmonary 
fibrosis (IPF) and sarcoidosis 
Subjects: 281 subjects with LAM, 
76 with IPF and 92 with 
sarcoidosis admitted to NIH 
Clinical Research Center. 
Intervention:  
travel by commercial air 
Outcome:  
new onset pneumothorax 
2% (7/281) LAM 
patients had evidence 
of a new 
pneumothorax.  
Pneumothorax patients 
did not experience 
symptoms of dyspnea 
or chest pain during 
travel  
Prior history of 
pneumothorax 
correlated 100% to 
new onset 
pneumothorax 
diagnosis in LAM 
patients. 
 
None of the patients 
with IPF or sarcoidosis 
presented with 
pneumothorax. 
●●○○ 
Low 
Martin, 2008 Case-control study Purpose: investigate how well the 
pre-flight hypoxia test cutoff 
values of 85% and 90% 
discriminated between health 
children and those with neonatal 
chronic lung disease (nCLD).   
Subjects: 34 healthy children and 
35 children with a history of 
nCLD.   
Intervention: 
Hypoxia challenge test 
 
Outcomes:  
 SpO2 and heart rate  
90% cutoff value did 
not discriminate 
between the two 
groups.  12/24 healthy 
and 14/23 nCLD failed 
the hypoxia test 
(p=0.56) 
85% was more 
discriminatory test.  
1/24 healthy and 6/23 
nCLD failed hypoxia 
test (p=0.048) 
In both groups children 
> 2 years passed the 
hypoxia test at 90%. 
Children with nCLD 
who were <2 years had 
an increased risk of 
failing the hypoxia test 
at 85% cutoff (p = 
0.039) and a 
correlation was noted 
with failure and 
neonatal supplemental 
oxygen use 
●●○○ 
Low 
Kelly, 2008 Longitudinal cohort Purpose: assess the predictive 
capability of the hypoxia 
inhalation test (HIT) in passengers 
with COPD 
Subjects: 13 volunteers with 
COPD (7 female) 
 
Intervention: 
Hypoxia inhalation test 
Travel by commercial aircraft 
6-minute walk test 
Air travel caused 
significant desaturation 
preflight (95 ± 1%); 
mean in-flight (86 ± 
4%) which was 
worsened by activity 
(78 ± 6%).   
HIT resulted in 
desaturation 
comparable to that of 
air travel (84 ± 4%).   
 
●●○○ 
Low 
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Outcomes: respiratory function, 
pulse oximetry, cabin pressure 
and dyspnea 
Mean in-flight partial 
pressure of inspired 
oxygen (PIO2) was 
higher than the HIT 
PIO2 (113 ± 3 mm HG 
vs. 107 ± 1 mm Hg, p 
<0.001) 
The strongest 
correlation was found 
between the HIT SpO2 
and in-flight SpO2(r = 
0.84; p<0.001) 
 
Jones, 2008 Quasi-experimental Purpose: evaluate the role of 
ventilation-perfusion ratio (VA/Q) 
and pulmonary shunt on SpO2 of 
patients with pulmonary 
dysfunction when exposed to 
air/nitrogen mixtures as cabin 
pressure (PIO2) falls. 
Subjects: 18 patients with chronic 
lung disease 
Intervention: airline equivalent 
hypoxia delivered by nitrogen 
mixtures of 17kPa (equivalent to 
5000 ft altitude)  and 15kPa 
(equivalent to 8000 ft altitude) 
Outcomes: 
PIO2 vs. SpO2 along the PO2  axis 
and. VA/Q shunt (change of shape 
and downward shift of the same 
curve) 
During hypoxia, the 
lowest SpO2 was 
correlated with reduced 
VA/Q (R
2=0.89). 
9/10 patients with 
VA/Q ≤ 0.69 developed 
profound hypoxia.  5/9 
hypoxic had ground 
level SpO2 ≥ 92%. 
Patients with VA/Q 
>0.70 maintained SpO2 
≥84%. 
Reduced VA/Q 
predisposed to a 
greater degree of 
hypoxemia than 
increased shunt at 
15kPa PIO2. 
Measurement of VA/Q 
and shunt during 
hypoxic hypoxia 
improves prediction of 
patient need for 
supplemental O2 during 
air travel 
●●○○ 
Low 
Broberg, 2007 Cross-sectional survey Purpose: analyze experience and 
determine incidence of adverse 
events in patients with 
Eisenmenger syndrome who 
travel by air compared to controls 
with known congenital heart 
disease (CHD) 
Subjects: 53 adult patients with 
Eisenmenger syndrome, 48 
acyanotic patients with known 
CHD 
 
Intervention:  
travel by commercial aircraft 
Outcomes: 
Major adverse events requiring 
hospitalization: stroke, ischemic 
chest pain, syncope or heart 
failure 
Minor adverse events: headache, 
edema, supplemental oxygen 
No difference was 
found between groups 
for use of supplemental 
oxygen during flight (1 
of each group) 
Nonsignificant 
incidence in report of 
headache during flight 
(6/40, 9%) 
Eisenmenger and 
(4/48, 9%)control 
subjects) 
 
●●○○ 
Low 
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required during flight 
Currie, 2007 Case Report Evaluation of two adult patients 
with history of chronic 
pneumothorax requesting fitness 
to fly exams 
 
Subject : 36 year old male smoker 
and 31 year old female smoker 
both with history of stable 
pneumothorax for > 1 year 
Evaluation: review of history, 
clinical assessment, computed 
tomographic imaging, hypoxic 
challenge test and exposure to 
hypoxic hypobaric environment in 
a decompression chamber 
Both patients sustained 
oxygen saturations 
>90% during testing 
and were 
asymptomatic.   
 
Both patients 
successfully traveled 
by air without adverse 
events. 
Patients with closed 
chronic pneumothorax 
can fly without adverse 
consequences. Risk 
determination should 
be made through 
assessment, CT of 
chest, a hypoxic 
challenge test and 
simulation of flying at 
altitude in a 
decompression 
chamber with close 
monitoring of 
symptoms and oxygen 
saturation. 
●○○○ 
Very 
Low 
Udomittipong, 
2006 
Cross-sectional 
retrospective review 
Purpose: identify clinical factors 
predictive of an in-flight oxygen 
requirement from a review of 
hypoxia challenge tests  in infants 
referred for fitness to fly 
assessment  
Subjects: 47 infants with a history 
of neonatal lung disease not 
receiving O2 at the time of 
hypoxia testing 
Intervention:  
Hypoxic challenge test 
Outcome:  
SpO2, pulse rate and activity state 
81% of children 
studied exhibited 
desaturation below 
85% during hypoxic 
testing despite all 
infants having normal 
room air SpO2 ≥ 95%. 
Age at the time of 
hypoxia test 
significantly predicted 
the outcome of the 
hypoxia test (OR 0.82; 
95% CI 0.62-0.95; p = 
0.005). 
Children passing the 
hypoxia test were 
significantly older (12 
months vs. 37 weeks) 
than those requiring in-
flight oxygen 
(p<0.0001). 
●●○○ 
Low 
Kelly, 2006 Quasi-experimental Purpose: quantify the degree of 
desaturation in healthy subjects 
during a normobaric hypoxia 
inhalation test (NHIT) and air 
travel and to assess the validity of 
the NHIT when compared with 
actual in-flight responses 
Subjects: 15 health adults (age 23-
57 years: 10 women) volunteers 
 
Intervention: NHIT (inspired 
oxygen 15%), cruising altitude in 
commercial aircraft 
Significant 
desaturation was noted 
during NHIT (pre: 98 ± 
2%; post 92 ± 2%) and 
at cruising altitude 
(pre: 97 ± 1%; post 92 
± 2%) 
No difference was 
found between the final 
NHIT SpO2 and the 
mean in-flight SpO2.  
Significant difference 
●●○○ 
Low 
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Outcomes: lung function, arterial 
blood gas, pulse oximetry.  In-
flight oxygenation was compared 
with preflight NHIT. 
was noted between the 
lowest in-flight SpO2 
(88 ± 2%) versus the 
lowest NHIT SpO2 (90 
± 2%) 
Almeida, 2006 Case study 71 year-old male experiencing 
right-sided chest discomfort 
shortly after take-off of a 
commercial flight, followed by 
headache and sudden loss of 
consciousness 
48-72 hours patient admitted to 
prior treating facility was noted 
that CT scan performed prior 
imaging studies revealed a right 
pulmonary cyst 
Authors posit that pre-
existing 
intrapulmonary cyst 
expansion led to 
leakage of air into the 
surrounding vessels 
followed by brain gas 
emboli. 
●○○○ 
Very 
Low 
Humphreys, 2005 Prospective cohort 
study 
Purpose: determine the degree of 
hypoxemia during short haul and 
long haul air travel 
Subjects: 84 passengers (55 long 
haul > 2 hr duration and 29 short 
haul < 2 hr duration) aged 1-78 
years.  Subjects were anesthetists 
and their traveling companions; 
each passenger was their own 
control). 
Intervention:  
travel by commercial air 
 
Outcomes:  
SpO2  
Statistically significant 
reduction in SpO2 in all 
passengers traveling 
regardless of flight 
duration (p<0.05).   
Mean ground level 
SpO2 was 97% (93-
100; 1.33) and at 
cruising altitude was 
93% (85-98; 2.33) 
54% of healthy 
passengers had SpO2 ≤ 
94% at cruising 
altitudes 
●●○○ 
Low 
Closon, 2004 Case Report 43 year-old male asthmatic 
smoker experiencing sudden loss 
of consciousness followed by 
dyspnea and agitation 20 minutes 
after take-off of a commercial 
flight.   
 
Flight diverted and patient was 
admitted to ICU, CT scan 
demonstrated right lower lube 
bulla.   
Diagnosis of air 
embolism involving 
the brain and heart was 
made based on the 
presence of the 
pulmonary cyst. 
●○○○ 
Very 
Low 
ASMA, 2003 Recommendations 
based on expert 
opinion for primary 
care and specialist 
physicians to advise 
patients with medical 
conditions 
Establish recommendations for 
fitness of passengers with 
pulmonary and other medical 
diseases to fly on commercial 
airlines 
Studies utilized to establish 
recommendation were not 
identified in the report. 
 
Ground level PaO2 of 
>70 mm Hg does not 
require restriction. 
PaO2 of <70 mm Hg 
may be effectively 
managed with in-flight 
medical oxygen 
therapy. 
Hypercapnea (elevated 
Pco2 = poor pulmonary 
reserve and indicates 
potential risk at 
altitude, even with 
oxygen therapy. 
Fitness to fly testing: 
Most practical: 50 yard 
walk without severe 
dyspnea 
●○○○ 
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More sophisticated 
testing: hypoxia 
altitude simulation test 
or HAST.  If Pao2 is 
low during testing (<55 
mm HG), medical 
oxygen must be 
considered. 
 
Asthma – air travel 
contraindicated if 
asthma is labile, severe 
or passenger has had 
recent hospitalization. 
COPD – preflight 
evaluation by Pao2, 
HAST or ability to 
walk & climb stairs is 
extremely important 
 
Bronchiectasis and 
cystic fibrosis – no 
restriction if lung 
infection controlled 
and secretions are 
loose and clear 
Pneumothorax – travel 
contraindicated for 2-3 
weeks after successful 
draining. 
Pleural effusion – 
delay travel for 14 days 
post drainage and 
clearance by CXR 
prior to travel 
Pulmonary vascular 
disease – medical 
oxygen, 
anticoagulation and 
restriction from 
exercise during flight 
to reduce risk of 
hypoxia-induced 
pulmonary 
vasoconstriction. 
 
Lee, 2002 Prospective cohort 
study 
Purpose: determine the degree of 
oxygen saturation decline 
occurring in children during long-
haul commercial air travel 
Subjects: 80 healthy children (43 
boys) ages 6 mos – 14 years 
flying between Honolulu Hawaii 
and Taipei, Taiwan.  
 
Intervention: travel by 
commercial aircraft  
 
Outcomes: SpO2 and heart rate 
preflight at sea level compared to 
3 hours and 7 hours in flight. 
Mean SpO2 declined 
from mean sea-level 
SpO2 of 98.5 to 95.7% 
after 3 hours and 
94.4% after 7 hours 
(p<0.001).   
Mean heart rate (BPM) 
increased from sea 
level of 100 BPM to 
105BPM after 3 hours 
and 108BPM after 7 
hours of flight 
(p<0.001 and p=0.01) 
●●○○ 
Low 
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Evidence Table: Venous Thromboembolism(VTE) 
 
Author/Year Study Design 
Level of Evidence 
Study Purpose/Study Sample 
Study Intervention 
Study Outcome 
Results GRADE 
Quality of 
Evidence 
MacCallum, 
2011 
Case-control study Purpose: quantify the risks of VTE 
associated with both long-haul air 
travel and cumulative flying time. 
 
Subjects: 550 VTE cases identified 
from practice records. 1971 controls. 
 
Intervention: travel by commercial 
air 
 
Outcomes:  
VTE, duration of travel 
Patients flying >12 hours within 
4 weeks before VTE had a 
threefold increase in the risk of 
VTE (OR 2.75, 95% CI, 1.44-
5.28) 
 
Patients flying >4 hours within 
4 weeks before VTE had a two-
fold increase risk of VTE (OR 
2.2, 95% CI, 1.29-3.73) 
 
No association between flying 
time and VTE was noted more 
than 12 weeks prior to VTE 
diagnosis. 
●●●○ 
Moderate 
Schreijer, 2010 Quasi-experimental Purpose: determine if hypoxia, 
stress, inflammation or viral 
infection are contributors to the 
prothrombotic state in air travelers.   
 
Subjects: 71 healthy adult volunteers 
 
Interventions: 
8 hour flight 
8 hour movie marathon 
8 hours of regular activities 
 
Outcomes: 
Plasminogen activator inhibitor-1 
(PAI-1), stress, plasma factor (F) 
VIII coagulant activity (FVIIIc), 
soluble P-selectine (sP-selectine), 
interleukin-8 (IL-8) and neutrophil 
elastase. 
PAI-1 increased by 4.2ng mL-1 
(CI95:-49.5 to 6.5) in volunteers 
with an activated clotting 
system and decreased in those 
without (-20.0ng mL-1, CI95:-
33.2 to-14.0).  FVIIIc levels 
rose more in individuals with 
clotting activation (18.0%, CI 
95:-1.0to 33.0) than in those 
without (2.0%, CI95:  -2.0 to 
5.0).  The increases in FVIIIc 
were not associated with stress, 
which was found to be unrelated 
to clotting activation.  sP-
selectin increased in those with 
clotting activation (3.5 µgL-1, 
CI95:-3.0to 10.0) and decreased 
in those without  
(-0.5 µgL-1, CI95:-2.0to 2.0)  
No difference was found in 
change in level of neutrophil 
elastase or IL-8 between subject 
groups. 
 
Results of the study do not 
support the hypotheses that 
stress, infection, or air pollution 
are involved in prothrombotic 
state development in air 
travelers.    
 
The authors posited that after 
long haul air travel, patients 
with risk factors may have a 
more pronounced state which 
may be caused by hypoxia, 
triggering systemic 
inflammation and platelet 
activation resulting in 
coagulation induction and 
degranulation of platelets. 
●●○○ 
Low 
Chandra, 2009 Meta-analysis Purpose: estimate the risk for VTE 
in travelers, determine whether a 
dose-response relationship exists 
and identify reasons for 
contradictory results in previous 
studies 
 
Compared with non-travelers, 
the overall pooled relative risk 
for VTE in travelers was 2.0 
(95%CI, 1.5-2.7). 
 
Excluding studies that used 
referred control participants 
●●●○ 
Moderate 
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Data Synthesis: 1560 abstracts were 
identified of which 14 studies (11 
case-control, 2 cohort and 1 case-
crossover) met inclusion criteria 
including 4055 cases of VTE 
resulted in an increased pooled 
relative risk for VTE in 
travelers to 2.8 (95% CI, 2.2-
3.7).  
 
A dose-response relationship 
was identified with an 18% 
higher risk for VTE for each 2-
hour increase in duration of 
travel by any mode (p = 0.010) 
and a 26% higher risk for every 
2 hours of air travel (p = 0.005). 
Kuipers, 2007 Systematic review 
of the literature 
Purpose: quantify the risk of VTE 
after long-distance travel. 
 
Data Synthesis: 528 Abstracts were 
reviewed and screened to 10 case-
control studies, 20 observational 
follow-up studies, 11 intervention 
studies and 14 pathophysiological 
studies.   
Long distance travel increased 
the risk of VTE two to fourfold.  
The absolute risk of VTE within 
4 weeks of flights longer than 4 
hours is 1/4600 fights.  The risk 
of severe pulmonary embolism 
(PE) occurring immediately 
after air travel increases with 
duration of travel from 0 in 
flights shorter than 3 hours up to 
4.8 per million in flights lasting 
longer than 12 hours.    The risk 
of fatal PE immediately after 
arrival is estimated at <0.6 per 
million passengers in flights 
longer than 3 hours.  The risk of 
VTE is not increased after travel 
shorter than 3-4 hours.  The risk 
of asymptomatic VTE after 
long-haul flights ranged up to 
12%. 
●●●○ 
Moderate 
Schreijer, 2008 Case-control study Purpose: Evaluate the effect of 
flight-related behavior on the risk of 
VTE after air travel 
 
Subjects: 80 patients and 108 control 
subjects who had travelled more 
than 4 hours by plane within 8 
weeks of the data collection. 
Intervention: travel by commercial 
air 
  
Outcomes:  
Venous thrombosis, anxiety, sleep, 
seat assignment, exercise, alcoholic 
beverage consumption 
 
The risk of VTE was slightly 
lower in passengers who flew 
business class compared to 
economy class (OR0.7; 95%CI; 
0.2-1.8)  Passengers seated in a 
window seat had a more than 
twofold increased risk of VTE 
than passengers who were 
seated at an aisle seat (OR 2.2; 
95%CI;1.1-4.4).  Risk increased 
with obesity (BMI>39 kg/m2, 
OR 6.1;95%CI:0.5-76.2 after 
adjustment for age and gender)  
and was also increased in 
overweight participants (BMI 
25-30 kg/m2, OR 2.6; 
95%CI:0.7-9.3).   
No increased risk was noted in 
passengers who were seated in 
the middle seat.  The use of 
alcohol did not increase the risk 
of VTE.  Drinking one glass of 
alcohol appeared to have a 
protective affect compared to 
non-alcohol drinkers (OR 0.5; 
95%CI: 0.2-1.2).    
With every hour of sleep, the 
risk of VTE after air travel 
increased by 10% (OR 1.10; 
95%CI: 0.2-1.2).   Passengers 
who slept during the flight had a 
1.5-fold increased risk of VTE 
compared to passengers who did 
not sleep during flight.   
Subjects who noted anxiety 
during travel had an increased 
relative risk of thrombosis of 
●●○○ 
Low 
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2.5 (OR 2.5; 95%CI: 0.9-7.0). 
 
Preventive measures of drinking 
non-alcoholic beverages, 
exercising during flight or 
wearing compression stockings 
did not have a protective effect. 
Kuipers, 2007 Cohort Study Purpose: to assess the absolute risk 
of venous thrombosis after air travel 
 
Subjects: 8,755 employees exposed 
to long-haul flight 
 
Outcome: VTE 
Incidence rate of 3.2/1000 PY 
compared to 1.0/000 PY in 
individuals not traveling by air 
(IRR 3.2, 95%CI: 1.8-5.6).  The 
rate was equivalent to a risk of 
one VTE per 4,656 long-haul 
flights.    Risk increased with 
exposure to more flights within 
a short time frame and with 
increasing flight duration.  
Higher risks were noted in 
travelers less than 30 years, 
women using oral 
contraceptives and individuals 
who were overweight, short or 
tall. 
●●○○ 
Low 
WHO, 2007 Meta-analysis Purpose: confirm the risk of VTE is 
increased by air travel and determine 
the magnitude of risk, the effect of 
other factors on the risk and to study 
the effect of preventive measures on 
risk 
 
Two-fold increased risk of VTE 
after long-haul flight of > 4 
hours.  Increased risk applied to 
other forms of travel (car, bus or 
train) where travelers were 
exposed to prolonged seated 
immobility.  Risk increases with 
the duration of travel and with 
multiple flights over a short 
period.  Obesity, height 
extremes, use of oral 
contraceptives and the presence 
of prothrombotic blood 
abnormalities were found to 
contribute to increased risk of 
travel-related VTE.   
The absolute risk of VTE per 
more than 4 hours flight in a 
cohort of healthy passengers 
was 1 in 6,000. 
●●●○ 
Moderate 
Philbrick, 2006 Systematic Review Purpose: To review the 
methodologic strength of the 
literature, estimate the risk of travel-
related VTE, evaluate the efficacy of 
preventive treatments and develop 
evidence-based recommendations 
for practice. 
 
Study selection: all clinical studies  
reporting primary data concerning 
travel as a risk factor for VTE or 
testing preventive measures for 
travel-related VTE were included 
 
Data Synthesis: 25 studies met 
inclusion criteria – 6 case control 
studies, 10 cohort studies and 9 
randomized controlled trials.   
Method of screening for VTE 
(ultrasound versus clinical 
assessment, OR 390), outcome 
measure (all VTE compared to 
PE only, OR 21), duration of 
travel (<6 hours compared to 6-
8 hours , OR 0.011) and clinical 
risk (higher compared to lower 
OR 3.5) were significantly 
related to VTE rate.   
 
Graduated compression 
stockings prevented travel-
related VTE (p<0.05 in 4 of 6 
studies).  Aspirin and low-
molecular-weight heparin  
failed to demonstrate significant 
protective benefits in any of the 
studies. 
●●●○ 
Moderate 
Aryal, 2006 Literature Review Purpose: to quantify the risk of VTE 
following air travel and assess 
methods of prevention 
 
Study Selection: 43 studies were 
found relevant to the study variables, 
18 of which met the inclusion 
An association of VTE with air 
travel was found to have a 
pooled odds ration 1.59 (CI 
1.04-2.43) from three case 
control studies and a relative 
risk of 2.93 (CI 1.5-5.58) in two 
cohort studies.   
●●○○ 
Low 
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criteria – 5 case control studies, 2 
controlled cohort and 8 randomized  
controlled trials. 
 
Outcome: 
VTE with air travel 
 
 
The incidence of pulmonary 
embolism increases when the 
distance travelled is more than 
5,000 miles (1.5 PE per million 
passengers) or the flight time is 
more than 8 hours in duration  
(2.57 PE/1 million passengers). 
 
The quantitative risk of lower 
limb VTE after long haul flights 
in high risk-subjects was 5% per 
flight and 1.6% per flight in low 
risk subjects. 
Schwarz, 2003 Prospective, 
controlled cohort 
study 
Purpose: To assess the incidence of 
venous thrombosis with long-haul 
flights 
 
Subjects: 964 passengers with flight 
durations  ≥  hours and 1213 non-
traveling control subjects. 
 
Intervention: travel by commercial 
air 
 
Outcome:  
Venous thrombosis diagnosed by 
ultrasound 
Symptomatic pulmonary embolism 
and death 
The risk of venous thrombosis 
after air travel of  ≥ 8 hours 
duration was double for isolated 
calf muscle venous thrombosis 
when compared to non-traveling 
controls (RR 2.83, 95% CI, 
1.46-5.49) 
 
Symptomatic pulmonary 
embolism occurred in only 1 
passenger (p=.44) 
●●○○ 
Low 
Jacobson, 2003 Prospective study Purpose: To determine the incidence 
of DVT in low and intermediate-risk 
passengers comparing passengers 
travelling in business and economy 
class. 
 
Subjects: 434 subjects 
 
Outcomes:                       DVT as 
diagnosed by ultrasound, D-dimer 
levels 
No passengers developed VTE 
by ultrasound.   
 
10%  of passengers travelling 
by air had elevated D-dimer 
levels upon arrival at destination 
regardless of class travelled by 
air (OR 0.61, p=0.038).   
●●○○ 
Low 
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Evidence Table: Blood Disorders 
 
Author/Year Study Design 
Level of Evidence 
Study Purpose/Study 
Sample 
Study Intervention 
Study Outcome 
Results GRADE 
Quality of 
Evidence 
IATA, 2011 Executive summary of 
the International Air 
Transport Association 
of travel  restrictions 
based on expert 
opinion 
Establish a guide to the 
timeframe that should 
elapse between a 
medical event and 
commercial air travel 
Studies utilized to 
establish 
recommendation were 
not identified in the 
report. 
 
Patients with hemoglobin 
levels <9.5 g/dl should defer 
travel until hemodynamically  
stable. If acutely anemic, Hgb 
level should be assessed more 
than 24 hrs after last 
 
Sickle Cell Disease- travel is 
not recommended within 9 
days of sickling crises.  
Travel clearance can be 
provided after 10 days.  
Oxygen supplementation is 
always needed. 
  
All conditions not meeting 
above requirements for 
clearance should have  
“assessment by a doctor with 
aviation medicine 
experience” (IATA, 2011 p. 
54-55). 
 
●○○○ 
Very Low 
ASMA, 2003 Recommendations 
based on expert 
opinion for primary 
care and specialist 
physicians to advise 
patients with medical 
conditions 
Establish 
recommendations for 
fitness of passengers 
with pulmonary and 
other medical diseases 
to fly on commercial 
airlines 
Studies utilized to 
establish 
recommendation were 
not identified in the 
report. 
 
Special consideration 
should be given to anyone 
with a hemoglobin 
below 8.5 g /dl  due to 
increased risk of  
lightheadedness or loss of 
consciousness 
during flight, particularly 
with physical exertion during 
flight. 
 
Sickle cell disease, may be 
exacerbated by reduced 
oxygen 
Pressures during flight. 
Because such a crisis could 
be life-threatening, sickle cell 
patients should be advised 
not to travel by air without 
medical oxygen. 
●○○○ 
Very Low 
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Evidence Table: Neurologic Disorders 
 
Author/Year Study Design 
Level of Evidence 
Study Purpose/Study 
Sample 
Study Intervention 
Study Outcome 
Results GRADE 
Quality of 
Evidence 
Berilgen, 2011 Retrospective Case 
Reviews 
Purpose: To determine 
if there are specific 
characteristics of 
headaches associated 
with air travel  
 
Subjects: 22 cases of 
headache referred to an 
outpatient Neurology 
clinic 
 
Outcome:  
ENT examination, 
Neurologic 
examination, Brain 
MRI & MRA, CT of 
paranasal sinus, 
description of 
headache by timing, 
location, quality, 
intensity, duration, 
accompanying 
symptoms, pre-existing 
diseases and other 
primary headache 
history 
Airplane headache 
characterized as starting 
suddenly during ascent and/or 
descent of the aircraft, mean 
duration 20 minutes, usually 
unilaterally and commonly 
localized to the periorbital 
region.  Described as severe, 
stabbing or jabbing, and 
generally subsides in a short 
time period. 
 
Authors proposed that 
headache associated with 
airplane travel results from 
the temporary local 
inflammation caused by 
hypoxia or dryness in the 
sinus mucosa or sinus 
barotraumas. 
 
All 22 subjects reported 
headache during flight.  
Headache associated with 
airplane travel did not occur 
in 95% of the patients in 
subsequent flights when they 
received naproxen sodium 
(550mg) 1 hour prior to take 
off. 
●○○○ 
Very Low 
Arnaiz, 2011 Case report 52 year old woman 
who experienced 
sudden episode of 
dyspnea and a 5-
minute generalized 
tonic-clonic seizure 
followed by loss of 
consciousness. The 
patient had 
experienced two 
similar episodes on 
prior flights and had no 
non-flight related 
seizure activity. 
CT of head revealed small 
corticosubortical gas emboli 
and subsequent thoracic CT 
demonstrated a large 
bronchogenic cysts on the 
right lung. 
 
●○○○ 
Very low 
Alonso-Canolvas, 
2011 
Prospective analysis of 
registry of referred 
patients 
Purpose: To study 
neurological problems 
associated with air 
travel 
 
Subjects: 77 patients 
with neurologic 
problems associated 
with air travel 
 
Outcomes:  
Seizures, stroke, 
alternative diagnosis 
53.2% (41/77) presented with 
seizures of which 61% (25) 
had no prior seizure history.  
Long flight duration was 
noted in 53.6% of the cases.  
56.6% (19) subjects had a 
history of regular or recent 
use of drugs , especially 
alcohol (14; 34.1%).  51.2 
%(21) had a single seizure, 
31.7% (13) multiple and 
17.1% (7) had status 
epilepticus.  Of the 13 
patients with known epilepsy, 
10 had missed doses of 
antiepileptics in prior days, 4 
had sleep deprivation and 3 
had used recreational drugs 
●●○○ 
Low 
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Stroke 
23.4% (18/77) had diagnoses 
of stroke.  Of those affected 
hypertension was noted in 10, 
tobacco use in 4, cardiopathy 
with high embolic risk in 4, 
hypercholesterolemia in 3 and 
diabetes mellitus in 1.  10.4% 
(8 patients) had an ischemic 
stroke and 10.4% (8 patients) 
patients had an intracranial 
hemorrhage. 
 
26% (20/77) cases had an 
alternative diagnosis: drug 
toxicity (4), non-organic 
symptoms (4), syncope (2), 
peripheral neuropathy (2), 
delirium (2), neoplasms of the 
CNS (2), viral 
meningoencephalitis (1), 
chronic stroke (1), migraine 
with aura (1) and transient 
global amnesia (1) 
IATA, 2011 Executive summary of 
the International Air 
Transport Association 
of travel  restrictions 
based on expert 
opinion 
Establish a guide to the 
timeframe that should 
elapse between a 
medical event and 
commercial air travel 
Studies utilized to 
establish 
recommendation were 
not identified in the 
report. 
 
Patients are cleared to fly 
without restriction who have 
the following respiratory 
conditions: 
 
Transient Ischemic Attack – 2 
days after evaluation 
 
CVA 5-14 days if stable or 
improving with a nurse 
escort.  Supplemental oxygen 
is recommended the first 2 
weeks after stroke 
 
Grand mal fit ≥ 24 hours if 
generally well controlled 
 
Cranial surgery ≥ 10 days, 
cranium free of air and 
adequate general condition. 
 
All conditions not meeting 
above requirements for 
clearance should have  
“assessment by a doctor with 
aviation medicine experience” 
(IATA, 2011 p. 54). 
●○○○ 
Very Low 
Parees, 2010 Case Report 44 year old woman 
with an acute anterior 
circulation stroke after 
a transatlantic flight.   
CT and MRA revealed a 
single pulmonary 
arteriovenous malformation 
in the lower right lung lobe. 
●○○○ 
Very low 
Ipekdal, 2010 Case Report Three cases of airplane 
headache were 
reported on in children 
ages 12, 13, & 14 
Barotrauma due to nasal 
mucosal inflammation, 
adenoidal and tonsillar 
hypertrophy and sinusitis 
were found to be the 
causative factors for the 
airplane headache. 
●○○○ 
Very low 
Domitrz, 2010 Case Report Case report of a 
“young man” with 
airplane headache 
Author posits that 
pathophysiology of airplane 
headache is unclear and 
secondary causes must be 
ruled out. 
●○○○ 
Very low 
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Seth, 2009 Case Report 51-year-old male post 
craniotomy for a 
glioblastoma 
multiforme and the 
determination of 
fitness to fly 
The authors noted concerns 
for post-surgical 
pneumocephalus based upon 
literature review encountering 
only case reports and posited 
that the absence of any intra-
cranial air is the best indicator 
of fitness to fly.   
●○○○ 
Very low 
Almeida, 2007 Case Report 62-year-old female 
who became 
unresponsive and rigid 
20 minutes into a 
commercial flight from 
Denver to Omaha 
Bilateral acute infarcts 
associated with cerebral 
edema secondary to air 
emboli were noted on CT of 
the head.  CT of the chest 
with contrast revealed a large 
thin-walled cystic lesion with 
a small air-fluid level 
consistent with the diagnosis 
of congenital cystic 
adenomatoid malformation. 
●○○○ 
Very low 
Mainardi, 2007 Case Report A case of airplane 
headache was reported 
in Italy 
First Italian reported case of a 
headache consistent with the 
characteristics of  airplane 
headache. 
●○○○ 
Very low 
Aquilina, 2006 Case Reports Two case reports of air 
travelers – an 81-year-
old male and a 74-year 
old female who 
experienced cognitive 
impairment 
precipitated by travel 
Both cases had an association 
between air travel and a 
sudden decline in cognitive 
function which presented 
initially as delirium.  The 
only diagnostic changes 
found on examination were 
cerebral ischemia and partial 
improvement occurred in both 
cases after several months. 
●○○○ 
Very low 
Berilgen, 2006 Case Reports Six case reports of 
headache associated 
with airplane travel 
All patients were male, 
suffering from severe, short 
lasting, unilateral, periocular 
localized cluster-like 
headaches. None of the 
patients had a prior history of 
cluster headache.  Attacks 
lasted between 15-20 minutes 
and resolved spontaneously.   
 
The authors posit that 
barotraumas caused by 
changes in cabin pressure 
during take-off and landing 
could affect the ethmoidal 
nerves and/or nocioceptors in 
the ethmoidal arteries 
activating the 
trigeminovascular system 
resulting in headache. 
●○○○ 
Very low 
Trevorrow, 2006 Prospective survey 
 
Purpose: determine if 
air travel increases 
seizure activity both 
during and after flying, 
and to identify flight 
characteristics that 
promote increased 
seizure activity  
 
Subjects: 37 patients 
with known seizure 
diagnosis 
 
Intervention: travel by 
commercial aircraft 
 
Seizures were significantly 
more common after flying 
(p=.02).   
 
No in-flight seizure activity 
was noted by participants 
 
Participants experiencing an 
increase in seizure frequency 
had: a higher baseline seizure 
frequency (p = .004),  were 
more likely to have 
experienced increased seizure 
activity after flying (p= .001), 
were more worried about 
having a seizure while flying 
●●○○ 
Low 
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Outcomes: 
Self-monitored seizure 
activity 
(p=.001) and were more 
likely to avoid air  travel 
(p=.02). 
There was no significant 
correlation between distance 
traveled, time zones crossed, 
duration of flight or direction 
of flight with increased 
seizure activity. 
Belvis, 2005 Case Report 36-year-old female 
with no significant 
medical or family 
history had onset of 
dyspnea followed 20 
minutes later by 
depressed level of 
consciousness, right 
hemiparesis and global 
aphasia after an 11.35 
hour flight from Peru 
to Spain. 
A pulmonary scintigraphy 
demonstrated a pulmonary 
thromboembolism and a 
cranial MRI revealed 
ischemic infarct in the left 
middle cerebral artery.  
 
The authors posit that the 
appearance of a stroke 
following long-haul travel 
was suggestive of paradoxical 
embolism through a patent 
foramen ovale. 
●○○○ 
Very low 
Kakkos, 2003 Case Report and 
literature review 
49-year-old male who 
collapsed two days 
after traveling by air 
for 19 hours from 
Alaska to London. 
The authors located 12 
similar cases of stroke 
occurring in close 
approximation to long-haul 
flight travel.  Venous 
thromboembolism was parent 
in 58% and patent foramen 
ovale was diagnosed in all but 
one case.   
●○○○ 
Very low 
Foerch, 2003 Case Reports Report of three long-
distance air passengers 
(ages 21, 63 & 64 
years) with first-time 
neurological deficits 
that occurred during 
long-haul flights 
Embolic cerebral ischemia 
with persistent foramen ovale 
was found by MRI in all three 
cases.  No venous thrombosis 
was found on scans of the 
patient’s legs. 
●○○○ 
Very low 
Lapostolle, 2003 Case Reports Four cases of stroke 
associated with 
pulmonary embolism 
and deep venous 
thrombosis associated 
with long-haul travel 
Patent foramen ovale was 
found to be the mechanism 
for ischemic stroke in all four 
cases.   
●○○○ 
Very low 
ASMA, 2003 Recommendations 
based on expert 
opinion for primary 
care and specialist 
physicians to advise 
patients with medical 
conditions 
Establish 
recommendations for 
fitness of passengers 
with neurologic and 
other medical diseases 
to fly on commercial 
airlines 
Studies utilized to 
establish 
recommendation were 
not identified in the 
report. 
 
Patients with epilepsy can fly 
safely but should be made 
aware of the potential seizure 
threshold-lowering effects of 
fatigue, delayed meals, 
hypoxia and disturbed 
circadian rhythm if passing 
through multiple time zones. 
Patients who have had a 
recent cerebral infarction or 
other acute neurological event 
should not travel until 
neurological condition is 
stable.  
●○○○ 
Very Low 
Sirven, 2002 Retrospective review 
of medical incidents 
that led to flight 
diversions 
Purpose: analyze the 
frequency of 
neurologic events 
during commercial 
airline flights and to 
assess whether 
onboard emergency 
medical kits were 
adequate for in-flight 
Neurologic symptoms were 
the most frequent source of 
emergency calls and the 
fourth most likely cause for 
flight diversion.   
 
Incidence of symptoms: 
Dizziness/vertigo (354)  
Seizures (131) 
●●○○ 
Low 
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neurologic 
emergencies. 
 
Subjects: 2,042 
medical incidents 
leading to 312 
diversions between 
1995-2000 reported to 
the Mayo clinic air-to-
ground medical service 
 
Outcomes: 
Neurologic symptoms 
reported in-flight 
Headache (37) 
Loss of 
consciousness/syncope (34) 
Pain (no organ system) (25) 
CVA (21) 
Confusion (6) 
Numbness (6) 
Tremor (2) 
 
The authors posited that 
pressurization of the cabin, 
turbulence and hypoxemia 
may be causative factors for 
neurologic symptoms in-
flight 
 
  
 102 
 
Evidence Table: Ophthalmology, Otolaryngology & Allergy 
 
Author/Year Study Design 
Level of Evidence 
Study Purpose/ 
Study Sample 
Study Intervention 
Study Outcome 
Results GRADE 
Quality of 
Evidence 
IATA, 2011 Executive summary of 
the International Air 
Transport Association 
of travel  restrictions 
based on expert 
opinion 
Establish a guide to the 
timeframe that should 
elapse between a 
medical event and 
commercial air travel 
Studies utilized to 
establish 
recommendation were 
not identified in the 
report. 
 
Patients are cleared to fly 
without restriction who have 
the following conditions: 
 
Otitis Media & Sinusitis – if 
able to clear ears and not 
acutely ill 
 
Middle ear surgery ≥ 10 days 
post operatively with medical 
certificate from treating ENT 
 
Tonsillectomy ≥ 4 days 
 
Wired Jaw – if escorted with 
cutters or self quick release 
wiring 
 
Penetrating eye injury ≥ 7 
days after injury 
 
Intra-ocular surgery ≥ 7 days 
post operative 
 
Cataract surgery ≥ 24 hour 
 
Corneal laser surgery ≥ 24 
hour 
  
All conditions not meeting 
above requirements for 
clearance should have 
“assessment by a doctor with 
aviation medicine 
experience” (IATA, 2011 p. 
54-55). 
●○○○ 
Very Low 
Bayer, 2008 Longitudinal cohort Purpose: to investigate 
the effect of air flight 
on intraocular pressure 
(IOP) 
 
Subjects: 25 healthy 
volunteers 
 
Intervention: Cruising 
cabin pressure of 
8,000ft 
 
Outcomes: Change in 
IOP  
Baseline IOP 14.2 ± 2.7 
mmHg.  Non-significant 
reduction at reaching cruising 
altitude -0.2 ± 2.7 mmHg (-
1.4%). 
 
Significant IOP reduction 
12.3 ± 2.5 mmHg (-13.4%) 
on the second hour of flight 
(p=0.005) and after landing 
12.0 ± 1.7 mmHg (-15.8%) 
(p=0.001).   
●●○○ 
Low 
Comstock, 2008 Cross-sectional survey Purpose: Characterize 
reactions to foods 
experienced by 
passengers on 
commercial planes 
 
Subjects: 41 
respondents with 
known nut and seed 
allergy 
 
Outcome: 
9% (41/471) respondent’s 
self-reported nut and seed 
allergy associated with air 
travel.  10% (4/41) had 
experienced more than one 
reaction on an airplane. 
 
Mode of exposure: 58% 
(n=26) inhalation, 9% (n=4) 
contact, 33% (n=33%) 
ingestion. 
 
●○○○ 
Very Low 
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Self-report of allergic 
symptoms and severity 
or reaction by 
symptoms of pruritus, 
urticaria, flushing, 
angioedema, nasal 
congestion, sneezing,  
nausea vomiting, throat 
tightness or throat 
pruritus, diarrhea, 
hoarseness, wheezing, 
cyanosis, mild 
hypotension or light-
headedness ,respiratory 
arrest, severe 
hypotension or loss of 
consciousness 
 
63% reported carrying 
epinephrine although 80% 
had been given a 
prescription. 
 
Peanuts were the primary 
cause of reaction (73%) 
followed by tree nuts (18%), 
sesame seeds (4.5%) and 
mixed nuts (4.5%).   
 
80% of reactions during 
flight caused moderate-to-
severe symptoms by self-
report  
 
29% (12/41) individuals 
reported the reaction to a 
flight attendant 
 
32% (11/34) experiencing 
moderate to severe reactions 
reported the reaction a flight 
attendant. 
 
Mahmood, 2003 Cross-sectional survey Purpose: to determine 
current professional 
advice to patient 
related to air travel 
following zygomatic 
fractures 
 
Subjects: 184 oral and 
maxillofacial surgeons 
(OMFS) in the United 
Kingdom.  71% 
response rate 184/261 
questionnaires sent. 
 
Outcomes: Length of 
time to refrain from 
travelling by air 
No restrictions were advised 
by OMFS for: 
40% open reduction and 
internal fixation 
42% closed reduction 
47% non-operative 
management 
 
30% advised delay of travel 
for 8-14 days 
 
15% advised delay of travel 
for 3-8 weeks 
 
  
●●○○ 
Low 
ASMA, 2003 Recommendations 
based on expert 
opinion for primary 
care and specialist 
physicians to advise 
patients with medical 
conditions 
Purpose: establish 
recommendations for 
fitness of passengers 
with medical diseases 
and conditions to fly on 
commercial airlines 
Studies utilized to 
establish 
recommendation were 
not identified in the 
report. 
Post-op facial plastic surgical 
procedures, tonsillectormy & 
adenoidectomy, palatoplasty, 
nasal or facial fractures can 
fly once postoperative 
bleeding risk has passed after 
clearance by their surgeon 
(usually 1-2 weeks). 
●○○○ 
Very Low 
Monaghan, 2002 Case Report Report of orbital 
emphysema caused by 
pressure changes 
during air travel 
 
Subject: 21 year old 
male 
Subject hit his face on a curb 
resulting in laceration repair 
and routine radiological 
examination after injury.  
Subject flew 2 days post-
injury and developed intense 
pain in the affected eye and 
edema of the periorbital 
tissues with residual double 
vision and eye pain. 
 
Post-flight CT revealed an 
orbital floor fracture with 
large quantities of intraorbital 
air with proptosis of the 
●○○○ 
Very Low 
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globe 
Jassar, 2001 Controlled cohort 
study 
Purpose: evaluate 
whether air travel 
affects graft take rates 
after myringoplasty 
 
Subjects: 37 adult and 
pediatric post-
myringoplasty  subjects 
who traveled by air 
within a week of 
surgery compared with 
37 matched non-
traveling post-
myringoplasty 
 
Intervention: 
45-60 minute flight 
duration 
 
Outcome: 
Graft status at first 
follow-up 
No difference in take rates 
between study and control 
groups (p=0.32) 
 
 95% CI of difference in take 
rates were -9% (flying group 
9% worse) to 27% (flying 
group 27% better). 
●○○○ 
Very Low 
Mills, 2001 Nonrandomized 
comparative trial 
Purpose: To investigate 
the safety of air flight 
for patients with small 
volumes of residual 
postoperative 
intraocular gas 
 
Subjects: 17 eye (9 gas 
filled (7 with 10-15% 
gas volume and 2 with 
20% gas volume) and 8 
control eyes) of nine 
eye patients and one 
eye of one control 
subject 
 
Outcome: absolute and 
percentage change in 
IOP with varied cabin 
pressure 
Results of 10-15% gas 
volume group: IOP increased 
an average of 109% from 
baseline during ascent to an 
average cabin altitude of 
7429 ft.  IOP decreased to 
30% above baseline during 
cruise altitude and further 
decreased to an an average of 
38% below baseline on return 
to baseline altitude.  
 
Results for 20% gas volume 
group: 
IOP raised an average of 84% 
from baseline during ascent 
and dropped to an average of 
42% below baseline on return 
to baseline altitude.  
 
IOP in the contralateral 
control eyes did not vary with 
altitude changes. 
●●○○ 
Low 
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Evidence Table: Pregnancy  
 
Author/Year Study Design 
Level of Evidence 
Study Purpose/ 
Study Sample 
Study Intervention 
Study Outcome 
Results GRADE 
Quality of 
Evidence 
IATA, 2011 Executive summary of 
the International Air 
Transport Association 
of travel  restrictions 
based on expert 
opinion 
Establish a guide to the 
timeframe that should 
elapse between a 
medical event and 
commercial air travel 
Studies utilized to 
establish 
recommendation were 
not identified in the 
report. 
 
Clearance not required before 
36 weeks for single, 
uncomplicated pregnancy or 
before 32 weeks for multiple, 
uncomplicated pregnancy but 
doctors certificate needed 
after 28 weeks.   
 
Assessment by a doctor with 
aviation medicine experience 
is recommended beyond the 
end of the 32nd week for 
multiple uncomplicated, 
beyond the end of the 36th 
week of Gestation. For single, 
uncomplicated pregnancy, 
and for miscarriage 
(threatened or complete) with 
active bleeding. 
●○○○ 
Very Low 
Magann, 2010 Literature review Purpose: Examine 
current information 
available on air travel 
and pregnancy 
outcomes for the 
frequent air traveler, 
flight attendant and 
female aviator.   
 
Sample: 128 abstracts 
evaluated, 9 of which 
evaluated air travel and 
pregnancy outcomes 
 
Outcomes: spontaneous 
pregnancy loss (SAB), 
intrauterine fetal 
demise (IUFD), low 
birth weight (<10th 
percentile), preterm 
delivery and neonatal 
intensive care unit 
admissions.   
Risk of pregnancy loss (SAB 
or IUFD) was greater in flight 
attendants than controls (OR 
1.52, 95% CI; 1.29, 2.04).  
Meta-analysis of data on SAB 
alone did not reveal 
significant differences in 
flight attendants when 
compared to controls 
 
Risk of preterm birth <37 
weeks greater in passengers 
than controls (OR 1.44, 95% 
CI; 1.07, 1.93) 
 
No increased risk noted for 
preeclampsia, neonatal 
intensive care unit 
admissions, or low birth 
weight noted among groups. 
●●○○ 
Low 
ACOG, 2009 Advisory Committee 
Opinion 
Purpose: Consensus 
statement on risk of air 
travel during pregnancy 
 
Studies utilized to 
establish 
recommendation were 
not identified in the 
report. 
In the absence of obstetric or 
medical complications 
occasional air travel is safe 
for pregnant women. 
●○○○ 
Very Low 
RCOG, 2008 Advisory Committee 
Opinion 
Purpose: Consensus 
statement on risk of air 
travel during pregnancy 
 
Studies utilized to 
establish 
recommendation were 
not identified in the 
There is no specific risk to 
pregnancy associated with air 
travel.  
 
For women with 
uncomplicated pregnancy and 
no medical or obstetric risk 
factors for complications that 
would contraindicate air 
travel, there is no indication 
●○○○ 
Very Low 
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report. 
 
to advice against commercial 
air travel. 
Chibber, 2006 Case-control survey Purpose: Assess 
whether air travel 
increases the risk of 
adverse pregnancy 
outcomes  
 
Subjects: 992 women 
admitted for delivery at 
a Saudi Arabian 
hospital within a 12 
month period.  55% 
(546) traveled at least 
once during pregnancy, 
45% (447) controls 
who did not travel 
 
Outcomes: pre-
eclampsia, vaginal 
bleeding, birth <34 
weeks, birth >34 weeks 
<37 weeks, birth 
weight <10 centile, 
cesarean section, 
admission to NICU, 
stillbirth, and neonatal 
death 
Among primagravidae 
women who traveled by air 
there was an increased risk of 
preterm birth >34 weeks <37 
weeks when compared to 
controls (OR 1.5; 95% CI, 
1.2, 1.8).   
 
Preterm birth was noted to be 
more frequent among 
expatriate women traveling 
long distances and frequent 
flights during pregnancy. 
 
No other outcomes had 
significant increased risk 
between groups 
●●○○ 
Low 
Freeman, 2004 Retrospective analysis Purpose: To evaluate if 
air travel affects 
pregnancy outcome 
 
Subjects: 222 women 
admitted for delivery at 
a gestational age >20 
weeks over a 6-month 
period.  53%  (n=118) 
traveled at least once 
during pregnancy 
 
Outcomes: gestational 
age at delivery, 
neonatal birthweight, 
vaginal bleeding, 
preterm delivery < 37 
weeks, preeclampsia, 
neonatal intensive care 
unit admission or 
cumulative adverse 
obstetric outcome 
There were no statistical 
differences in pregnancy 
outcomes between  traveling 
and non-traveling women 
●●○○ 
Low 
ASMA, 2003 Recommendations 
based on expert 
opinion for primary 
care and specialist 
physicians to advise 
patients with medical 
conditions 
Establish 
recommendations for 
fitness of  pregnant 
passengers with and 
those with other 
medical diseases to fly 
on commercial airlines 
Studies utilized to 
establish 
recommendation were 
not identified in the 
report. 
No increased risk from 
commercial aircraft 
environment to normal 
pregnancy.   
 
 
●○○○ 
Very Low 
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Evidence Table: Psychological Disorders 
 
Author/Year Study Design 
Level of Evidence 
Study Purpose/Study Sample 
Study Intervention 
Study Outcome 
Results GRADE 
Quality of 
Evidence 
IATA, 2011 Executive summary of 
the International Air 
Transport Association 
of travel  restrictions 
based on expert 
opinion 
Establish a guide to the 
timeframe that should elapse 
between a medical event and 
commercial air travel 
 
Studies utilized to establish 
recommendation were not 
identified in the report. 
 
Patients are cleared to 
fly without restriction 
who have the following 
psychiatric conditions: 
 
Chronic psychiatric 
disorders – properly 
controlled by 
medication and stable 
 
Acute psychosis and 
unstable chronic 
psychiatric disorders 
should be assessed by a 
doctor with aviation 
medicine experience 
●○○○ 
Very low 
Bor, 2003 Retrospective study 
 
Evaluation of 487 incidences of 
physical violence on board 
British aircraft.  48%; 
(236/487) involved passengers. 
Use of alcohol 45% and 
illegal smoking in the 
aircraft toilet 36% were 
the two main factors 
 
Disruptive passenger 
profiles were consistent 
over the four year 
reporting period: 
74-78% male 
75% between ages 30-
49 years 
5% business or first 
class passengers 
 
On average 22 
passengers/year 
required physical 
restraint 
●○○○ 
Very low 
ASMA, 2003 Recommendations 
based on expert 
opinion for primary 
care and specialist 
physicians to advise 
patients with medical 
conditions 
Establish recommendations for 
fitness of passengers with 
medical diseases to fly on 
commercial airlines 
Studies utilized to establish 
recommendation were not 
identified in the report. 
 
 
 
Persons with 
psychiatric disorders 
whose behavior is 
unpredictable, 
aggressive, 
disorganized, disruptive 
or unsafe should not 
travel by air.  Patients 
with psychotic 
disorders who are 
stabilized on 
medication and are 
accompanied by a 
knowledgeable 
companion may be able 
to fly. (ASMA, 2003, p. 
A13) 
●○○○ 
Very low 
Smart, 2003 Case Reports Analysis of 29 air rage cases 
reported to Canadian Press 
from 1998-2000 
Use of excessive 
alcohol and tobacco 
smoking were most 
important precipitating 
factors.   
●○○○ 
Very low 
Matsumoto, 2001 Retrospective study Purpose: Ascertain the 
incidence of in-flight 
psychiatric emergencies, their 
associated factors and 
outcomes. 
 
3.5% (48/1375) calls 
were categorized as 
psychiatric 
emergencies. 
 
Mean age of affected 
●○○○ 
Very low 
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Subjects: 1375 in-flight calls 
for physician consultation of 
company providing consult to 
24% of the flights within the 
U.S. during the time of the 
events. 
 
Outcomes: events categorized 
as psychiatric/psychological 
emergencies 
 
 
passenger was 39.6 yr, 
median 35 yr 
 
73% of calls (35/48) 
were for female 
passengers 
 
90% (43/48) were for 
anxiety 
4% (2/48) psychosis 
4% (2/48) non-
psychotic disruptive 
passenger 
2% (1/48) conversion 
disorder 
No incidences of air 
rage or other aggressive 
behaviors were 
reported. 
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Evidence Table: Diabetes 
 
Author/Year Study Design 
Level of Evidence 
Study Purpose/Study 
Sample 
Study Intervention 
Study Outcome 
Results GRADE 
Quality of 
Evidence 
King, 2011 Quasi-experimental Purpose: study the effects 
of atmospheric pressure 
during airplane flight on 
insulin pump delivery 
 
Subjects: 10 insulin 
pumps(5 Animas 2020 
and 5 Medtronic 
Paradigm) 
 
Intervention:  
 
Outcome: insulin delivery 
During ascent both pumps 
delivered excess insulin 
(Animas 1.37 units (u) and 
Medtronic 1.01 u) 
(P<.001) 
 
During descent both 
pumps delivered a deficit 
of insulin (Animas 0.87 u 
and Medtronic 0.58 u) 
(P<0.01) 
 
Unintended insulin 
delivery was determined to 
be due to air coming out of 
the solution and forming 
bubbles when the pressure 
decreased. Bubbles 
displace insulin in the 
pump causing excess 
delivery.  During descent, 
increase in air pressure 
leads to the bubbles 
redissolving which stops 
insulin delivery until the 
deficit is replaced. 
Mechanical function was 
not affected by changes in 
ambient pressure. 
●●●○ 
Moderate 
Hinninghofen, 2006 Two by two repeated 
measurement design 
Simulated in 
hypobaric chamber 
Purpose: To evaluate the 
effects of altitude and diet 
on gastric emptying 
cardiovascular function 
and bodily complaints 
 
Subjects:16 healthy 
volunteer adults 
 
Intervention: Hypobaric 
chamber simulated flight 
altitude of equivalent to 
8200 ft 
Outcomes:   
Heart rate, gastrointestinal 
symptoms of distension, 
bloating, belching and 
gastric emptying assessed 
by 13C-octanoic acid 
breath test. 
Heart rate increased 
throughout the simulation 
independent of the dietary 
condition.  (p=0.011)  
 
At 8200 ft altitude gastric 
emptying was significantly 
delayed when a high-fiber 
meal was given (146.3 ± 
48.4 min low fiber vs. 
193.9 ± 54.3 m high fiber; 
p= 0.039).   
 
The symptom score for 
gastric distention (1.33 ± 
0.3 vs. mean 1.07 ± 0.15; p 
= 0.022) and bloating 
(1.82 ± 0.47 vs. mean 1.34 
± 0.35; p=0.015) were also 
significantly increased at 
8200 ft altitude for the 
high-fiber meal compared 
with the low-fiber meal. 
●●●○ 
Moderate 
Burnett, 2006 Census study self-
administered 
questionnaire 
Purpose: To determine 
types of problems 
experienced by people 
with diabetes mellitus 
while traveling by air 
 
Subjects: 493 (37.1% 
response rate) patients 
using insulin from a clinic 
in Aberdeen UK over a 
94% denied experiencing 
problems related to air 
travel.  Those with 
difficulty noted difficulty 
in obtaining diabetic meals 
ordered or low blood sugar 
due to delay in meal 
delivery. 
 
91% carried food with 
●●○○ 
Low 
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period of 3 months 
 
Outcomes: 
hypoglycemia 
them for the journey.  
More men than women did 
not take additional food (x2 
= 5.54, p = 0.019).   
 
15% of insulin users did 
not inform any airline 
personnel of their diabetes. 
8 patients (x2 = 4.84, p = 
0.028) did not carry 
identification of their 
disease on their person. 
 
20.1% of long-haul 
travelers and 32.1% of 
short-haul travelers 
experienced delays.  10% 
of delayed travelers 
experienced difficulties 
due to late meals as a 
result of the delay. 
 
10.2% of both long and 
short haul travelers 
experienced hypoglycemia 
while traveling abroad and 
for the first 24 hours after 
arrival.  Hypoglycemia 
was more likely to be 
delayed until the first 8 
hours after arrival at the 
destination in the long-
haul group and was less 
likely to be severe. 31% of 
those experiencing 
hypoglycemic  
symptoms described them 
as severe and requiring 
help. 
 
Hyperglycemia while 
traveling was more likely 
to occur in long-haul 
travelers than short-haul 
travelers (x2 = 10.1, 
p=0.00) 
 
50% of long-haul and 
41.6% of short-haul 
travelers sought advice 
about managing their 
diabetes while traveling 
ASMA, 2003 Recommendations 
based on expert 
opinion for primary 
care and specialist 
physicians to advise 
patients with medical 
conditions 
Establish 
recommendations for 
fitness of passengers with 
medical diseases and 
conditions to fly on 
commercial airlines 
Studies utilized to 
establish recommendation 
were not identified in the 
report. 
 
 
Diabetic travelers under 
reasonable control can fly 
anywhere safely if they 
plan in advance and 
discuss the proposed 
journey with their 
healthcare provider.   
 
Travel crossing several 
time zones and depending 
on the direction traveled 
may shorten or lengthen 
the 24 hour day which 
may require adjustments in 
insulin regimens. 
 
The use of short-acting 
soluble insulin or fast-
●○○○ 
Very low 
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acting insulin analogues 
during long flights is 
recommended. 
 
Traveling east the day is 
shortened by 2 hours and 
there may be the need to 
take fewer units of 
intermediate or long acting 
insulin.  Conversely 
traveling west may require 
supplemental injections or 
increased dosing of 
insulin. 
 
On the first morning of 
eastbound travel at the end 
destination 2/3 dose of the 
usual morning dose of 
insulin should be taken to 
account for the decreased 
hours since the previous 
morning’s injection.   
When traveling 
westbound, no adjustments 
in daily dosing need to be 
made. 
 
Type 1 diabetics should 
carry additional 
carbohydrate to cover 
meal delayed meals, 
should consider alerting 
flight crew to their 
condition and should have 
accessible identification on 
their person. 
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 APPENDIX G: CLINICAL PRACTICE GUIDELINE 
Guideline Title 
 
Guideline for Passenger Fitness to Fly Evaluation in Primary Care 
 
Bibliographic Source 
 
 Pending acceptance by peer-reviewed journal 
 
Guideline Status 
 
This is the current recommendation report pending review by expert panel prior to 
dissemination. 
 
FDA Warning/Regulatory Alert 
 
Not applicable as no drugs or devices are recommended in this guideline 
  
Scope 
 
Disease/Condition(s) 
 Cardiovascular disease (CVD) 
 Pulmonary disease 
 Deep Vein Thrombosis/Venous Thromboembolism 
 Neurologic disease 
 Ear, eye, nose and throat disease 
 Pregnancy 
 Psychiatric disorders 
 Diabetes mellitus 
 
Guideline Category 
  Counseling 
 Evaluation 
 Management 
 Prevention 
 Risk Assessment 
 Screening 
 
Clinical Specialty 
 Family Practice 
 Internal Medicine 
 Obstetrics 
 Pediatrics 
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 Preventive Medicine 
 Travel Medicine 
 
Intended Users 
 Advanced Practice Nurses 
 Health Care Providers 
 Physician Assistants 
 Physicians 
  
Guideline Objective 
 To identify medical conditions that may be affected by the physiologic and 
pathologic effects of commercial air travel 
 To assist the primary care provider in making fitness to fly decisions to improve 
practice 
 
Target Population 
Any patient planning commercial air travel particularly those with pre-existing 
medical conditions 
 
Interventions and Practices Considered 
1. Screening for pre-existing medical conditions that may be adversely affected by 
commercial air travel 
2. Assessment of fitness to fly 
 
Management/Prevention 
1. Management of specific patient populations 
 Patients with cardiovascular conditions 
 Patients with respiratory conditions 
 Patients with risk for venous thromboembolism 
 Patients with neurologic conditions 
 Patients with eye, ear, nose and throat conditions 
 Patients who are pregnant 
 Patients with psychiatric conditions 
 
Major Outcomes Considered 
 Morbidity and Mortality associated with commercial air travel 
 Quality of life 
 Adherence to lifestyle modifications           
 
Methodology 
Methods Used to Collect/Select the Evidence 
             
Searches of Electronic Databases 
 
Description of Methods Used to Collect/Select the Evidence 
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Medline, PubMed, the Cochrane Library CINAHL (EBSCOHost), and other 
electronic sources for admissible evidence or studies published between February 
2001 and February 2012.  Search terms included  air, plane, aircraft, travel, 
airline, fitness to fly, commercial air, hypoxia, hypoxemia, pre-flight, post-flight, 
cardiovascular, circulatory, blood, hematology, anemia, pulmonary, COPD, 
respiratory, asthma, restrictive lung, non-restrictive lung, neurologic, neurology, 
central nervous system, gastrointestinal, abdomen, ear, nose, throat, psychiatric, 
anxiety, psychosis, eye, ophthalmologic, pregnancy, children, pediatric, 
orthopedic, surgical, surgery, trauma, disease, infection, pain, and prevention.  
Identified studies were limited to those written in English or with available 
English translations.  Expert opinion and guidelines developed by other sources 
were included in the guideline development and all efforts were be made to 
correlate opinion and published guidelines to primary sources of research.   
Number of Source Documents 
 
72 articles were included in the evidence review. 
 
Methods Used to Assess the Quality and Strength of the Evidence 
              
Weighting according to the Rating Scheme (Scheme Given) 
 
Rating Scheme for the Strength of the Evidence 
 
Level of evidence Qualifying Studies 
High (4) 
●●●● 
 
High-quality, multi-centered or single-centered, randomized 
controlled trial with adequate power; or a systematic review of these 
studies 
Moderate (3) 
●●●○ 
Lesser-quality, randomized controlled trial; prospective cohort study; 
or a systematic review of these studies 
Low (2) 
●●○○ 
Retrospective comparative study, case-control study or a systematic 
review of these studies 
Very Low (1) 
●○○○ 
Case reports, expert opinion or evidence based on physiology 
 *Evidence level can be increased or decreased based upon study quality directness and    
strength of association. 
 
Methods Used to Analyze the Evidence 
 
Systematic Review 
 
Description of the Methods Used to Analyze the Evidence 
 
The supporting literature was critically appraised for study quality according to 
criteria referenced in key publications on evidence-based practice.  Depending on 
the study design and quality, each reference was assigned a corresponding level of 
evidence (High-Low) and the evidence was synthesized into practice 
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recommendations.   
 
Methods Used to Formulate Recommendations 
Expert Consensus (pending) 
 
Description of Methods Used to Formulate Recommendations 
Systematic Review 
 
Rating Scheme for the Strength of the Recommendations 
 
Grade Descriptor Qualifying 
Evidence 
Implications for 
practice 
A Strong 
Recommendation 
Level 4 evidence or 
consistent findings 
from multiple studies of 
levels 3, 2 or 1 
Primary care providers 
should follow a strong 
recommendation unless 
a clear and compelling 
rationale for alternative 
approach is present 
B Recommendation Levels 3, 2 or 1 
evidence and findings 
are generally consistent 
Primary care providers 
should follow a 
recommendation but 
should monitor new 
information and be 
sensitive to patient 
preference. 
C Option Levels 3, 2 or 1 
evidence and findings 
are inconsistent 
Primary care providers 
hold be flexible in their 
decision-making 
regarding appropriate 
practice, although they 
may set bounds on 
alternatives; patient 
preference should have 
a substantial 
influencing role. 
D Option Little or no systematic 
empirical evidence 
Primary care providers 
should consider all 
options in their 
decision-making and 
monitor for new 
published evidence that 
clarifies the risk versus 
benefit; patient 
preference should have 
a substantial 
influencing role. 
 
 
Cost Analysis 
 
A cost analysis was not performed and published cost analyses wee not reviewed. 
 
Method of Guideline Validation 
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Comparison with guidelines from other groups 
External peer review 
Internal peer review 
 
Description of Method of Guideline Validation 
 
The guideline will be submitted for approval by the International Society of 
Travel Medicine. 
 
Recommendations 
 
Major Recommendations 
Definitions for the levels of evidence (1-4) and the grades of the recommendations (A-D) 
are provided at the end of the “Major Recommendations” field (Appendix G). 
 
Recommendations Supporting Evidence Grade 
Cardiovascular Conditions/Disorders 
 Patients with hemodynamically stable, 
asymptomatic cardiac conditions without recent 
changes in symptoms or medications should not be 
restricted from travel by commercial air 
 Chronic Heart Failure – clear to fly if able to climb 
one flight of stairs or walk 50 meters at normal 
pace without breathlessness.  Flying 
contraindicated for severe, decompensated 
conditions.  Consider supplemental O2 for NYHA 
class IV or those with comorbid conditions which 
may impact oxygenation. 
 Cardiac Surgery – travel should be delayed for at 
least 10 days post operatively without 
complications.  Additional ground support may be 
needed to meet the travel to/within/from the 
airport. 
 Angiography – cleared to fly ≥ 24 hours after 
procedure if condition is stable 
 Angioplasty -  cleared to fly ≥ 3 days after 
procedure if asymptomatic 
 Eisenmenger Syndrome – consider O2 in flight  
 Cardiac conditions or procedures requiring 
anticoagulation – delay travel until stable 
anticoagulation levels achieved  
 Pacemakers and ICDs – delay travel one days post 
placement if asymptomatic and no pneumothorax 
 
** Supplemental and in-flight oxygen should be 
considered to meet the additional physical demands of 
travel to/within/from the airport to destination as well 
as for potential hypoxemia associated with hypobaric 
aircraft cabin conditions for any patient with labile 
health condition or with cormobidity that may affect 
oxygenation. 
Ingle et al., 2011;  IATA, 2011;  
Smith et al., 2010; ASMA, 2003; 
Roby, Lee, & Hopkins, 2002; 
Zahger, Leibowitz, Tabb & Weiss, 
2000 
    C 
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Recommendations Supporting Evidence Grade 
Respiratory Conditions/Disorders 
 Patients with stable, asymptomatic respiratory 
conditions  with full recovery from any 
exacerbation and an exercise tolerance of >50 
meters without dyspnea can be cleared to fly 
without restrictions 
 Pneumothorax and pleural effusion- delay travel 
for at least 7 days after full inflation 
 Chest surgery – clear to travel once free from 
residual air. 
 Pulmonary arteriovenous malformation (PAVM) 
and pulmonary cysts – advise significant caution 
against travel by air due to high risk for venous 
thromboembolism (VTE), stroke and sudden death. 
 Any condition where pre-flight SpO2 <89% of 
PaO2 <70 mmHg, in-flight oxygen should be 
considered 
 
** Supplemental and in-flight oxygen should be 
considered to meet the additional physical demands of 
travel to/within/from the airport to destination as well 
as for potential hypoxemia associated with hypobaric 
aircraft cabin conditions for any patient with labile 
health condition or with comobidity that may affect 
oxygenation. 
Akero et al., 2011; Tam et al., 2011; 
Bossley et al.,  2011; Edvardsen et 
al., 2011; IATA, 2011; Thamm et al., 
2011; Ahmedzai et al., 2011; 
Tiemensma, Buys & Wadee, 2010; 
Lapostolle et al., 2009; Kelly et al., 
2009; Lehmann et al., 2009; Taveira-
DaSilva et al, 2009; Martin et al, 
2008; Kelly et al., 2008; Jones et al, 
2008; Broberg et al, 2007; Currie, 
Kennedy, Paterson, & Watt, 2007; 
Udomittipong et al., 2006; Kelly et 
al., 2006; Almeida et al., 2006; 
Humphreys et al., 2005; Closon et 
al., 2004; ASMA, 2003; Lee, 
Yamamoto, & Relles, 2002 
     C 
 
 
Recommendations Supporting Evidence Grade 
Venous Thromboembolism Risk 
 Prior history of Cerebral emboli, PE, VTE or DVT 
should have ultrasound screening before clearance 
to fly to rule out presence of asymptomatic 
thrombus 
 Patients on anticoagulation therapy should be 
stable at therapeutic level before clearance to fly 
 Flight times or multiple short leg air travel >4 
hours within 4 weeks increases risk of VTE 2-4 
fold 
MacCallum et al., 2011; Schreijer, et 
al, 2010; Chandra et al., 2009; 
Schreijer et al., 2008; Kuipers et all, 
2007; WHO, 2007; Philbrick et al., 
2006; Aryal et al., 2006; Schwarz et 
al., 2003; Jacobson et al., 2003 
     B 
 
Anemia and Bleeding disorders 
 Caution should be advised to patients with 
hemoglobin levels below 8.5 g /dl due to increased 
risk of lightheadedness or loss of consciousness 
during flight, particularly with physical exertion 
during flight. 
 Patients with Sickle cell disease need to be made 
aware that their condition can be exacerbated by 
reduced oxygen pressures during flight. Because 
such a crisis could be life-threatening, sickle cell 
patients should be advised not to travel by air 
without medical oxygen. 
IATA, 2011 & ASMA, 2003      D 
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Neurologic Disorders 
 Stable CNS disorders without recent exacerbation 
or prior history of event associated with air travel 
do not require restrictions. 
 History of CNS changes in prior air travel should 
be a contraindication for travel until complete 
cardiopulmonary and CNS examination has been 
performed 
 CVA – delay travel at least two weeks post event 
unless medically escorted with supplemental O2 
 Seizure Disorder/Epilepsy – clear to fly if stable on 
medications and no recent change in dosage.  
Caution patient regarding seizure-threshold 
lowering effects of ETOH, fatigue, delayed meals, 
hypoxia and disturbed circadian rhythm.  Advise 
patient to carry identification and medication on 
person during travel. 
 Headache (in absence of migraine history or other 
CNS disorder) associated with ascent/descent may 
respond to Naproxen 550 mg po one hour before 
take-off 
MacCallum et al., 2011; Schreijer, et 
al, 2010; Chandra et al., 2009; 
Schreijer et al., 2008; Kuipers et all, 
2007; WHO, 2007; Philbrick et al., 
2006; Aryal et al., 2006; Schwarz et 
al., 2003; Jacobson et al., 2003 
     C 
 
Ophthalmology, Otolaryngology & Allergy 
 Cataract or corneal laser surgery – delay travel for 
24 hours after procedure 
 Intra-ocular surgery or penetrating eye injury – 
delay travel for 7 days after injury or procedure 
 Ophthalmologic conditions negatively affected by 
changes in intra-ocular pressure should avoid 
travel 
 Orbital, zygomatic or sinus surgery – delay travel 
until bleeding risk controlled and cleared by 
surgeon 
 Tonsillectomy delay travel for at least 4 days after 
surgery or control of active bleeding 
 Patients with known significant allergy-sensitive 
conditions should travel with antihistamines and 
epinephrine as medically indicated.    
 Passengers with pet allergies should be aware of 
the possible contact or inhalation of pet dander 
from cabin-traveling animals.  
 Passengers with peanut, nut or seed allergies can 
avoid potential inhalation exposure by requesting 
information in advance from the airline.  Note, as 
many passengers are now carrying food on planes, 
the likelihood of inhalation exposure can still exist. 
IATA, 2011; Bayer et al., 2008; 
Comstock et al., 2008; Mahmood et 
al., 2003; ASMA, 2003; Monaghan 
et al., 2002; Jassar et al., 2001; Mills 
et al., 2001 
     D 
 
Pregnancy 
 Pregnancy is not a contraindication for air travel 
*Airlines may require clearance to fly for pregnant 
women >28 week gestation.   
**The availability of OB/GYN services at the travel 
destinations should be weighted into passenger’s 
decision to travel by air. 
IATA, 2011; Magann et al., 2010; 
ACOG, 2009; RCOG, 2008; Chibber 
et al., 2006; Freeman et al., 2004, 
ASMA, 2003 
     B 
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Psychiatric Disorders 
 A stable, controlled, psychiatric condition is not a 
contraindication to air travel.  Acute psychosis and 
unstable chronic psychiatric disorders should be 
assessed by a doctor with aviation medicine 
experience 
IATA, 2011; Bor et al, 2003; ASMA, 
2003; Smart et al., 2003; Matsumoto 
et al., 2001 
     D 
 
Diabetes Mellitus 
 Patients with diabetes controlled by insulin pump 
should monitor blood sugars closely during travel 
by air 
 Diabetics should carry medical condition 
identification, medications and on person 
 King et al., 2011; Hinninghofen 
et al, 2006; Burnett et al., 2006; 
ASMA, 2003 
 D 
 
Definitions: 
 
Evidence Rating Scale for Studies Reviewed 
Level of evidence Qualifying Studies 
High (4) 
●●●● 
 
High-quality, multi-centered or single-centered, randomized controlled trial with adequate power; or a 
systematic review of these studies 
Moderate (3) 
●●●○ 
Lesser-quality, randomized controlled trial; prospective cohort study; or a systematic review of these 
studies 
Low (2) 
●●○○ 
Retrospective comparative study, case-control study or a systematic review of these studies 
Very Low (1) 
●○○○ 
Case reports, expert opinion or evidence based on physiology 
 
Scale for Grading Recommendations 
Grade Descriptor Qualifying Evidence Implications for practice 
A Strong Recommendation Level 4 evidence or 
consistent findings from 
multiple studies of levels 3, 2 
or 1 
Primary care providers should follow a strong 
recommendation unless a clear and 
compelling rationale for alternative approach 
is present 
B Recommendation Levels 3, 2 or 1 evidence and 
findings are generally 
consistent 
Primary care providers should follow a 
recommendation but should monitor new 
information and be sensitive to patient 
preference. 
C Option Levels 3, 2 or 1 evidence and 
findings are inconsistent 
Primary care providers hold be flexible in 
their decision-making regarding appropriate 
practice, although they may set bounds on 
alternatives; patient preference should have a 
substantial influencing role. 
D Option Little or no systematic 
empirical evidence 
Primary care providers should consider all 
options in their decision-making and monitor 
for new published evidence that clarifies the 
risk versus benefit; patient preference should 
have a substantial influencing role. 
 
Clinical Algorithm(s) 
None provided 
 
Evidence Supporting the Recommendations 
 
References Supporting the Recommendations 
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Types of Evidence Supporting the Recommendations 
 
The type of supporting evidence is identified and graded for each 
recommendation (see “Major Recommendations”). 
 
Benefits/Harms of Implementing the Guideline Recommendations 
 
Potential Benefits 
 
These guidelines will assist primary care providers in the screening and clinical 
decision-making regarding clearance to fly for their patients with pre-existing 
medical conditions that may be adversely affected by commercial air travel. 
 
Potential Harms 
 
Risks inherent in commercial air travel, which can be minimized through 
appropriate patient screening and adherence to recommended practices.   
 
Qualifying Statement 
 
The recommendations are provided only as assistance to primary care providers 
making clinical decisions regarding the care of their patients by providing a 
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framework for screening and assessment.  It is not intended to replace or 
substitute for individual provider judgment made in each clinical situation.   
 
The recommendations reflect the best understanding of the science of medicine 
available at the time of publication.  Guideline implementation should be used 
with the clear understanding that continued research may result in new knowledge 
and recommendations. 
 
This guideline has several limitations, largely due to the paucity of clinical 
research in the areas and limitations in the available evidence base.  Further 
research is needed to establish more accurate incidence of morbidity and mortality 
as well as improved methods of screening for fitness to fly. 
 
Implementation of the Guideline 
 
An implementation strategy is pending peer review. 
 
Institute of Medicine (IOM) National Healthcare Quality Report Categories 
 
IOM Care Need 
 
Living with Illness 
 
Staying Healthy 
 
IOM Domain 
 
 Effectiveness 
 
 Patient-centeredness 
 
Identifying Information and Availability 
 
Pending peer review and approval of guidelines 
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